id	sid	tid	token	lemma	pos
bjos-8668473	1	1	1	1	NUM
bjos-8668473	1	2	volume	volume	NOUN
bjos-8668473	1	3	22	22	NUM
bjos-8668473	1	4	2023	2023	NUM
bjos-8668473	1	5	e238473	e238473	NUM
bjos-8668473	1	6	original	original	ADJ
bjos-8668473	1	7	article	article	NOUN
bjos-8668473	1	8	braz	braz	PROPN
bjos-8668473	1	9	j	j	PROPN
bjos-8668473	1	10	oral	oral	PROPN
bjos-8668473	1	11	sci	sci	PROPN
bjos-8668473	1	12	.	.	PUNCT
bjos-8668473	2	1	2023;22	2023;22	NUM
bjos-8668473	2	2	:	:	PUNCT
bjos-8668473	2	3	e238473http://dx.doi.org/10.20396	e238473http://dx.doi.org/10.20396	SYM
bjos-8668473	2	4	/	/	SYM
bjos-8668473	2	5	bjos.v22i00.8668473	bjos.v22i00.8668473	NOUN
bjos-8668473	2	6	1	1	NUM
bjos-8668473	2	7	department	department	NOUN
bjos-8668473	2	8	of	of	ADP
bjos-8668473	2	9	pathology	pathology	PROPN
bjos-8668473	2	10	,	,	PUNCT
bjos-8668473	2	11	federal	federal	ADJ
bjos-8668473	2	12	university	university	PROPN
bjos-8668473	2	13	of	of	ADP
bjos-8668473	2	14	santa	santa	PROPN
bjos-8668473	2	15	maria	maria	PROPN
bjos-8668473	2	16	,	,	PUNCT
bjos-8668473	2	17	santa	santa	PROPN
bjos-8668473	2	18	maria	maria	PROPN
bjos-8668473	2	19	,	,	PUNCT
bjos-8668473	2	20	rs	rs	PROPN
bjos-8668473	2	21	,	,	PUNCT
bjos-8668473	2	22	brazil	brazil	PROPN
bjos-8668473	2	23	.	.	PUNCT
bjos-8668473	3	1	2	2	NUM
bjos-8668473	3	2	department	department	NOUN
bjos-8668473	3	3	of	of	ADP
bjos-8668473	3	4	chemistry	chemistry	NOUN
bjos-8668473	3	5	,	,	PUNCT
bjos-8668473	3	6	federal	federal	ADJ
bjos-8668473	3	7	university	university	PROPN
bjos-8668473	3	8	of	of	ADP
bjos-8668473	3	9	santa	santa	PROPN
bjos-8668473	3	10	maria	maria	PROPN
bjos-8668473	3	11	,	,	PUNCT
bjos-8668473	3	12	santa	santa	PROPN
bjos-8668473	3	13	maria	maria	PROPN
bjos-8668473	3	14	,	,	PUNCT
bjos-8668473	3	15	rs	rs	PROPN
bjos-8668473	3	16	,	,	PUNCT
bjos-8668473	3	17	brazil	brazil	PROPN
bjos-8668473	3	18	.	.	PUNCT
bjos-8668473	4	1	3	3	NUM
bjos-8668473	4	2	dentistry	dentistry	NOUN
bjos-8668473	4	3	school	school	NOUN
bjos-8668473	4	4	,	,	PUNCT
bjos-8668473	4	5	federal	federal	ADJ
bjos-8668473	4	6	university	university	PROPN
bjos-8668473	4	7	of	of	ADP
bjos-8668473	4	8	santa	santa	PROPN
bjos-8668473	4	9	maria	maria	PROPN
bjos-8668473	4	10	,	,	PUNCT
bjos-8668473	4	11	santa	santa	PROPN
bjos-8668473	4	12	maria	maria	PROPN
bjos-8668473	4	13	,	,	PUNCT
bjos-8668473	4	14	rs	rs	PROPN
bjos-8668473	4	15	,	,	PUNCT
bjos-8668473	4	16	brazil	brazil	PROPN
bjos-8668473	4	17	.	.	PUNCT
bjos-8668473	5	1	corresponding	correspond	VERB
bjos-8668473	5	2	author	author	NOUN
bjos-8668473	5	3	:	:	PUNCT
bjos-8668473	5	4	kívia	kívia	PROPN
bjos-8668473	5	5	linhares	linhare	NOUN
bjos-8668473	5	6	ferrazzo	ferrazzo	VERB
bjos-8668473	5	7	roraima	roraima	PROPN
bjos-8668473	5	8	avenue	avenue	PROPN
bjos-8668473	5	9	,	,	PUNCT
bjos-8668473	5	10	1000	1000	NUM
bjos-8668473	5	11	,	,	PUNCT
bjos-8668473	5	12	building	build	VERB
bjos-8668473	5	13	20	20	NUM
bjos-8668473	5	14	;	;	PUNCT
bjos-8668473	5	15	cep	cep	NOUN
bjos-8668473	5	16	:	:	PUNCT
bjos-8668473	5	17	97105	97105	NUM
bjos-8668473	5	18	-	-	SYM
bjos-8668473	5	19	900	900	NUM
bjos-8668473	5	20	;	;	PUNCT
bjos-8668473	5	21	santa	santa	PROPN
bjos-8668473	5	22	maria	maria	PROPN
bjos-8668473	5	23	/	/	SYM
bjos-8668473	5	24	rs	rs	PROPN
bjos-8668473	5	25	–	–	PUNCT
bjos-8668473	5	26	brazil	brazil	PROPN
bjos-8668473	5	27	phone	phone	NOUN
bjos-8668473	5	28	:	:	PUNCT
bjos-8668473	5	29	55	55	NUM
bjos-8668473	5	30	(	(	PUNCT
bjos-8668473	5	31	55	55	NUM
bjos-8668473	5	32	)	)	PUNCT
bjos-8668473	5	33	99131	99131	NUM
bjos-8668473	5	34	-	-	SYM
bjos-8668473	5	35	7537	7537	NUM
bjos-8668473	5	36	;	;	PUNCT
bjos-8668473	5	37	fax	fax	NOUN
bjos-8668473	5	38	:	:	PUNCT
bjos-8668473	5	39	55	55	NUM
bjos-8668473	5	40	(	(	PUNCT
bjos-8668473	5	41	55	55	NUM
bjos-8668473	5	42	)	)	SYM
bjos-8668473	5	43	3225	3225	NUM
bjos-8668473	5	44	-	-	SYM
bjos-8668473	5	45	3353	3353	NUM
bjos-8668473	5	46	email	email	NOUN
bjos-8668473	5	47	:	:	PUNCT
bjos-8668473	5	48	kivialinhares@uol.com.br	kivialinhares@uol.com.br	PROPN
bjos-8668473	5	49	editor	editor	NOUN
bjos-8668473	5	50	:	:	PUNCT
bjos-8668473	5	51	altair	altair	PROPN
bjos-8668473	5	52	a.	a.	PROPN
bjos-8668473	5	53	del	del	PROPN
bjos-8668473	5	54	bel	bel	PROPN
bjos-8668473	5	55	cury	cury	PROPN
bjos-8668473	5	56	received	receive	VERB
bjos-8668473	5	57	:	:	PUNCT
bjos-8668473	5	58	feb	feb	PROPN
bjos-8668473	5	59	18	18	NUM
bjos-8668473	5	60	,	,	PUNCT
bjos-8668473	5	61	2022	2022	NUM
bjos-8668473	5	62	accepted	accept	VERB
bjos-8668473	5	63	:	:	PUNCT
bjos-8668473	5	64	jan	jan	PROPN
bjos-8668473	5	65	10	10	NUM
bjos-8668473	5	66	,	,	PUNCT
bjos-8668473	5	67	2023	2023	NUM
bjos-8668473	5	68	sensitivity	sensitivity	NOUN
bjos-8668473	5	69	and	and	CCONJ
bjos-8668473	5	70	specificity	specificity	NOUN
bjos-8668473	5	71	of	of	ADP
bjos-8668473	5	72	salivary	salivary	ADJ
bjos-8668473	5	73	pipecolic	pipecolic	NOUN
bjos-8668473	5	74	acid	acid	NOUN
bjos-8668473	5	75	in	in	ADP
bjos-8668473	5	76	head	head	NOUN
bjos-8668473	5	77	and	and	CCONJ
bjos-8668473	5	78	neck	neck	VERB
bjos-8668473	5	79	squamous	squamous	ADJ
bjos-8668473	5	80	cell	cell	NOUN
bjos-8668473	5	81	carcinoma	carcinoma	NOUN
bjos-8668473	5	82	kívia	kívia	VERB
bjos-8668473	5	83	linhares	linhare	NOUN
bjos-8668473	5	84	ferrazzo1	ferrazzo1	PROPN
bjos-8668473	5	85	,	,	PUNCT
bjos-8668473	5	86	larissa	larissa	PROPN
bjos-8668473	5	87	daiane	daiane	PROPN
bjos-8668473	5	88	willrich	willrich	PROPN
bjos-8668473	5	89	de	de	PROPN
bjos-8668473	5	90	melo2	melo2	PROPN
bjos-8668473	5	91	,	,	PUNCT
bjos-8668473	5	92	cristiane	cristiane	PROPN
bjos-8668473	5	93	cademartori	cademartori	PROPN
bjos-8668473	5	94	danesi1	danesi1	PROPN
bjos-8668473	5	95	,	,	PUNCT
bjos-8668473	5	96	alexander	alexander	PROPN
bjos-8668473	5	97	thomas3	thomas3	PROPN
bjos-8668473	5	98	,	,	PUNCT
bjos-8668473	5	99	laura	laura	PROPN
bjos-8668473	5	100	izabel	izabel	VERB
bjos-8668473	5	101	lampert	lampert	PROPN
bjos-8668473	5	102	bonzanini3	bonzanini3	PROPN
bjos-8668473	5	103	,	,	PUNCT
bjos-8668473	5	104	nilo	nilo	PROPN
bjos-8668473	5	105	zanatta2	zanatta2	NOUN
bjos-8668473	5	106	aim	aim	VERB
bjos-8668473	5	107	:	:	PUNCT
bjos-8668473	5	108	the	the	DET
bjos-8668473	5	109	aim	aim	NOUN
bjos-8668473	5	110	of	of	ADP
bjos-8668473	5	111	the	the	DET
bjos-8668473	5	112	present	present	ADJ
bjos-8668473	5	113	preliminary	preliminary	ADJ
bjos-8668473	5	114	case	case	NOUN
bjos-8668473	5	115	-	-	PUNCT
bjos-8668473	5	116	control	control	NOUN
bjos-8668473	5	117	study	study	NOUN
bjos-8668473	5	118	was	be	AUX
bjos-8668473	5	119	to	to	PART
bjos-8668473	5	120	test	test	VERB
bjos-8668473	5	121	the	the	DET
bjos-8668473	5	122	sensitivity	sensitivity	NOUN
bjos-8668473	5	123	and	and	CCONJ
bjos-8668473	5	124	specificity	specificity	NOUN
bjos-8668473	5	125	of	of	ADP
bjos-8668473	5	126	salivary	salivary	ADJ
bjos-8668473	5	127	pipecolic	pipecolic	NOUN
bjos-8668473	5	128	acid	acid	NOUN
bjos-8668473	5	129	in	in	ADP
bjos-8668473	5	130	predicting	predict	VERB
bjos-8668473	5	131	head	head	NOUN
bjos-8668473	5	132	and	and	CCONJ
bjos-8668473	5	133	neck	neck	VERB
bjos-8668473	5	134	squamous	squamous	ADJ
bjos-8668473	5	135	cell	cell	NOUN
bjos-8668473	5	136	carcinoma	carcinoma	NOUN
bjos-8668473	5	137	(	(	PUNCT
bjos-8668473	5	138	hnscc	hnscc	NOUN
bjos-8668473	5	139	)	)	PUNCT
bjos-8668473	5	140	.	.	PUNCT
bjos-8668473	6	1	methods	method	NOUN
bjos-8668473	6	2	:	:	PUNCT
bjos-8668473	6	3	high	high	ADJ
bjos-8668473	6	4	-	-	PUNCT
bjos-8668473	6	5	performance	performance	NOUN
bjos-8668473	6	6	liquid	liquid	ADJ
bjos-8668473	6	7	chromatography	chromatography	NOUN
bjos-8668473	6	8	was	be	AUX
bjos-8668473	6	9	used	use	VERB
bjos-8668473	6	10	for	for	ADP
bjos-8668473	6	11	the	the	DET
bjos-8668473	6	12	analysis	analysis	NOUN
bjos-8668473	6	13	of	of	ADP
bjos-8668473	6	14	non	non	ADJ
bjos-8668473	6	15	-	-	ADJ
bjos-8668473	6	16	stimulated	stimulated	ADJ
bjos-8668473	6	17	saliva	saliva	NOUN
bjos-8668473	6	18	samples	sample	NOUN
bjos-8668473	6	19	from	from	ADP
bjos-8668473	6	20	40	40	NUM
bjos-8668473	6	21	individuals	individual	NOUN
bjos-8668473	6	22	:	:	PUNCT
bjos-8668473	6	23	20	20	NUM
bjos-8668473	6	24	in	in	ADP
bjos-8668473	6	25	the	the	DET
bjos-8668473	6	26	case	case	NOUN
bjos-8668473	6	27	group	group	NOUN
bjos-8668473	6	28	(	(	PUNCT
bjos-8668473	6	29	recently	recently	ADV
bjos-8668473	6	30	diagnosed	diagnose	VERB
bjos-8668473	6	31	with	with	ADP
bjos-8668473	6	32	untreated	untreated	ADJ
bjos-8668473	6	33	hnscc	hnscc	NOUN
bjos-8668473	6	34	)	)	PUNCT
bjos-8668473	6	35	and	and	CCONJ
bjos-8668473	6	36	20	20	NUM
bjos-8668473	6	37	in	in	ADP
bjos-8668473	6	38	the	the	DET
bjos-8668473	6	39	control	control	NOUN
bjos-8668473	6	40	group	group	NOUN
bjos-8668473	6	41	(	(	PUNCT
bjos-8668473	6	42	individuals	individual	NOUN
bjos-8668473	6	43	without	without	ADP
bjos-8668473	6	44	cancer	cancer	NOUN
bjos-8668473	6	45	)	)	PUNCT
bjos-8668473	6	46	.	.	PUNCT
bjos-8668473	7	1	both	both	DET
bjos-8668473	7	2	groups	group	NOUN
bjos-8668473	7	3	included	include	VERB
bjos-8668473	7	4	patients	patient	NOUN
bjos-8668473	7	5	taking	take	VERB
bjos-8668473	7	6	daily	daily	ADJ
bjos-8668473	7	7	oral	oral	ADJ
bjos-8668473	7	8	hypoglycemic	hypoglycemic	ADJ
bjos-8668473	7	9	drugs	drug	NOUN
bjos-8668473	7	10	(	(	PUNCT
bjos-8668473	7	11	comorbidity	comorbidity	NOUN
bjos-8668473	7	12	)	)	PUNCT
bjos-8668473	7	13	.	.	PUNCT
bjos-8668473	8	1	the	the	DET
bjos-8668473	8	2	case	case	NOUN
bjos-8668473	8	3	and	and	CCONJ
bjos-8668473	8	4	control	control	NOUN
bjos-8668473	8	5	groups	group	NOUN
bjos-8668473	8	6	were	be	AUX
bjos-8668473	8	7	matched	match	VERB
bjos-8668473	8	8	at	at	ADP
bjos-8668473	8	9	a	a	DET
bjos-8668473	8	10	proportion	proportion	NOUN
bjos-8668473	8	11	of	of	ADP
bjos-8668473	8	12	1:1	1:1	NUM
bjos-8668473	8	13	for	for	ADP
bjos-8668473	8	14	sex	sex	NOUN
bjos-8668473	8	15	and	and	CCONJ
bjos-8668473	8	16	comorbidity	comorbidity	NOUN
bjos-8668473	8	17	.	.	PUNCT
bjos-8668473	9	1	results	result	NOUN
bjos-8668473	9	2	:	:	PUNCT
bjos-8668473	9	3	mean	mean	VERB
bjos-8668473	9	4	salivary	salivary	ADJ
bjos-8668473	9	5	levels	level	NOUN
bjos-8668473	9	6	of	of	ADP
bjos-8668473	9	7	pipecolic	pipecolic	NOUN
bjos-8668473	9	8	acid	acid	NOUN
bjos-8668473	9	9	were	be	AUX
bjos-8668473	9	10	169.38	169.38	NUM
bjos-8668473	9	11	ng/	ng/	VERB
bjos-8668473	9	12	ml	ml	ADV
bjos-8668473	9	13	in	in	ADP
bjos-8668473	9	14	the	the	DET
bjos-8668473	9	15	case	case	NOUN
bjos-8668473	9	16	group	group	NOUN
bjos-8668473	9	17	and	and	CCONJ
bjos-8668473	9	18	114.66	114.66	NUM
bjos-8668473	9	19	ng	ng	PROPN
bjos-8668473	9	20	/	/	SYM
bjos-8668473	9	21	ml	ml	NOUN
bjos-8668473	9	22	in	in	ADP
bjos-8668473	9	23	the	the	DET
bjos-8668473	9	24	control	control	NOUN
bjos-8668473	9	25	group	group	NOUN
bjos-8668473	9	26	(	(	PUNCT
bjos-8668473	9	27	p<0.001	p<0.001	PROPN
bjos-8668473	9	28	)	)	PUNCT
bjos-8668473	9	29	.	.	PUNCT
bjos-8668473	10	1	individuals	individual	NOUN
bjos-8668473	10	2	who	who	PRON
bjos-8668473	10	3	took	take	VERB
bjos-8668473	10	4	oral	oral	ADJ
bjos-8668473	10	5	hypoglycemic	hypoglycemic	ADJ
bjos-8668473	10	6	drugs	drug	NOUN
bjos-8668473	10	7	had	have	VERB
bjos-8668473	10	8	higher	high	ADJ
bjos-8668473	10	9	levels	level	NOUN
bjos-8668473	10	10	of	of	ADP
bjos-8668473	10	11	pipecolic	pipecolic	NOUN
bjos-8668473	10	12	acid	acid	NOUN
bjos-8668473	10	13	in	in	ADP
bjos-8668473	10	14	both	both	CCONJ
bjos-8668473	10	15	the	the	DET
bjos-8668473	10	16	case	case	NOUN
bjos-8668473	10	17	and	and	CCONJ
bjos-8668473	10	18	control	control	NOUN
bjos-8668473	10	19	groups	group	NOUN
bjos-8668473	10	20	(	(	PUNCT
bjos-8668473	10	21	p<0.001	p<0.001	PROPN
bjos-8668473	10	22	)	)	PUNCT
bjos-8668473	10	23	.	.	PUNCT
bjos-8668473	11	1	the	the	DET
bjos-8668473	11	2	receiver	receiver	NOUN
bjos-8668473	11	3	operating	operate	VERB
bjos-8668473	11	4	characteristic	characteristic	ADJ
bjos-8668473	11	5	curve	curve	NOUN
bjos-8668473	11	6	analysis	analysis	NOUN
bjos-8668473	11	7	revealed	reveal	VERB
bjos-8668473	11	8	90	90	NUM
bjos-8668473	11	9	%	%	NOUN
bjos-8668473	11	10	sensitivity	sensitivity	NOUN
bjos-8668473	11	11	and	and	CCONJ
bjos-8668473	11	12	65	65	NUM
bjos-8668473	11	13	%	%	NOUN
bjos-8668473	11	14	specificity	specificity	NOUN
bjos-8668473	11	15	for	for	ADP
bjos-8668473	11	16	head	head	NOUN
bjos-8668473	11	17	and	and	CCONJ
bjos-8668473	11	18	neck	neck	NOUN
bjos-8668473	11	19	cancer	cancer	NOUN
bjos-8668473	11	20	,	,	PUNCT
bjos-8668473	11	21	with	with	ADP
bjos-8668473	11	22	an	an	DET
bjos-8668473	11	23	area	area	NOUN
bjos-8668473	11	24	under	under	ADP
bjos-8668473	11	25	the	the	DET
bjos-8668473	11	26	curve	curve	NOUN
bjos-8668473	11	27	of	of	ADP
bjos-8668473	11	28	0.838	0.838	NUM
bjos-8668473	11	29	between	between	ADP
bjos-8668473	11	30	the	the	DET
bjos-8668473	11	31	case	case	NOUN
bjos-8668473	11	32	and	and	CCONJ
bjos-8668473	11	33	control	control	NOUN
bjos-8668473	11	34	groups	group	NOUN
bjos-8668473	11	35	.	.	PUNCT
bjos-8668473	12	1	conclusions	conclusion	NOUN
bjos-8668473	12	2	:	:	PUNCT
bjos-8668473	12	3	pipecolic	pipecolic	PROPN
bjos-8668473	12	4	acid	acid	PROPN
bjos-8668473	12	5	had	have	VERB
bjos-8668473	12	6	high	high	ADJ
bjos-8668473	12	7	sensitivity	sensitivity	NOUN
bjos-8668473	12	8	for	for	ADP
bjos-8668473	12	9	the	the	DET
bjos-8668473	12	10	diagnosis	diagnosis	NOUN
bjos-8668473	12	11	of	of	ADP
bjos-8668473	12	12	hnscc	hnscc	NOUN
bjos-8668473	12	13	but	but	CCONJ
bjos-8668473	12	14	low	low	ADJ
bjos-8668473	12	15	specificity	specificity	NOUN
bjos-8668473	12	16	in	in	ADP
bjos-8668473	12	17	the	the	DET
bjos-8668473	12	18	sample	sample	NOUN
bjos-8668473	12	19	analyzed	analyze	VERB
bjos-8668473	12	20	.	.	PUNCT
bjos-8668473	13	1	our	our	PRON
bjos-8668473	13	2	findings	finding	NOUN
bjos-8668473	13	3	suggest	suggest	VERB
bjos-8668473	13	4	that	that	SCONJ
bjos-8668473	13	5	salivary	salivary	ADJ
bjos-8668473	13	6	pipecolic	pipecolic	NOUN
bjos-8668473	13	7	acid	acid	NOUN
bjos-8668473	13	8	levels	level	NOUN
bjos-8668473	13	9	are	be	AUX
bjos-8668473	13	10	associated	associate	VERB
bjos-8668473	13	11	with	with	ADP
bjos-8668473	13	12	glucose	glucose	NOUN
bjos-8668473	13	13	homeostasis	homeostasis	NOUN
bjos-8668473	13	14	.	.	PUNCT
bjos-8668473	14	1	studies	study	NOUN
bjos-8668473	14	2	with	with	ADP
bjos-8668473	14	3	larger	large	ADJ
bjos-8668473	14	4	samples	sample	NOUN
bjos-8668473	14	5	are	be	AUX
bjos-8668473	14	6	required	require	VERB
bjos-8668473	14	7	to	to	PART
bjos-8668473	14	8	evaluate	evaluate	VERB
bjos-8668473	14	9	the	the	DET
bjos-8668473	14	10	specificity	specificity	NOUN
bjos-8668473	14	11	of	of	ADP
bjos-8668473	14	12	this	this	DET
bjos-8668473	14	13	metabolite	metabolite	NOUN
bjos-8668473	14	14	.	.	PUNCT
bjos-8668473	15	1	keywords	keyword	NOUN
bjos-8668473	15	2	:	:	PUNCT
bjos-8668473	15	3	saliva	saliva	NOUN
bjos-8668473	15	4	.	.	PUNCT
bjos-8668473	16	1	biomarkers	biomarker	NOUN
bjos-8668473	16	2	.	.	PUNCT
bjos-8668473	17	1	squamous	squamous	ADJ
bjos-8668473	17	2	cell	cell	NOUN
bjos-8668473	17	3	carcinoma	carcinoma	NOUN
bjos-8668473	17	4	of	of	ADP
bjos-8668473	17	5	head	head	NOUN
bjos-8668473	17	6	and	and	CCONJ
bjos-8668473	17	7	neck	neck	NOUN
bjos-8668473	17	8	.	.	PUNCT
bjos-8668473	18	1	https://orcid.org/0000-0002-6651-5651	https://orcid.org/0000-0002-6651-5651	PROPN
bjos-8668473	18	2	https://orcid.org/0000-0003-3141-7119	https://orcid.org/0000-0003-3141-7119	PROPN
bjos-8668473	18	3	https://orcid.org/0000-0001-9170-5791	https://orcid.org/0000-0001-9170-5791	PROPN
bjos-8668473	18	4	https://orcid.org/0000-0002-6482-1399	https://orcid.org/0000-0002-6482-1399	PROPN
bjos-8668473	18	5	https://orcid.org/0000-0002-0959-9043	https://orcid.org/0000-0002-0959-9043	PROPN
bjos-8668473	18	6	2	2	NUM
bjos-8668473	18	7	ferrazzo	ferrazzo	VERB
bjos-8668473	18	8	et	et	PROPN
bjos-8668473	18	9	al	al	PROPN
bjos-8668473	18	10	.	.	PROPN
bjos-8668473	19	1	braz	braz	PROPN
bjos-8668473	19	2	j	j	PROPN
bjos-8668473	19	3	oral	oral	PROPN
bjos-8668473	19	4	sci	sci	PROPN
bjos-8668473	19	5	.	.	PUNCT
bjos-8668473	20	1	2023;22	2023;22	NUM
bjos-8668473	20	2	:	:	PUNCT
bjos-8668473	20	3	e238473	e238473	NUM
bjos-8668473	20	4	introduction	introduction	NOUN
bjos-8668473	20	5	approximately	approximately	ADV
bjos-8668473	20	6	744,000	744,000	NUM
bjos-8668473	20	7	new	new	ADJ
bjos-8668473	20	8	cases	case	NOUN
bjos-8668473	20	9	and	and	CCONJ
bjos-8668473	20	10	more	more	ADJ
bjos-8668473	20	11	than	than	ADP
bjos-8668473	20	12	360,000	360,000	NUM
bjos-8668473	20	13	deaths	death	NOUN
bjos-8668473	20	14	from	from	ADP
bjos-8668473	20	15	cancer	cancer	NOUN
bjos-8668473	20	16	of	of	ADP
bjos-8668473	20	17	the	the	DET
bjos-8668473	20	18	oral	oral	ADJ
bjos-8668473	20	19	cavity	cavity	NOUN
bjos-8668473	20	20	,	,	PUNCT
bjos-8668473	20	21	pharynx	pharynx	NOUN
bjos-8668473	20	22	and	and	CCONJ
bjos-8668473	20	23	larynx	larynx	NOUN
bjos-8668473	20	24	were	be	AUX
bjos-8668473	20	25	estimated	estimate	VERB
bjos-8668473	20	26	worldwide	worldwide	ADV
bjos-8668473	20	27	in	in	ADP
bjos-8668473	20	28	2020	2020	NUM
bjos-8668473	20	29	.	.	PUNCT
bjos-8668473	21	1	in	in	ADP
bjos-8668473	21	2	most	most	ADJ
bjos-8668473	21	3	cases	case	NOUN
bjos-8668473	21	4	,	,	PUNCT
bjos-8668473	21	5	tumors	tumor	NOUN
bjos-8668473	21	6	are	be	AUX
bjos-8668473	21	7	diagnosed	diagnose	VERB
bjos-8668473	21	8	in	in	ADP
bjos-8668473	21	9	an	an	DET
bjos-8668473	21	10	advanced	advanced	ADJ
bjos-8668473	21	11	stage1	stage1	NOUN
bjos-8668473	21	12	.	.	PUNCT
bjos-8668473	22	1	as	as	SCONJ
bjos-8668473	22	2	the	the	DET
bjos-8668473	22	3	early	early	ADJ
bjos-8668473	22	4	detection	detection	NOUN
bjos-8668473	22	5	of	of	ADP
bjos-8668473	22	6	these	these	DET
bjos-8668473	22	7	neoplasms	neoplasm	NOUN
bjos-8668473	22	8	and	and	CCONJ
bjos-8668473	22	9	the	the	DET
bjos-8668473	22	10	rapid	rapid	ADJ
bjos-8668473	22	11	institution	institution	NOUN
bjos-8668473	22	12	of	of	ADP
bjos-8668473	22	13	treatment	treatment	NOUN
bjos-8668473	22	14	are	be	AUX
bjos-8668473	22	15	associated	associate	VERB
bjos-8668473	22	16	with	with	ADP
bjos-8668473	22	17	a	a	DET
bjos-8668473	22	18	better	well	ADJ
bjos-8668473	22	19	prognosis	prognosis	NOUN
bjos-8668473	22	20	and	and	CCONJ
bjos-8668473	22	21	survival	survival	PROPN
bjos-8668473	22	22	rate2	rate2	PROPN
bjos-8668473	22	23	,	,	PUNCT
bjos-8668473	22	24	the	the	DET
bjos-8668473	22	25	development	development	NOUN
bjos-8668473	22	26	of	of	ADP
bjos-8668473	22	27	fast	fast	ADJ
bjos-8668473	22	28	,	,	PUNCT
bjos-8668473	22	29	efficient	efficient	ADJ
bjos-8668473	22	30	,	,	PUNCT
bjos-8668473	22	31	noninvasive	noninvasive	ADJ
bjos-8668473	22	32	diagnostic	diagnostic	ADJ
bjos-8668473	22	33	techniques	technique	NOUN
bjos-8668473	22	34	that	that	PRON
bjos-8668473	22	35	can	can	AUX
bjos-8668473	22	36	be	be	AUX
bjos-8668473	22	37	widely	widely	ADV
bjos-8668473	22	38	used	use	VERB
bjos-8668473	22	39	in	in	ADP
bjos-8668473	22	40	populations	population	NOUN
bjos-8668473	22	41	at	at	ADP
bjos-8668473	22	42	risk	risk	NOUN
bjos-8668473	22	43	is	be	AUX
bjos-8668473	22	44	of	of	ADP
bjos-8668473	22	45	considerable	considerable	ADJ
bjos-8668473	22	46	importance	importance	NOUN
bjos-8668473	22	47	.	.	PUNCT
bjos-8668473	23	1	the	the	DET
bjos-8668473	23	2	malignant	malignant	ADJ
bjos-8668473	23	3	transformation	transformation	NOUN
bjos-8668473	23	4	of	of	ADP
bjos-8668473	23	5	a	a	DET
bjos-8668473	23	6	cell	cell	NOUN
bjos-8668473	23	7	involves	involve	VERB
bjos-8668473	23	8	complex	complex	ADJ
bjos-8668473	23	9	reactions	reaction	NOUN
bjos-8668473	23	10	that	that	PRON
bjos-8668473	23	11	ultimately	ultimately	ADV
bjos-8668473	23	12	alter	alter	VERB
bjos-8668473	23	13	the	the	DET
bjos-8668473	23	14	genotype	genotype	NOUN
bjos-8668473	23	15	and	and	CCONJ
bjos-8668473	23	16	phenotype	phenotype	NOUN
bjos-8668473	23	17	of	of	ADP
bjos-8668473	23	18	cells	cell	NOUN
bjos-8668473	23	19	,	,	PUNCT
bjos-8668473	23	20	leaving	leave	VERB
bjos-8668473	23	21	specific	specific	ADJ
bjos-8668473	23	22	markers	marker	NOUN
bjos-8668473	23	23	in	in	ADP
bjos-8668473	23	24	the	the	DET
bjos-8668473	23	25	process	process	NOUN
bjos-8668473	23	26	,	,	PUNCT
bjos-8668473	23	27	which	which	PRON
bjos-8668473	23	28	are	be	AUX
bjos-8668473	23	29	denominated	denominate	VERB
bjos-8668473	23	30	biomarkers	biomarker	NOUN
bjos-8668473	23	31	.	.	PUNCT
bjos-8668473	24	1	the	the	DET
bjos-8668473	24	2	study	study	NOUN
bjos-8668473	24	3	of	of	ADP
bjos-8668473	24	4	biomarkers	biomarker	NOUN
bjos-8668473	24	5	involves	involve	VERB
bjos-8668473	24	6	proteomic	proteomic	ADJ
bjos-8668473	24	7	,	,	PUNCT
bjos-8668473	24	8	genomic	genomic	NOUN
bjos-8668473	24	9	and	and	CCONJ
bjos-8668473	24	10	,	,	PUNCT
bjos-8668473	24	11	more	more	ADV
bjos-8668473	24	12	recently	recently	ADV
bjos-8668473	24	13	,	,	PUNCT
bjos-8668473	24	14	metabolomic	metabolomic	PROPN
bjos-8668473	24	15	analyses3	analyses3	PROPN
bjos-8668473	24	16	-	-	PUNCT
bjos-8668473	24	17	6	6	NUM
bjos-8668473	24	18	.	.	PUNCT
bjos-8668473	24	19	saliva	saliva	NOUN
bjos-8668473	24	20	has	have	AUX
bjos-8668473	24	21	attracted	attract	VERB
bjos-8668473	24	22	attention	attention	NOUN
bjos-8668473	24	23	in	in	ADP
bjos-8668473	24	24	the	the	DET
bjos-8668473	24	25	study	study	NOUN
bjos-8668473	24	26	of	of	ADP
bjos-8668473	24	27	biomarkers	biomarker	NOUN
bjos-8668473	24	28	and	and	CCONJ
bjos-8668473	24	29	has	have	AUX
bjos-8668473	24	30	been	be	AUX
bjos-8668473	24	31	the	the	DET
bjos-8668473	24	32	target	target	NOUN
bjos-8668473	24	33	of	of	ADP
bjos-8668473	24	34	numerous	numerous	ADJ
bjos-8668473	24	35	studies7	studies7	NOUN
bjos-8668473	24	36	-	-	PUNCT
bjos-8668473	24	37	9	9	NUM
bjos-8668473	24	38	.	.	PUNCT
bjos-8668473	25	1	studies	study	NOUN
bjos-8668473	25	2	conducted	conduct	VERB
bjos-8668473	25	3	in	in	ADP
bjos-8668473	25	4	the	the	DET
bjos-8668473	25	5	last	last	ADJ
bjos-8668473	25	6	ten	ten	NUM
bjos-8668473	25	7	years	year	NOUN
bjos-8668473	25	8	have	have	AUX
bjos-8668473	25	9	demonstrated	demonstrate	VERB
bjos-8668473	25	10	that	that	SCONJ
bjos-8668473	25	11	human	human	ADJ
bjos-8668473	25	12	saliva	saliva	NOUN
bjos-8668473	25	13	can	can	AUX
bjos-8668473	25	14	be	be	AUX
bjos-8668473	25	15	used	use	VERB
bjos-8668473	25	16	for	for	ADP
bjos-8668473	25	17	the	the	DET
bjos-8668473	25	18	diagnosis	diagnosis	NOUN
bjos-8668473	25	19	of	of	ADP
bjos-8668473	25	20	several	several	ADJ
bjos-8668473	25	21	diseases	disease	NOUN
bjos-8668473	25	22	,	,	PUNCT
bjos-8668473	25	23	such	such	ADJ
bjos-8668473	25	24	as	as	ADP
bjos-8668473	25	25	cardiovascular	cardiovascular	ADJ
bjos-8668473	25	26	diseases10	diseases10	NOUN
bjos-8668473	25	27	,	,	PUNCT
bjos-8668473	25	28	prostate	prostate	NOUN
bjos-8668473	25	29	cancer,11	cancer,11	NOUN
bjos-8668473	25	30	pancreatic	pancreatic	ADJ
bjos-8668473	25	31	cancer12	cancer12	NOUN
bjos-8668473	25	32	and	and	CCONJ
bjos-8668473	25	33	head	head	NOUN
bjos-8668473	25	34	and	and	CCONJ
bjos-8668473	25	35	neck	neck	NOUN
bjos-8668473	25	36	cancer4,9,13	cancer4,9,13	NOUN
bjos-8668473	25	37	.	.	PUNCT
bjos-8668473	26	1	saliva	saliva	NOUN
bjos-8668473	26	2	can	can	AUX
bjos-8668473	26	3	reflect	reflect	VERB
bjos-8668473	26	4	systemic	systemic	ADJ
bjos-8668473	26	5	as	as	ADV
bjos-8668473	26	6	well	well	ADV
bjos-8668473	26	7	as	as	ADP
bjos-8668473	26	8	local	local	ADJ
bjos-8668473	26	9	changes	change	NOUN
bjos-8668473	26	10	,	,	PUNCT
bjos-8668473	26	11	which	which	PRON
bjos-8668473	26	12	underscores	underscore	VERB
bjos-8668473	26	13	the	the	DET
bjos-8668473	26	14	importance	importance	NOUN
bjos-8668473	26	15	of	of	ADP
bjos-8668473	26	16	this	this	DET
bjos-8668473	26	17	diagnostic	diagnostic	ADJ
bjos-8668473	26	18	method14	method14	NOUN
bjos-8668473	26	19	.	.	PUNCT
bjos-8668473	27	1	pipecolic	pipecolic	PROPN
bjos-8668473	27	2	acid	acid	PROPN
bjos-8668473	27	3	is	be	AUX
bjos-8668473	27	4	a	a	DET
bjos-8668473	27	5	product	product	NOUN
bjos-8668473	27	6	of	of	ADP
bjos-8668473	27	7	the	the	DET
bjos-8668473	27	8	metabolism	metabolism	NOUN
bjos-8668473	27	9	of	of	ADP
bjos-8668473	27	10	lysine	lysine	NOUN
bjos-8668473	27	11	found	find	VERB
bjos-8668473	27	12	in	in	ADP
bjos-8668473	27	13	physiological	physiological	ADJ
bjos-8668473	27	14	body	body	NOUN
bjos-8668473	27	15	fluids	fluid	NOUN
bjos-8668473	27	16	,	,	PUNCT
bjos-8668473	27	17	such	such	ADJ
bjos-8668473	27	18	as	as	ADP
bjos-8668473	27	19	plasma	plasma	NOUN
bjos-8668473	27	20	,	,	PUNCT
bjos-8668473	27	21	urine	urine	NOUN
bjos-8668473	27	22	and	and	CCONJ
bjos-8668473	27	23	cerebrospinal	cerebrospinal	ADJ
bjos-8668473	27	24	fluid15	fluid15	NOUN
bjos-8668473	27	25	.	.	PUNCT
bjos-8668473	28	1	pipecolic	pipecolic	NOUN
bjos-8668473	28	2	acidemia	acidemia	NOUN
bjos-8668473	28	3	is	be	AUX
bjos-8668473	28	4	well	well	ADV
bjos-8668473	28	5	recognized	recognize	VERB
bjos-8668473	28	6	in	in	ADP
bjos-8668473	28	7	peroxisomal	peroxisomal	ADJ
bjos-8668473	28	8	diseases	disease	NOUN
bjos-8668473	28	9	,	,	PUNCT
bjos-8668473	28	10	such	such	ADJ
bjos-8668473	28	11	as	as	ADP
bjos-8668473	28	12	zellweger	zellweger	PROPN
bjos-8668473	28	13	syndrome16,17	syndrome16,17	PROPN
bjos-8668473	28	14	,	,	PUNCT
bjos-8668473	28	15	although	although	SCONJ
bjos-8668473	28	16	its	its	PRON
bjos-8668473	28	17	participation	participation	NOUN
bjos-8668473	28	18	in	in	ADP
bjos-8668473	28	19	the	the	DET
bjos-8668473	28	20	pathogenesis	pathogenesis	NOUN
bjos-8668473	28	21	has	have	AUX
bjos-8668473	28	22	not	not	PART
bjos-8668473	28	23	yet	yet	ADV
bjos-8668473	28	24	been	be	AUX
bjos-8668473	28	25	fully	fully	ADV
bjos-8668473	28	26	clarified	clarify	VERB
bjos-8668473	28	27	.	.	PUNCT
bjos-8668473	29	1	pipecolic	pipecolic	PROPN
bjos-8668473	29	2	acid	acid	PROPN
bjos-8668473	29	3	has	have	AUX
bjos-8668473	29	4	been	be	AUX
bjos-8668473	29	5	identified	identify	VERB
bjos-8668473	29	6	as	as	ADP
bjos-8668473	29	7	a	a	DET
bjos-8668473	29	8	potential	potential	ADJ
bjos-8668473	29	9	biomarker	biomarker	NOUN
bjos-8668473	29	10	with	with	ADP
bjos-8668473	29	11	the	the	DET
bjos-8668473	29	12	capacity	capacity	NOUN
bjos-8668473	29	13	to	to	PART
bjos-8668473	29	14	detect	detect	VERB
bjos-8668473	29	15	oral	oral	ADJ
bjos-8668473	29	16	squamous	squamous	ADJ
bjos-8668473	29	17	cell	cell	NOUN
bjos-8668473	29	18	carcinoma	carcinoma	NOUN
bjos-8668473	29	19	in	in	ADP
bjos-8668473	29	20	the	the	DET
bjos-8668473	29	21	early	early	ADJ
bjos-8668473	29	22	stages	stage	NOUN
bjos-8668473	29	23	of	of	ADP
bjos-8668473	29	24	the	the	DET
bjos-8668473	29	25	disease3,6,18	disease3,6,18	PROPN
bjos-8668473	29	26	.	.	PUNCT
bjos-8668473	30	1	however	however	ADV
bjos-8668473	30	2	,	,	PUNCT
bjos-8668473	30	3	this	this	DET
bjos-8668473	30	4	metabolite	metabolite	NOUN
bjos-8668473	30	5	has	have	AUX
bjos-8668473	30	6	been	be	AUX
bjos-8668473	30	7	shown	show	VERB
bjos-8668473	30	8	to	to	PART
bjos-8668473	30	9	be	be	AUX
bjos-8668473	30	10	increased	increase	VERB
bjos-8668473	30	11	in	in	ADP
bjos-8668473	30	12	another	another	DET
bjos-8668473	30	13	systemic	systemic	ADJ
bjos-8668473	30	14	condition	condition	NOUN
bjos-8668473	30	15	as	as	ADV
bjos-8668473	30	16	well	well	ADV
bjos-8668473	30	17	.	.	PUNCT
bjos-8668473	31	1	an	an	DET
bjos-8668473	31	2	experimental	experimental	ADJ
bjos-8668473	31	3	model	model	NOUN
bjos-8668473	31	4	with	with	ADP
bjos-8668473	31	5	primates	primate	NOUN
bjos-8668473	31	6	and	and	CCONJ
bjos-8668473	31	7	rats	rat	NOUN
bjos-8668473	31	8	demonstrated	demonstrate	VERB
bjos-8668473	31	9	an	an	DET
bjos-8668473	31	10	increase	increase	NOUN
bjos-8668473	31	11	in	in	ADP
bjos-8668473	31	12	urinary	urinary	ADJ
bjos-8668473	31	13	levels	level	NOUN
bjos-8668473	31	14	of	of	ADP
bjos-8668473	31	15	pipecolic	pipecolic	NOUN
bjos-8668473	31	16	acid	acid	NOUN
bjos-8668473	31	17	in	in	ADP
bjos-8668473	31	18	diabetic	diabetic	ADJ
bjos-8668473	31	19	animals19	animals19	NOUN
bjos-8668473	31	20	.	.	PUNCT
bjos-8668473	32	1	moreover	moreover	ADV
bjos-8668473	32	2	,	,	PUNCT
bjos-8668473	32	3	pipecolic	pipecolic	ADJ
bjos-8668473	32	4	acid	acid	NOUN
bjos-8668473	32	5	has	have	AUX
bjos-8668473	32	6	been	be	AUX
bjos-8668473	32	7	identified	identify	VERB
bjos-8668473	32	8	as	as	ADP
bjos-8668473	32	9	a	a	DET
bjos-8668473	32	10	potential	potential	ADJ
bjos-8668473	32	11	biomarker	biomarker	NOUN
bjos-8668473	32	12	that	that	PRON
bjos-8668473	32	13	is	be	AUX
bjos-8668473	32	14	overregulated	overregulate	VERB
bjos-8668473	32	15	in	in	ADP
bjos-8668473	32	16	the	the	DET
bjos-8668473	32	17	corneas	cornea	NOUN
bjos-8668473	32	18	of	of	ADP
bjos-8668473	32	19	individuals	individual	NOUN
bjos-8668473	32	20	with	with	ADP
bjos-8668473	32	21	type	type	NOUN
bjos-8668473	32	22	1	1	NUM
bjos-8668473	32	23	diabetes	diabetes	NOUN
bjos-8668473	32	24	in	in	ADP
bjos-8668473	32	25	comparison	comparison	NOUN
bjos-8668473	32	26	to	to	ADP
bjos-8668473	32	27	healthy	healthy	ADJ
bjos-8668473	32	28	controls20	controls20	NOUN
bjos-8668473	32	29	.	.	PUNCT
bjos-8668473	33	1	a	a	DET
bjos-8668473	33	2	recent	recent	ADJ
bjos-8668473	33	3	study	study	NOUN
bjos-8668473	33	4	found	find	VERB
bjos-8668473	33	5	an	an	DET
bjos-8668473	33	6	association	association	NOUN
bjos-8668473	33	7	between	between	ADP
bjos-8668473	33	8	pipecolic	pipecolic	NOUN
bjos-8668473	33	9	acid	acid	NOUN
bjos-8668473	33	10	and	and	CCONJ
bjos-8668473	33	11	an	an	DET
bjos-8668473	33	12	increased	increase	VERB
bjos-8668473	33	13	risk	risk	NOUN
bjos-8668473	33	14	of	of	ADP
bjos-8668473	33	15	type	type	NOUN
bjos-8668473	33	16	ii	ii	PROPN
bjos-8668473	33	17	diabetes21	diabetes21	NOUN
bjos-8668473	33	18	.	.	PUNCT
bjos-8668473	34	1	therefore	therefore	ADV
bjos-8668473	34	2	,	,	PUNCT
bjos-8668473	34	3	the	the	DET
bjos-8668473	34	4	aim	aim	NOUN
bjos-8668473	34	5	of	of	ADP
bjos-8668473	34	6	this	this	DET
bjos-8668473	34	7	preliminary	preliminary	ADJ
bjos-8668473	34	8	study	study	NOUN
bjos-8668473	34	9	was	be	AUX
bjos-8668473	34	10	to	to	PART
bjos-8668473	34	11	test	test	VERB
bjos-8668473	34	12	the	the	DET
bjos-8668473	34	13	sensitivity	sensitivity	NOUN
bjos-8668473	34	14	and	and	CCONJ
bjos-8668473	34	15	specificity	specificity	NOUN
bjos-8668473	34	16	of	of	ADP
bjos-8668473	34	17	pipecolic	pipecolic	NOUN
bjos-8668473	34	18	acid	acid	NOUN
bjos-8668473	34	19	in	in	ADP
bjos-8668473	34	20	predicting	predict	VERB
bjos-8668473	34	21	head	head	NOUN
bjos-8668473	34	22	and	and	CCONJ
bjos-8668473	34	23	neck	neck	VERB
bjos-8668473	34	24	squamous	squamous	ADJ
bjos-8668473	34	25	cell	cell	NOUN
bjos-8668473	34	26	carcinoma	carcinoma	NOUN
bjos-8668473	34	27	(	(	PUNCT
bjos-8668473	34	28	hnscc	hnscc	NOUN
bjos-8668473	34	29	)	)	PUNCT
bjos-8668473	34	30	.	.	PUNCT
bjos-8668473	35	1	the	the	DET
bjos-8668473	35	2	metabolomic	metabolomic	ADJ
bjos-8668473	35	3	strategy	strategy	NOUN
bjos-8668473	35	4	was	be	AUX
bjos-8668473	35	5	targeted	target	VERB
bjos-8668473	35	6	tandem	tandem	NOUN
bjos-8668473	35	7	validation22	validation22	NOUN
bjos-8668473	35	8	.	.	PUNCT
bjos-8668473	36	1	the	the	DET
bjos-8668473	36	2	hypothesis	hypothesis	NOUN
bjos-8668473	36	3	is	be	AUX
bjos-8668473	36	4	that	that	SCONJ
bjos-8668473	36	5	pipecolic	pipecolic	NOUN
bjos-8668473	36	6	acid	acid	NOUN
bjos-8668473	36	7	has	have	VERB
bjos-8668473	36	8	high	high	ADJ
bjos-8668473	36	9	sensitivity	sensitivity	NOUN
bjos-8668473	36	10	and	and	CCONJ
bjos-8668473	36	11	specificity	specificity	NOUN
bjos-8668473	36	12	in	in	ADP
bjos-8668473	36	13	predicting	predict	VERB
bjos-8668473	36	14	hnscc	hnscc	NOUN
bjos-8668473	36	15	and	and	CCONJ
bjos-8668473	36	16	that	that	SCONJ
bjos-8668473	36	17	pipecolic	pipecolic	NOUN
bjos-8668473	36	18	acid	acid	NOUN
bjos-8668473	36	19	levels	level	NOUN
bjos-8668473	36	20	are	be	AUX
bjos-8668473	36	21	not	not	PART
bjos-8668473	36	22	influenced	influence	VERB
bjos-8668473	36	23	by	by	ADP
bjos-8668473	36	24	the	the	DET
bjos-8668473	36	25	presence	presence	NOUN
bjos-8668473	36	26	of	of	ADP
bjos-8668473	36	27	comorbidity	comorbidity	NOUN
bjos-8668473	36	28	related	relate	VERB
bjos-8668473	36	29	to	to	ADP
bjos-8668473	36	30	glycemic	glycemic	ADJ
bjos-8668473	36	31	control	control	NOUN
bjos-8668473	36	32	.	.	PUNCT
bjos-8668473	37	1	methods	method	NOUN
bjos-8668473	37	2	ethical	ethical	ADJ
bjos-8668473	37	3	considerations	consideration	NOUN
bjos-8668473	37	4	,	,	PUNCT
bjos-8668473	37	5	study	study	NOUN
bjos-8668473	37	6	design	design	NOUN
bjos-8668473	37	7	and	and	CCONJ
bjos-8668473	37	8	sample	sample	NOUN
bjos-8668473	37	9	size	size	NOUN
bjos-8668473	37	10	calculation	calculation	NOUN
bjos-8668473	37	11	the	the	DET
bjos-8668473	37	12	present	present	ADJ
bjos-8668473	37	13	case	case	NOUN
bjos-8668473	37	14	-	-	PUNCT
bjos-8668473	37	15	control	control	NOUN
bjos-8668473	37	16	study	study	NOUN
bjos-8668473	37	17	was	be	AUX
bjos-8668473	37	18	conducted	conduct	VERB
bjos-8668473	37	19	at	at	ADP
bjos-8668473	37	20	a	a	DET
bjos-8668473	37	21	university	university	NOUN
bjos-8668473	37	22	hospital	hospital	NOUN
bjos-8668473	37	23	of	of	ADP
bjos-8668473	37	24	the	the	DET
bjos-8668473	37	25	public	public	ADJ
bjos-8668473	37	26	education	education	NOUN
bjos-8668473	37	27	system	system	NOUN
bjos-8668473	37	28	in	in	ADP
bjos-8668473	37	29	southern	southern	ADJ
bjos-8668473	37	30	brazil	brazil	PROPN
bjos-8668473	37	31	that	that	PRON
bjos-8668473	37	32	serves	serve	VERB
bjos-8668473	37	33	as	as	ADP
bjos-8668473	37	34	a	a	DET
bjos-8668473	37	35	reference	reference	NOUN
bjos-8668473	37	36	for	for	ADP
bjos-8668473	37	37	the	the	DET
bjos-8668473	37	38	treatment	treatment	NOUN
bjos-8668473	37	39	of	of	ADP
bjos-8668473	37	40	3	3	NUM
bjos-8668473	37	41	ferrazzo	ferrazzo	VERB
bjos-8668473	38	1	et	et	PROPN
bjos-8668473	38	2	al	al	PROPN
bjos-8668473	38	3	.	.	PROPN
bjos-8668473	38	4	braz	braz	PROPN
bjos-8668473	38	5	j	j	PROPN
bjos-8668473	38	6	oral	oral	PROPN
bjos-8668473	38	7	sci	sci	PROPN
bjos-8668473	38	8	.	.	PUNCT
bjos-8668473	39	1	2023;22	2023;22	NUM
bjos-8668473	39	2	:	:	PUNCT
bjos-8668473	39	3	e238473	e238473	NUM
bjos-8668473	39	4	head	head	NOUN
bjos-8668473	39	5	and	and	CCONJ
bjos-8668473	39	6	neck	neck	NOUN
bjos-8668473	39	7	cancer	cancer	NOUN
bjos-8668473	39	8	.	.	PUNCT
bjos-8668473	40	1	the	the	DET
bjos-8668473	40	2	study	study	NOUN
bjos-8668473	40	3	was	be	AUX
bjos-8668473	40	4	conducted	conduct	VERB
bjos-8668473	40	5	in	in	ADP
bjos-8668473	40	6	accordance	accordance	NOUN
bjos-8668473	40	7	with	with	ADP
bjos-8668473	40	8	the	the	DET
bjos-8668473	40	9	precepts	precept	NOUN
bjos-8668473	40	10	stipulated	stipulate	VERB
bjos-8668473	40	11	in	in	ADP
bjos-8668473	40	12	the	the	DET
bjos-8668473	40	13	declaration	declaration	NOUN
bjos-8668473	40	14	of	of	ADP
bjos-8668473	40	15	helsinki	helsinki	PROPN
bjos-8668473	40	16	and	and	CCONJ
bjos-8668473	40	17	received	receive	VERB
bjos-8668473	40	18	approval	approval	NOUN
bjos-8668473	40	19	from	from	ADP
bjos-8668473	40	20	the	the	DET
bjos-8668473	40	21	local	local	ADJ
bjos-8668473	40	22	human	human	ADJ
bjos-8668473	40	23	research	research	PROPN
bjos-8668473	40	24	ethics	ethic	NOUN
bjos-8668473	40	25	committee	committee	PROPN
bjos-8668473	40	26	(	(	PUNCT
bjos-8668473	40	27	certificate	certificate	NOUN
bjos-8668473	40	28	number	number	NOUN
bjos-8668473	40	29	:	:	PUNCT
bjos-8668473	40	30	63198116.3.0000.5346/1.889.748	63198116.3.0000.5346/1.889.748	NOUN
bjos-8668473	40	31	)	)	PUNCT
bjos-8668473	40	32	.	.	PUNCT
bjos-8668473	41	1	voluntary	voluntary	ADJ
bjos-8668473	41	2	research	research	NOUN
bjos-8668473	41	3	participants	participant	NOUN
bjos-8668473	41	4	were	be	AUX
bjos-8668473	41	5	recruited	recruit	VERB
bjos-8668473	41	6	from	from	ADP
bjos-8668473	41	7	the	the	DET
bjos-8668473	41	8	head	head	NOUN
bjos-8668473	41	9	and	and	CCONJ
bjos-8668473	41	10	neck	neck	NOUN
bjos-8668473	41	11	surgery	surgery	NOUN
bjos-8668473	41	12	clinic	clinic	NOUN
bjos-8668473	41	13	between	between	ADP
bjos-8668473	41	14	november	november	PROPN
bjos-8668473	41	15	2016	2016	NUM
bjos-8668473	41	16	and	and	CCONJ
bjos-8668473	41	17	november	november	PROPN
bjos-8668473	41	18	2017	2017	NUM
bjos-8668473	41	19	.	.	PUNCT
bjos-8668473	42	1	volunteers	volunteer	NOUN
bjos-8668473	42	2	in	in	ADP
bjos-8668473	42	3	the	the	DET
bjos-8668473	42	4	test	test	NOUN
bjos-8668473	42	5	group	group	NOUN
bjos-8668473	42	6	were	be	AUX
bjos-8668473	42	7	patients	patient	NOUN
bjos-8668473	42	8	who	who	PRON
bjos-8668473	42	9	received	receive	VERB
bjos-8668473	42	10	a	a	DET
bjos-8668473	42	11	diagnosis	diagnosis	NOUN
bjos-8668473	42	12	of	of	ADP
bjos-8668473	42	13	hnscc	hnscc	NOUN
bjos-8668473	42	14	.	.	PUNCT
bjos-8668473	43	1	volunteers	volunteer	NOUN
bjos-8668473	43	2	in	in	ADP
bjos-8668473	43	3	the	the	DET
bjos-8668473	43	4	control	control	NOUN
bjos-8668473	43	5	group	group	NOUN
bjos-8668473	43	6	were	be	AUX
bjos-8668473	43	7	the	the	DET
bjos-8668473	43	8	companions	companion	NOUN
bjos-8668473	43	9	of	of	ADP
bjos-8668473	43	10	the	the	DET
bjos-8668473	43	11	patients	patient	NOUN
bjos-8668473	43	12	and	and	CCONJ
bjos-8668473	43	13	were	be	AUX
bjos-8668473	43	14	recruited	recruit	VERB
bjos-8668473	43	15	from	from	ADP
bjos-8668473	43	16	the	the	DET
bjos-8668473	43	17	waiting	waiting	NOUN
bjos-8668473	43	18	room	room	NOUN
bjos-8668473	43	19	.	.	PUNCT
bjos-8668473	44	1	all	all	DET
bjos-8668473	44	2	volunteers	volunteer	NOUN
bjos-8668473	44	3	received	receive	VERB
bjos-8668473	44	4	clarifications	clarification	NOUN
bjos-8668473	44	5	regarding	regard	VERB
bjos-8668473	44	6	the	the	DET
bjos-8668473	44	7	objectives	objective	NOUN
bjos-8668473	44	8	and	and	CCONJ
bjos-8668473	44	9	procedures	procedure	NOUN
bjos-8668473	44	10	of	of	ADP
bjos-8668473	44	11	the	the	DET
bjos-8668473	44	12	study	study	NOUN
bjos-8668473	44	13	and	and	CCONJ
bjos-8668473	44	14	those	those	PRON
bjos-8668473	44	15	agreeing	agree	VERB
bjos-8668473	44	16	to	to	PART
bjos-8668473	44	17	participate	participate	VERB
bjos-8668473	44	18	signed	sign	VERB
bjos-8668473	44	19	a	a	DET
bjos-8668473	44	20	statement	statement	NOUN
bjos-8668473	44	21	of	of	ADP
bjos-8668473	44	22	informed	informed	ADJ
bjos-8668473	44	23	consent	consent	NOUN
bjos-8668473	44	24	.	.	PUNCT
bjos-8668473	45	1	the	the	DET
bjos-8668473	45	2	sample	sample	NOUN
bjos-8668473	45	3	size	size	NOUN
bjos-8668473	45	4	was	be	AUX
bjos-8668473	45	5	calculated	calculate	VERB
bjos-8668473	45	6	using	use	VERB
bjos-8668473	45	7	data	datum	NOUN
bjos-8668473	45	8	from	from	ADP
bjos-8668473	45	9	a	a	DET
bjos-8668473	45	10	previous	previous	ADJ
bjos-8668473	45	11	study,18	study,18	NOUN
bjos-8668473	45	12	which	which	PRON
bjos-8668473	45	13	demonstrated	demonstrate	VERB
bjos-8668473	45	14	that	that	SCONJ
bjos-8668473	45	15	pipecolic	pipecolic	NOUN
bjos-8668473	45	16	acid	acid	NOUN
bjos-8668473	45	17	has	have	VERB
bjos-8668473	45	18	more	more	ADJ
bjos-8668473	45	19	than	than	ADP
bjos-8668473	45	20	90	90	NUM
bjos-8668473	45	21	%	%	NOUN
bjos-8668473	45	22	sensitivity	sensitivity	NOUN
bjos-8668473	45	23	and	and	CCONJ
bjos-8668473	45	24	specificity	specificity	NOUN
bjos-8668473	45	25	for	for	ADP
bjos-8668473	45	26	predicting	predict	VERB
bjos-8668473	45	27	whether	whether	SCONJ
bjos-8668473	45	28	a	a	DET
bjos-8668473	45	29	tumor	tumor	NOUN
bjos-8668473	45	30	is	be	AUX
bjos-8668473	45	31	positive	positive	ADJ
bjos-8668473	45	32	or	or	CCONJ
bjos-8668473	45	33	negative	negative	ADJ
bjos-8668473	45	34	for	for	ADP
bjos-8668473	45	35	oral	oral	ADJ
bjos-8668473	45	36	squamous	squamous	ADJ
bjos-8668473	45	37	cell	cell	NOUN
bjos-8668473	45	38	carcinoma	carcinoma	NOUN
bjos-8668473	45	39	.	.	PUNCT
bjos-8668473	46	1	considering	consider	VERB
bjos-8668473	46	2	a	a	DET
bjos-8668473	46	3	population	population	NOUN
bjos-8668473	46	4	of	of	ADP
bjos-8668473	46	5	100	100	NUM
bjos-8668473	46	6	individuals	individual	NOUN
bjos-8668473	46	7	(	(	PUNCT
bjos-8668473	46	8	approximate	approximate	ADJ
bjos-8668473	46	9	number	number	NOUN
bjos-8668473	46	10	of	of	ADP
bjos-8668473	46	11	new	new	ADJ
bjos-8668473	46	12	cases	case	NOUN
bjos-8668473	46	13	of	of	ADP
bjos-8668473	46	14	hnscc	hnscc	NOUN
bjos-8668473	46	15	diagnosed	diagnose	VERB
bjos-8668473	46	16	at	at	ADP
bjos-8668473	46	17	the	the	DET
bjos-8668473	46	18	hospital	hospital	NOUN
bjos-8668473	46	19	per	per	ADP
bjos-8668473	46	20	year	year	NOUN
bjos-8668473	46	21	)	)	PUNCT
bjos-8668473	46	22	,	,	PUNCT
bjos-8668473	46	23	a	a	DET
bjos-8668473	46	24	90	90	NUM
bjos-8668473	46	25	%	%	NOUN
bjos-8668473	46	26	confidence	confidence	NOUN
bjos-8668473	46	27	level	level	NOUN
bjos-8668473	46	28	and	and	CCONJ
bjos-8668473	46	29	10	10	NUM
bjos-8668473	46	30	%	%	NOUN
bjos-8668473	46	31	sampling	sampling	NOUN
bjos-8668473	46	32	error	error	NOUN
bjos-8668473	46	33	,	,	PUNCT
bjos-8668473	46	34	a	a	DET
bjos-8668473	46	35	minimum	minimum	NOUN
bjos-8668473	46	36	of	of	ADP
bjos-8668473	46	37	20	20	NUM
bjos-8668473	46	38	individuals	individual	NOUN
bjos-8668473	46	39	was	be	AUX
bjos-8668473	46	40	determined	determine	VERB
bjos-8668473	46	41	for	for	ADP
bjos-8668473	46	42	the	the	DET
bjos-8668473	46	43	case	case	NOUN
bjos-8668473	46	44	group	group	NOUN
bjos-8668473	46	45	.	.	PUNCT
bjos-8668473	47	1	sample	sample	NOUN
bjos-8668473	47	2	and	and	CCONJ
bjos-8668473	47	3	eligibility	eligibility	NOUN
bjos-8668473	47	4	criteria	criterion	NOUN
bjos-8668473	47	5	the	the	DET
bjos-8668473	47	6	sample	sample	NOUN
bjos-8668473	47	7	was	be	AUX
bjos-8668473	47	8	composed	compose	VERB
bjos-8668473	47	9	of	of	ADP
bjos-8668473	47	10	40	40	NUM
bjos-8668473	47	11	male	male	ADJ
bjos-8668473	47	12	and	and	CCONJ
bjos-8668473	47	13	female	female	ADJ
bjos-8668473	47	14	adults	adult	NOUN
bjos-8668473	47	15	(	(	PUNCT
bjos-8668473	47	16	>	>	X
bjos-8668473	47	17	18	18	NUM
bjos-8668473	47	18	years	year	NOUN
bjos-8668473	47	19	of	of	ADP
bjos-8668473	47	20	age	age	NOUN
bjos-8668473	47	21	):	):	PUNCT
bjos-8668473	47	22	20	20	NUM
bjos-8668473	47	23	in	in	ADP
bjos-8668473	47	24	the	the	DET
bjos-8668473	47	25	case	case	NOUN
bjos-8668473	47	26	group	group	NOUN
bjos-8668473	47	27	(	(	PUNCT
bjos-8668473	47	28	patients	patient	NOUN
bjos-8668473	47	29	with	with	ADP
bjos-8668473	47	30	histological	histological	ADJ
bjos-8668473	47	31	diagnosis	diagnosis	NOUN
bjos-8668473	47	32	of	of	ADP
bjos-8668473	47	33	hnscc	hnscc	NOUN
bjos-8668473	47	34	not	not	PART
bjos-8668473	47	35	yet	yet	ADV
bjos-8668473	47	36	treated	treat	VERB
bjos-8668473	47	37	)	)	PUNCT
bjos-8668473	47	38	and	and	CCONJ
bjos-8668473	47	39	20	20	NUM
bjos-8668473	47	40	in	in	ADP
bjos-8668473	47	41	the	the	DET
bjos-8668473	47	42	control	control	NOUN
bjos-8668473	47	43	group	group	NOUN
bjos-8668473	47	44	(	(	PUNCT
bjos-8668473	47	45	patients	patient	NOUN
bjos-8668473	47	46	with	with	ADP
bjos-8668473	47	47	no	no	DET
bjos-8668473	47	48	current	current	ADJ
bjos-8668473	47	49	or	or	CCONJ
bjos-8668473	47	50	past	past	ADJ
bjos-8668473	47	51	history	history	NOUN
bjos-8668473	47	52	of	of	ADP
bjos-8668473	47	53	cancer	cancer	NOUN
bjos-8668473	47	54	)	)	PUNCT
bjos-8668473	47	55	.	.	PUNCT
bjos-8668473	48	1	each	each	DET
bjos-8668473	48	2	group	group	NOUN
bjos-8668473	48	3	included	include	VERB
bjos-8668473	48	4	three	three	NUM
bjos-8668473	48	5	individuals	individual	NOUN
bjos-8668473	48	6	who	who	PRON
bjos-8668473	48	7	used	use	VERB
bjos-8668473	48	8	oral	oral	ADJ
bjos-8668473	48	9	hypoglycemic	hypoglycemic	ADJ
bjos-8668473	48	10	drugs	drug	NOUN
bjos-8668473	48	11	(	(	PUNCT
bjos-8668473	48	12	comorbidity	comorbidity	NOUN
bjos-8668473	48	13	)	)	PUNCT
bjos-8668473	48	14	.	.	PUNCT
bjos-8668473	49	1	the	the	DET
bjos-8668473	49	2	case	case	NOUN
bjos-8668473	49	3	and	and	CCONJ
bjos-8668473	49	4	control	control	NOUN
bjos-8668473	49	5	groups	group	NOUN
bjos-8668473	49	6	were	be	AUX
bjos-8668473	49	7	matched	match	VERB
bjos-8668473	49	8	at	at	ADP
bjos-8668473	49	9	a	a	DET
bjos-8668473	49	10	proportion	proportion	NOUN
bjos-8668473	49	11	of	of	ADP
bjos-8668473	49	12	1:1	1:1	NUM
bjos-8668473	49	13	for	for	ADP
bjos-8668473	49	14	sex	sex	NOUN
bjos-8668473	49	15	and	and	CCONJ
bjos-8668473	49	16	comorbidity	comorbidity	NOUN
bjos-8668473	49	17	.	.	PUNCT
bjos-8668473	50	1	the	the	DET
bjos-8668473	50	2	eligibility	eligibility	NOUN
bjos-8668473	50	3	criteria	criterion	NOUN
bjos-8668473	50	4	for	for	ADP
bjos-8668473	50	5	the	the	DET
bjos-8668473	50	6	case	case	NOUN
bjos-8668473	50	7	group	group	NOUN
bjos-8668473	50	8	were	be	AUX
bjos-8668473	50	9	a	a	DET
bjos-8668473	50	10	recent	recent	ADJ
bjos-8668473	50	11	diagnosis	diagnosis	NOUN
bjos-8668473	50	12	of	of	ADP
bjos-8668473	50	13	hnscc	hnscc	NOUN
bjos-8668473	50	14	(	(	PUNCT
bjos-8668473	50	15	oral	oral	ADJ
bjos-8668473	50	16	cavity	cavity	NOUN
bjos-8668473	50	17	,	,	PUNCT
bjos-8668473	50	18	oropharynx	oropharynx	NOUN
bjos-8668473	50	19	,	,	PUNCT
bjos-8668473	50	20	hypopharynx	hypopharynx	NOUN
bjos-8668473	50	21	or	or	CCONJ
bjos-8668473	50	22	larynx	larynx	NOUN
bjos-8668473	50	23	)	)	PUNCT
bjos-8668473	50	24	with	with	ADP
bjos-8668473	50	25	no	no	DET
bjos-8668473	50	26	prior	prior	ADJ
bjos-8668473	50	27	treatment	treatment	NOUN
bjos-8668473	50	28	(	(	PUNCT
bjos-8668473	50	29	surgical	surgical	ADJ
bjos-8668473	50	30	approach	approach	NOUN
bjos-8668473	50	31	,	,	PUNCT
bjos-8668473	50	32	chemotherapy	chemotherapy	NOUN
bjos-8668473	50	33	or	or	CCONJ
bjos-8668473	50	34	radiotherapy	radiotherapy	NOUN
bjos-8668473	50	35	)	)	PUNCT
bjos-8668473	50	36	.	.	PUNCT
bjos-8668473	51	1	the	the	DET
bjos-8668473	51	2	diagnosis	diagnosis	NOUN
bjos-8668473	51	3	of	of	ADP
bjos-8668473	51	4	hnscc	hnscc	NOUN
bjos-8668473	51	5	was	be	AUX
bjos-8668473	51	6	based	base	VERB
bjos-8668473	51	7	on	on	ADP
bjos-8668473	51	8	clinical	clinical	ADJ
bjos-8668473	51	9	criteria	criterion	NOUN
bjos-8668473	51	10	and	and	CCONJ
bjos-8668473	51	11	confirmed	confirm	VERB
bjos-8668473	51	12	through	through	ADP
bjos-8668473	51	13	histological	histological	ADJ
bjos-8668473	51	14	analysis	analysis	NOUN
bjos-8668473	51	15	.	.	PUNCT
bjos-8668473	52	1	individuals	individual	NOUN
bjos-8668473	52	2	with	with	ADP
bjos-8668473	52	3	a	a	DET
bjos-8668473	52	4	past	past	ADJ
bjos-8668473	52	5	history	history	NOUN
bjos-8668473	52	6	of	of	ADP
bjos-8668473	52	7	a	a	DET
bjos-8668473	52	8	malignant	malignant	ADJ
bjos-8668473	52	9	disease	disease	NOUN
bjos-8668473	52	10	,	,	PUNCT
bjos-8668473	52	11	auto	auto	NOUN
bjos-8668473	52	12	-	-	PUNCT
bjos-8668473	52	13	immune	immune	ADJ
bjos-8668473	52	14	disease	disease	NOUN
bjos-8668473	52	15	,	,	PUNCT
bjos-8668473	52	16	psychiatric	psychiatric	ADJ
bjos-8668473	52	17	disease	disease	NOUN
bjos-8668473	52	18	or	or	CCONJ
bjos-8668473	52	19	infectious	infectious	ADJ
bjos-8668473	52	20	-	-	PUNCT
bjos-8668473	52	21	contagious	contagious	ADJ
bjos-8668473	52	22	disease	disease	NOUN
bjos-8668473	52	23	were	be	AUX
bjos-8668473	52	24	excluded	exclude	VERB
bjos-8668473	52	25	from	from	ADP
bjos-8668473	52	26	both	both	DET
bjos-8668473	52	27	groups	group	NOUN
bjos-8668473	52	28	.	.	PUNCT
bjos-8668473	53	1	data	datum	NOUN
bjos-8668473	53	2	collection	collection	NOUN
bjos-8668473	53	3	a	a	DET
bjos-8668473	53	4	questionnaire	questionnaire	NOUN
bjos-8668473	53	5	was	be	AUX
bjos-8668473	53	6	created	create	VERB
bjos-8668473	53	7	to	to	PART
bjos-8668473	53	8	collect	collect	VERB
bjos-8668473	53	9	socio	socio	NOUN
bjos-8668473	53	10	-	-	ADJ
bjos-8668473	53	11	demographic	demographic	ADJ
bjos-8668473	53	12	characteristics	characteristic	NOUN
bjos-8668473	53	13	,	,	PUNCT
bjos-8668473	53	14	clinical	clinical	ADJ
bjos-8668473	53	15	data	datum	NOUN
bjos-8668473	53	16	,	,	PUNCT
bjos-8668473	53	17	risk	risk	NOUN
bjos-8668473	53	18	factors	factor	NOUN
bjos-8668473	53	19	(	(	PUNCT
bjos-8668473	53	20	e.g.	e.g.	ADV
bjos-8668473	53	21	,	,	PUNCT
bjos-8668473	53	22	smoking	smoking	NOUN
bjos-8668473	53	23	)	)	PUNCT
bjos-8668473	53	24	and	and	CCONJ
bjos-8668473	53	25	data	datum	NOUN
bjos-8668473	53	26	on	on	ADP
bjos-8668473	53	27	the	the	DET
bjos-8668473	53	28	neoplasm	neoplasm	NOUN
bjos-8668473	53	29	.	.	PUNCT
bjos-8668473	54	1	the	the	DET
bjos-8668473	54	2	following	follow	VERB
bjos-8668473	54	3	data	datum	NOUN
bjos-8668473	54	4	were	be	AUX
bjos-8668473	54	5	collected	collect	VERB
bjos-8668473	54	6	:	:	PUNCT
bjos-8668473	54	7	age	age	NOUN
bjos-8668473	54	8	,	,	PUNCT
bjos-8668473	54	9	sex	sex	NOUN
bjos-8668473	54	10	,	,	PUNCT
bjos-8668473	54	11	ethnicity	ethnicity	NOUN
bjos-8668473	54	12	,	,	PUNCT
bjos-8668473	54	13	years	year	NOUN
bjos-8668473	54	14	of	of	ADP
bjos-8668473	54	15	formal	formal	ADJ
bjos-8668473	54	16	schooling	schooling	NOUN
bjos-8668473	54	17	,	,	PUNCT
bjos-8668473	54	18	type	type	NOUN
bjos-8668473	54	19	and	and	CCONJ
bjos-8668473	54	20	location	location	NOUN
bjos-8668473	54	21	of	of	ADP
bjos-8668473	54	22	tumor	tumor	NOUN
bjos-8668473	54	23	,	,	PUNCT
bjos-8668473	54	24	tumor	tumor	NOUN
bjos-8668473	54	25	-	-	PUNCT
bjos-8668473	54	26	node	node	NOUN
bjos-8668473	54	27	-	-	PUNCT
bjos-8668473	54	28	metastasis	metastasis	NOUN
bjos-8668473	54	29	(	(	PUNCT
bjos-8668473	54	30	tnm)-based	tnm)-base	VERB
bjos-8668473	54	31	staging	staging	NOUN
bjos-8668473	54	32	system	system	NOUN
bjos-8668473	54	33	of	of	ADP
bjos-8668473	54	34	cancer	cancer	NOUN
bjos-8668473	54	35	according	accord	VERB
bjos-8668473	54	36	to	to	ADP
bjos-8668473	54	37	the	the	DET
bjos-8668473	54	38	seventh	seventh	ADJ
bjos-8668473	54	39	edition	edition	NOUN
bjos-8668473	54	40	of	of	ADP
bjos-8668473	54	41	the	the	DET
bjos-8668473	54	42	american	american	PROPN
bjos-8668473	54	43	joint	joint	PROPN
bjos-8668473	54	44	committee	committee	PROPN
bjos-8668473	54	45	on	on	ADP
bjos-8668473	54	46	cancer	cancer	NOUN
bjos-8668473	54	47	(	(	PUNCT
bjos-8668473	54	48	ajc)23	ajc)23	NOUN
bjos-8668473	54	49	and	and	CCONJ
bjos-8668473	54	50	comorbidity	comorbidity	NOUN
bjos-8668473	54	51	.	.	PUNCT
bjos-8668473	55	1	with	with	ADP
bjos-8668473	55	2	regards	regard	NOUN
bjos-8668473	55	3	to	to	ADP
bjos-8668473	55	4	smoking	smoking	NOUN
bjos-8668473	55	5	,	,	PUNCT
bjos-8668473	55	6	the	the	DET
bjos-8668473	55	7	individuals	individual	NOUN
bjos-8668473	55	8	were	be	AUX
bjos-8668473	55	9	classified	classify	VERB
bjos-8668473	55	10	as	as	ADP
bjos-8668473	55	11	non	non	ADJ
bjos-8668473	55	12	-	-	NOUN
bjos-8668473	55	13	smokers	smoker	NOUN
bjos-8668473	55	14	(	(	PUNCT
bjos-8668473	55	15	those	those	PRON
bjos-8668473	55	16	who	who	PRON
bjos-8668473	55	17	never	never	ADV
bjos-8668473	55	18	smoked	smoke	VERB
bjos-8668473	55	19	or	or	CCONJ
bjos-8668473	55	20	smoked	smoke	VERB
bjos-8668473	55	21	less	less	ADJ
bjos-8668473	55	22	than	than	ADP
bjos-8668473	55	23	one	one	NUM
bjos-8668473	55	24	cigarette	cigarette	NOUN
bjos-8668473	55	25	per	per	ADP
bjos-8668473	55	26	day	day	NOUN
bjos-8668473	55	27	for	for	ADP
bjos-8668473	55	28	less	less	ADJ
bjos-8668473	55	29	than	than	ADP
bjos-8668473	55	30	one	one	NUM
bjos-8668473	55	31	year	year	NOUN
bjos-8668473	55	32	)	)	PUNCT
bjos-8668473	55	33	,	,	PUNCT
bjos-8668473	55	34	ex	ex	NOUN
bjos-8668473	55	35	-	-	NOUN
bjos-8668473	55	36	smokers	smoker	NOUN
bjos-8668473	55	37	(	(	PUNCT
bjos-8668473	55	38	those	those	PRON
bjos-8668473	55	39	who	who	PRON
bjos-8668473	55	40	quit	quit	VERB
bjos-8668473	55	41	smoking	smoking	NOUN
bjos-8668473	55	42	at	at	ADV
bjos-8668473	55	43	least	least	ADV
bjos-8668473	55	44	one	one	NUM
bjos-8668473	55	45	year	year	NOUN
bjos-8668473	55	46	earlier	early	ADV
bjos-8668473	55	47	)	)	PUNCT
bjos-8668473	55	48	or	or	CCONJ
bjos-8668473	55	49	current	current	ADJ
bjos-8668473	55	50	smokers	smoker	NOUN
bjos-8668473	55	51	.	.	PUNCT
bjos-8668473	56	1	cumulative	cumulative	ADJ
bjos-8668473	56	2	smoking	smoking	NOUN
bjos-8668473	56	3	was	be	AUX
bjos-8668473	56	4	evaluated	evaluate	VERB
bjos-8668473	56	5	considering	consider	VERB
bjos-8668473	56	6	‘	'	PUNCT
bjos-8668473	56	7	pack	pack	NOUN
bjos-8668473	56	8	-	-	PUNCT
bjos-8668473	56	9	years	year	NOUN
bjos-8668473	56	10	’	'	PUNCT
bjos-8668473	56	11	,	,	PUNCT
bjos-8668473	56	12	which	which	PRON
bjos-8668473	56	13	is	be	AUX
bjos-8668473	56	14	defined	define	VERB
bjos-8668473	56	15	as	as	ADP
bjos-8668473	56	16	the	the	DET
bjos-8668473	56	17	number	number	NOUN
bjos-8668473	56	18	of	of	ADP
bjos-8668473	56	19	cigarette	cigarette	NOUN
bjos-8668473	56	20	packs	pack	NOUN
bjos-8668473	56	21	smoked	smoke	VERB
bjos-8668473	56	22	per	per	ADP
bjos-8668473	56	23	day	day	NOUN
bjos-8668473	56	24	multiplied	multiply	VERB
bjos-8668473	56	25	by	by	ADP
bjos-8668473	56	26	the	the	DET
bjos-8668473	56	27	number	number	NOUN
bjos-8668473	56	28	of	of	ADP
bjos-8668473	56	29	years	year	NOUN
bjos-8668473	56	30	in	in	ADP
bjos-8668473	56	31	which	which	PRON
bjos-8668473	56	32	the	the	DET
bjos-8668473	56	33	individual	individual	ADJ
bjos-8668473	56	34	smoked24	smoked24	NOUN
bjos-8668473	56	35	.	.	PUNCT
bjos-8668473	57	1	collection	collection	NOUN
bjos-8668473	57	2	of	of	ADP
bjos-8668473	57	3	saliva	saliva	NOUN
bjos-8668473	57	4	saliva	saliva	NOUN
bjos-8668473	57	5	samples	sample	NOUN
bjos-8668473	57	6	were	be	AUX
bjos-8668473	57	7	collected	collect	VERB
bjos-8668473	57	8	between	between	ADP
bjos-8668473	57	9	1:30	1:30	NUM
bjos-8668473	57	10	and	and	CCONJ
bjos-8668473	57	11	3:30	3:30	NUM
bjos-8668473	57	12	pm	pm	NOUN
bjos-8668473	57	13	.	.	PUNCT
bjos-8668473	58	1	for	for	ADP
bjos-8668473	58	2	such	such	ADJ
bjos-8668473	58	3	,	,	PUNCT
bjos-8668473	58	4	the	the	DET
bjos-8668473	58	5	participant	participant	NOUN
bjos-8668473	58	6	needed	need	VERB
bjos-8668473	58	7	to	to	PART
bjos-8668473	58	8	have	have	AUX
bjos-8668473	58	9	refrained	refrain	VERB
bjos-8668473	58	10	from	from	ADP
bjos-8668473	58	11	consuming	consume	VERB
bjos-8668473	58	12	solid	solid	ADJ
bjos-8668473	58	13	food	food	NOUN
bjos-8668473	58	14	or	or	CCONJ
bjos-8668473	58	15	liquids	liquid	NOUN
bjos-8668473	58	16	for	for	ADP
bjos-8668473	58	17	at	at	ADV
bjos-8668473	58	18	least	least	ADV
bjos-8668473	58	19	two	two	NUM
bjos-8668473	58	20	hours	hour	NOUN
bjos-8668473	58	21	4	4	NUM
bjos-8668473	58	22	ferrazzo	ferrazzo	VERB
bjos-8668473	58	23	et	et	PROPN
bjos-8668473	58	24	al	al	PROPN
bjos-8668473	58	25	.	.	PROPN
bjos-8668473	59	1	braz	braz	PROPN
bjos-8668473	59	2	j	j	PROPN
bjos-8668473	59	3	oral	oral	PROPN
bjos-8668473	59	4	sci	sci	PROPN
bjos-8668473	59	5	.	.	PUNCT
bjos-8668473	60	1	2023;22	2023;22	NUM
bjos-8668473	60	2	:	:	PUNCT
bjos-8668473	60	3	e238473	e238473	NOUN
bjos-8668473	60	4	prior	prior	ADV
bjos-8668473	60	5	to	to	ADP
bjos-8668473	60	6	the	the	DET
bjos-8668473	60	7	collection	collection	NOUN
bjos-8668473	60	8	.	.	PUNCT
bjos-8668473	61	1	non	non	ADJ
bjos-8668473	61	2	-	-	ADJ
bjos-8668473	61	3	stimulated	stimulated	ADJ
bjos-8668473	61	4	saliva	saliva	NOUN
bjos-8668473	61	5	was	be	AUX
bjos-8668473	61	6	collected	collect	VERB
bjos-8668473	61	7	following	follow	VERB
bjos-8668473	61	8	the	the	DET
bjos-8668473	61	9	method	method	NOUN
bjos-8668473	61	10	proposed	propose	VERB
bjos-8668473	61	11	by	by	ADP
bjos-8668473	61	12	navazesh	navazesh	NOUN
bjos-8668473	61	13	and	and	CCONJ
bjos-8668473	61	14	kumar25	kumar25	NOUN
bjos-8668473	61	15	(	(	PUNCT
bjos-8668473	61	16	2008	2008	NUM
bjos-8668473	61	17	)	)	PUNCT
bjos-8668473	61	18	.	.	PUNCT
bjos-8668473	62	1	after	after	ADP
bjos-8668473	62	2	rinsing	rinse	VERB
bjos-8668473	62	3	the	the	DET
bjos-8668473	62	4	mouth	mouth	NOUN
bjos-8668473	62	5	with	with	ADP
bjos-8668473	62	6	distilled	distil	VERB
bjos-8668473	62	7	water	water	NOUN
bjos-8668473	62	8	,	,	PUNCT
bjos-8668473	62	9	the	the	DET
bjos-8668473	62	10	participant	participant	NOUN
bjos-8668473	62	11	was	be	AUX
bjos-8668473	62	12	instructed	instruct	VERB
bjos-8668473	62	13	to	to	PART
bjos-8668473	62	14	remain	remain	VERB
bjos-8668473	62	15	seated	seated	ADJ
bjos-8668473	62	16	with	with	SCONJ
bjos-8668473	62	17	his	his	PRON
bjos-8668473	62	18	/	/	SYM
bjos-8668473	62	19	her	her	PRON
bjos-8668473	62	20	mouth	mouth	NOUN
bjos-8668473	62	21	partially	partially	ADV
bjos-8668473	62	22	open	open	ADJ
bjos-8668473	62	23	until	until	SCONJ
bjos-8668473	62	24	saliva	saliva	NOUN
bjos-8668473	62	25	accumulated	accumulate	VERB
bjos-8668473	62	26	on	on	ADP
bjos-8668473	62	27	the	the	DET
bjos-8668473	62	28	floor	floor	NOUN
bjos-8668473	62	29	of	of	ADP
bjos-8668473	62	30	the	the	DET
bjos-8668473	62	31	mouth	mouth	NOUN
bjos-8668473	62	32	.	.	PUNCT
bjos-8668473	63	1	the	the	DET
bjos-8668473	63	2	participant	participant	NOUN
bjos-8668473	63	3	then	then	ADV
bjos-8668473	63	4	deposited	deposit	VERB
bjos-8668473	63	5	the	the	DET
bjos-8668473	63	6	pooled	pool	VERB
bjos-8668473	63	7	saliva	saliva	NOUN
bjos-8668473	63	8	into	into	ADP
bjos-8668473	63	9	a	a	DET
bjos-8668473	63	10	sterilized	sterilize	VERB
bjos-8668473	63	11	universal	universal	ADJ
bjos-8668473	63	12	collector	collector	NOUN
bjos-8668473	63	13	(	(	PUNCT
bjos-8668473	63	14	duly	duly	ADV
bjos-8668473	63	15	labeled	label	VERB
bjos-8668473	63	16	with	with	ADP
bjos-8668473	63	17	the	the	DET
bjos-8668473	63	18	internal	internal	ADJ
bjos-8668473	63	19	control	control	NOUN
bjos-8668473	63	20	number	number	NOUN
bjos-8668473	63	21	of	of	ADP
bjos-8668473	63	22	the	the	DET
bjos-8668473	63	23	sample	sample	NOUN
bjos-8668473	63	24	)	)	PUNCT
bjos-8668473	63	25	until	until	ADP
bjos-8668473	63	26	obtaining	obtain	VERB
bjos-8668473	63	27	approximately	approximately	ADV
bjos-8668473	63	28	2	2	NUM
bjos-8668473	63	29	ml	ml	NOUN
bjos-8668473	63	30	of	of	ADP
bjos-8668473	63	31	saliva	saliva	NOUN
bjos-8668473	63	32	.	.	PUNCT
bjos-8668473	64	1	the	the	DET
bjos-8668473	64	2	samples	sample	NOUN
bjos-8668473	64	3	were	be	AUX
bjos-8668473	64	4	placed	place	VERB
bjos-8668473	64	5	in	in	ADP
bjos-8668473	64	6	a	a	DET
bjos-8668473	64	7	thermal	thermal	ADJ
bjos-8668473	64	8	bag	bag	NOUN
bjos-8668473	64	9	with	with	ADP
bjos-8668473	64	10	ice	ice	NOUN
bjos-8668473	64	11	for	for	ADP
bjos-8668473	64	12	transportation	transportation	NOUN
bjos-8668473	64	13	to	to	ADP
bjos-8668473	64	14	the	the	DET
bjos-8668473	64	15	laboratory	laboratory	NOUN
bjos-8668473	64	16	.	.	PUNCT
bjos-8668473	65	1	all	all	DET
bjos-8668473	65	2	samples	sample	NOUN
bjos-8668473	65	3	were	be	AUX
bjos-8668473	65	4	prepared	prepare	VERB
bjos-8668473	65	5	for	for	ADP
bjos-8668473	65	6	analysis	analysis	NOUN
bjos-8668473	65	7	within	within	ADP
bjos-8668473	65	8	a	a	DET
bjos-8668473	65	9	maximum	maximum	NOUN
bjos-8668473	65	10	of	of	ADP
bjos-8668473	65	11	three	three	NUM
bjos-8668473	65	12	hours	hour	NOUN
bjos-8668473	65	13	after	after	ADP
bjos-8668473	65	14	collection	collection	NOUN
bjos-8668473	65	15	.	.	PUNCT
bjos-8668473	66	1	preparation	preparation	NOUN
bjos-8668473	66	2	of	of	ADP
bjos-8668473	66	3	saliva	saliva	NOUN
bjos-8668473	66	4	the	the	DET
bjos-8668473	66	5	saliva	saliva	NOUN
bjos-8668473	66	6	samples	sample	NOUN
bjos-8668473	66	7	were	be	AUX
bjos-8668473	66	8	centrifuged	centrifuge	VERB
bjos-8668473	66	9	at	at	ADP
bjos-8668473	66	10	3500	3500	NUM
bjos-8668473	66	11	g	g	NOUN
bjos-8668473	66	12	for	for	ADP
bjos-8668473	66	13	20	20	NUM
bjos-8668473	66	14	min	min	NOUN
bjos-8668473	66	15	at	at	ADP
bjos-8668473	66	16	4º	4º	PROPN
bjos-8668473	66	17	c	c	PROPN
bjos-8668473	66	18	for	for	ADP
bjos-8668473	66	19	the	the	DET
bjos-8668473	66	20	removal	removal	NOUN
bjos-8668473	66	21	of	of	ADP
bjos-8668473	66	22	any	any	DET
bjos-8668473	66	23	insoluble	insoluble	ADJ
bjos-8668473	66	24	matter	matter	NOUN
bjos-8668473	66	25	,	,	PUNCT
bjos-8668473	66	26	cell	cell	NOUN
bjos-8668473	66	27	remains	remain	VERB
bjos-8668473	66	28	and	and	CCONJ
bjos-8668473	66	29	food	food	NOUN
bjos-8668473	66	30	scraps	scrap	NOUN
bjos-8668473	66	31	.	.	PUNCT
bjos-8668473	67	1	each	each	DET
bjos-8668473	67	2	sample	sample	NOUN
bjos-8668473	67	3	was	be	AUX
bjos-8668473	67	4	divided	divide	VERB
bjos-8668473	67	5	into	into	ADP
bjos-8668473	67	6	aliquots	aliquot	NOUN
bjos-8668473	67	7	of	of	ADP
bjos-8668473	67	8	400	400	NUM
bjos-8668473	67	9	µl	µl	ADV
bjos-8668473	67	10	and	and	CCONJ
bjos-8668473	67	11	frozen	freeze	VERB
bjos-8668473	67	12	at	at	ADP
bjos-8668473	67	13	-80	-80	NUM
bjos-8668473	67	14	°	°	ADP
bjos-8668473	67	15	c	c	NOUN
bjos-8668473	67	16	until	until	ADP
bjos-8668473	67	17	analysis	analysis	NOUN
bjos-8668473	67	18	,	,	PUNCT
bjos-8668473	67	19	which	which	PRON
bjos-8668473	67	20	was	be	AUX
bjos-8668473	67	21	performed	perform	VERB
bjos-8668473	67	22	within	within	ADP
bjos-8668473	67	23	a	a	DET
bjos-8668473	67	24	maximum	maximum	NOUN
bjos-8668473	67	25	of	of	ADP
bjos-8668473	67	26	four	four	NUM
bjos-8668473	67	27	weeks	week	NOUN
bjos-8668473	67	28	.	.	PUNCT
bjos-8668473	68	1	the	the	DET
bjos-8668473	68	2	saliva	saliva	NOUN
bjos-8668473	68	3	samples	sample	NOUN
bjos-8668473	68	4	were	be	AUX
bjos-8668473	68	5	thawed	thaw	VERB
bjos-8668473	68	6	at	at	ADP
bjos-8668473	68	7	room	room	NOUN
bjos-8668473	68	8	temperature	temperature	NOUN
bjos-8668473	68	9	prior	prior	ADV
bjos-8668473	68	10	to	to	ADP
bjos-8668473	68	11	analysis	analysis	NOUN
bjos-8668473	68	12	.	.	PUNCT
bjos-8668473	69	1	to	to	PART
bjos-8668473	69	2	precipitate	precipitate	VERB
bjos-8668473	69	3	the	the	DET
bjos-8668473	69	4	proteins	protein	NOUN
bjos-8668473	69	5	,	,	PUNCT
bjos-8668473	69	6	a	a	DET
bjos-8668473	69	7	mixture	mixture	NOUN
bjos-8668473	69	8	of	of	ADP
bjos-8668473	69	9	acetonitrile	acetonitrile	ADJ
bjos-8668473	69	10	/	/	SYM
bjos-8668473	69	11	methanol	methanol	NOUN
bjos-8668473	69	12	(	(	PUNCT
bjos-8668473	69	13	75:25	75:25	NUM
bjos-8668473	69	14	v	v	NOUN
bjos-8668473	69	15	/	/	SYM
bjos-8668473	69	16	v	v	NOUN
bjos-8668473	69	17	,	,	PUNCT
bjos-8668473	69	18	800	800	NUM
bjos-8668473	69	19	μl	μl	PRON
bjos-8668473	69	20	)	)	PUNCT
bjos-8668473	69	21	was	be	AUX
bjos-8668473	69	22	added	add	VERB
bjos-8668473	69	23	to	to	ADP
bjos-8668473	69	24	400	400	NUM
bjos-8668473	69	25	µl	µl	ADP
bjos-8668473	69	26	of	of	ADP
bjos-8668473	69	27	saliva	saliva	NOUN
bjos-8668473	69	28	in	in	ADP
bjos-8668473	69	29	a	a	DET
bjos-8668473	69	30	1.5	1.5	NUM
bjos-8668473	69	31	-	-	PUNCT
bjos-8668473	69	32	ml	ml	NOUN
bjos-8668473	69	33	eppendorf	eppendorf	PROPN
bjos-8668473	69	34	tube	tube	PROPN
bjos-8668473	69	35	,	,	PUNCT
bjos-8668473	69	36	followed	follow	VERB
bjos-8668473	69	37	by	by	ADP
bjos-8668473	69	38	vigorous	vigorous	ADJ
bjos-8668473	69	39	shaking	shake	VERB
bjos-8668473	69	40	for	for	ADP
bjos-8668473	69	41	60	60	NUM
bjos-8668473	69	42	seconds	second	NOUN
bjos-8668473	69	43	.	.	PUNCT
bjos-8668473	70	1	the	the	DET
bjos-8668473	70	2	mixture	mixture	NOUN
bjos-8668473	70	3	was	be	AUX
bjos-8668473	70	4	left	leave	VERB
bjos-8668473	70	5	to	to	PART
bjos-8668473	70	6	rest	rest	VERB
bjos-8668473	70	7	for	for	ADP
bjos-8668473	70	8	10	10	NUM
bjos-8668473	70	9	minutes	minute	NOUN
bjos-8668473	70	10	,	,	PUNCT
bjos-8668473	70	11	after	after	ADP
bjos-8668473	70	12	which	which	PRON
bjos-8668473	70	13	the	the	DET
bjos-8668473	70	14	samples	sample	NOUN
bjos-8668473	70	15	were	be	AUX
bjos-8668473	70	16	centrifuged	centrifuge	VERB
bjos-8668473	70	17	at	at	ADP
bjos-8668473	70	18	15400	15400	NUM
bjos-8668473	70	19	g	g	NOUN
bjos-8668473	70	20	for	for	ADP
bjos-8668473	70	21	20	20	NUM
bjos-8668473	70	22	min	min	NOUN
bjos-8668473	70	23	at	at	ADP
bjos-8668473	70	24	4	4	NUM
bjos-8668473	70	25	°	°	ADP
bjos-8668473	70	26	c.	c.	NOUN
bjos-8668473	70	27	the	the	DET
bjos-8668473	70	28	supernatant	supernatant	NOUN
bjos-8668473	70	29	was	be	AUX
bjos-8668473	70	30	filtered	filter	VERB
bjos-8668473	70	31	using	use	VERB
bjos-8668473	70	32	a	a	DET
bjos-8668473	70	33	syringe	syringe	NOUN
bjos-8668473	70	34	filter	filter	NOUN
bjos-8668473	70	35	and	and	CCONJ
bjos-8668473	70	36	the	the	DET
bjos-8668473	70	37	material	material	NOUN
bjos-8668473	70	38	was	be	AUX
bjos-8668473	70	39	analyzed18,26	analyzed18,26	ADJ
bjos-8668473	70	40	.	.	PUNCT
bjos-8668473	71	1	all	all	DET
bjos-8668473	71	2	saliva	saliva	NOUN
bjos-8668473	71	3	samples	sample	NOUN
bjos-8668473	71	4	were	be	AUX
bjos-8668473	71	5	collected	collect	VERB
bjos-8668473	71	6	,	,	PUNCT
bjos-8668473	71	7	prepared	prepared	ADJ
bjos-8668473	71	8	and	and	CCONJ
bjos-8668473	71	9	analyzed	analyze	VERB
bjos-8668473	71	10	by	by	ADP
bjos-8668473	71	11	the	the	DET
bjos-8668473	71	12	same	same	ADJ
bjos-8668473	71	13	researcher	researcher	NOUN
bjos-8668473	71	14	.	.	PUNCT
bjos-8668473	72	1	liquid	liquid	ADJ
bjos-8668473	72	2	chromatography	chromatography	NOUN
bjos-8668473	72	3	–	–	PUNCT
bjos-8668473	72	4	mass	mass	NOUN
bjos-8668473	72	5	spectrometry	spectrometry	NOUN
bjos-8668473	72	6	(	(	PUNCT
bjos-8668473	72	7	lc	lc	PROPN
bjos-8668473	72	8	-	-	PUNCT
bjos-8668473	72	9	ms	ms	PROPN
bjos-8668473	72	10	/	/	SYM
bjos-8668473	72	11	ms	ms	PROPN
bjos-8668473	72	12	)	)	PUNCT
bjos-8668473	72	13	the	the	DET
bjos-8668473	72	14	chromatographic	chromatographic	ADJ
bjos-8668473	72	15	analysis	analysis	NOUN
bjos-8668473	72	16	was	be	AUX
bjos-8668473	72	17	performed	perform	VERB
bjos-8668473	72	18	using	use	VERB
bjos-8668473	72	19	a	a	DET
bjos-8668473	72	20	1200	1200	NUM
bjos-8668473	72	21	series	series	NOUN
bjos-8668473	72	22	liquid	liquid	ADJ
bjos-8668473	72	23	chromatography	chromatography	NOUN
bjos-8668473	72	24	system	system	NOUN
bjos-8668473	72	25	(	(	PUNCT
bjos-8668473	72	26	agilent	agilent	PROPN
bjos-8668473	72	27	technologies	technology	NOUN
bjos-8668473	72	28	)	)	PUNCT
bjos-8668473	72	29	equipped	equip	VERB
bjos-8668473	72	30	with	with	ADP
bjos-8668473	72	31	a	a	DET
bjos-8668473	72	32	hypercarb	hypercarb	PROPN
bjos-8668473	72	33	column	column	NOUN
bjos-8668473	72	34	(	(	PUNCT
bjos-8668473	72	35	100	100	NUM
bjos-8668473	72	36	mm	mm	NOUN
bjos-8668473	72	37	×	×	NOUN
bjos-8668473	72	38	2.1	2.1	NUM
bjos-8668473	72	39	mm	mm	NOUN
bjos-8668473	72	40	i.d	i.d	PROPN
bjos-8668473	72	41	.	.	PROPN
bjos-8668473	72	42	5	5	NUM
bjos-8668473	72	43	μm	μm	NOUN
bjos-8668473	72	44	)	)	PUNCT
bjos-8668473	72	45	(	(	PUNCT
bjos-8668473	72	46	thermo	thermo	NOUN
bjos-8668473	72	47	scientific	scientific	NOUN
bjos-8668473	72	48	)	)	PUNCT
bjos-8668473	72	49	and	and	CCONJ
bjos-8668473	72	50	coupled	couple	VERB
bjos-8668473	72	51	to	to	ADP
bjos-8668473	72	52	a	a	DET
bjos-8668473	72	53	6460	6460	NUM
bjos-8668473	72	54	triple	triple	ADJ
bjos-8668473	72	55	quad	quad	NOUN
bjos-8668473	72	56	detector	detector	NOUN
bjos-8668473	72	57	(	(	PUNCT
bjos-8668473	72	58	agilent	agilent	PROPN
bjos-8668473	72	59	technologies	technology	NOUN
bjos-8668473	72	60	)	)	PUNCT
bjos-8668473	72	61	.	.	PUNCT
bjos-8668473	73	1	the	the	DET
bjos-8668473	73	2	column	column	NOUN
bjos-8668473	73	3	temperature	temperature	NOUN
bjos-8668473	73	4	was	be	AUX
bjos-8668473	73	5	set	set	VERB
bjos-8668473	73	6	at	at	ADP
bjos-8668473	73	7	30	30	NUM
bjos-8668473	73	8	°	°	ADP
bjos-8668473	73	9	c.	c.	NOUN
bjos-8668473	73	10	the	the	DET
bjos-8668473	73	11	autosampler	autosampler	NOUN
bjos-8668473	73	12	is	be	AUX
bjos-8668473	73	13	equipped	equip	VERB
bjos-8668473	73	14	with	with	ADP
bjos-8668473	73	15	a	a	DET
bjos-8668473	73	16	40	40	NUM
bjos-8668473	73	17	μl	μl	NOUN
bjos-8668473	73	18	loop	loop	NOUN
bjos-8668473	73	19	but	but	CCONJ
bjos-8668473	73	20	operated	operate	VERB
bjos-8668473	73	21	using	use	VERB
bjos-8668473	73	22	5	5	NUM
bjos-8668473	73	23	μl	μl	NOUN
bjos-8668473	73	24	.	.	PUNCT
bjos-8668473	74	1	the	the	DET
bjos-8668473	74	2	flow	flow	NOUN
bjos-8668473	74	3	rate	rate	NOUN
bjos-8668473	74	4	of	of	ADP
bjos-8668473	74	5	the	the	DET
bjos-8668473	74	6	mobile	mobile	ADJ
bjos-8668473	74	7	phase	phase	NOUN
bjos-8668473	74	8	was	be	AUX
bjos-8668473	74	9	0.8	0.8	NUM
bjos-8668473	74	10	ml	ml	NOUN
bjos-8668473	74	11	/	/	SYM
bjos-8668473	74	12	min	min	NOUN
bjos-8668473	74	13	.	.	PROPN
bjos-8668473	74	14	isocratic	isocratic	ADJ
bjos-8668473	74	15	elution	elution	NOUN
bjos-8668473	74	16	was	be	AUX
bjos-8668473	74	17	performed	perform	VERB
bjos-8668473	74	18	using	use	VERB
bjos-8668473	74	19	the	the	DET
bjos-8668473	74	20	following	follow	VERB
bjos-8668473	74	21	solvent	solvent	NOUN
bjos-8668473	74	22	system	system	NOUN
bjos-8668473	74	23	:	:	PUNCT
bjos-8668473	74	24	(	(	PUNCT
bjos-8668473	74	25	a	a	X
bjos-8668473	74	26	)	)	PUNCT
bjos-8668473	74	27	composed	compose	VERB
bjos-8668473	74	28	of	of	ADP
bjos-8668473	74	29	purified	purified	ADJ
bjos-8668473	74	30	water	water	NOUN
bjos-8668473	74	31	,	,	PUNCT
bjos-8668473	74	32	0.5	0.5	NUM
bjos-8668473	74	33	%	%	NOUN
bjos-8668473	74	34	ammonium	ammonium	NOUN
bjos-8668473	74	35	formate	formate	NOUN
bjos-8668473	74	36	and	and	CCONJ
bjos-8668473	74	37	0.01	0.01	NUM
bjos-8668473	74	38	%	%	NOUN
bjos-8668473	74	39	formic	formic	ADJ
bjos-8668473	74	40	acid	acid	NOUN
bjos-8668473	74	41	;	;	PUNCT
bjos-8668473	74	42	(	(	PUNCT
bjos-8668473	74	43	b	b	X
bjos-8668473	74	44	)	)	PUNCT
bjos-8668473	74	45	acetonitrile	acetonitrile	NOUN
bjos-8668473	74	46	,	,	PUNCT
bjos-8668473	74	47	4.5	4.5	NUM
bjos-8668473	74	48	%	%	NOUN
bjos-8668473	74	49	purified	purified	ADJ
bjos-8668473	74	50	water	water	NOUN
bjos-8668473	74	51	,	,	PUNCT
bjos-8668473	74	52	0.5	0.5	NUM
bjos-8668473	74	53	%	%	NOUN
bjos-8668473	74	54	ammonium	ammonium	NOUN
bjos-8668473	74	55	formate	formate	NOUN
bjos-8668473	74	56	and	and	CCONJ
bjos-8668473	74	57	0.01	0.01	NUM
bjos-8668473	74	58	%	%	NOUN
bjos-8668473	74	59	formic	formic	ADJ
bjos-8668473	74	60	acid	acid	NOUN
bjos-8668473	74	61	;	;	PUNCT
bjos-8668473	74	62	80	80	NUM
bjos-8668473	74	63	%	%	NOUN
bjos-8668473	74	64	a	a	PRON
bjos-8668473	74	65	and	and	CCONJ
bjos-8668473	74	66	20	20	NUM
bjos-8668473	74	67	%	%	NOUN
bjos-8668473	74	68	b	b	NOUN
bjos-8668473	74	69	for	for	ADP
bjos-8668473	74	70	5	5	NUM
bjos-8668473	74	71	min	min	NOUN
bjos-8668473	74	72	.	.	PROPN
bjos-8668473	74	73	lc	lc	PROPN
bjos-8668473	74	74	-	-	PUNCT
bjos-8668473	74	75	ms	ms	PROPN
bjos-8668473	74	76	/	/	PROPN
bjos-8668473	74	77	ms	ms	PROPN
bjos-8668473	74	78	was	be	AUX
bjos-8668473	74	79	operated	operate	VERB
bjos-8668473	74	80	in	in	ADP
bjos-8668473	74	81	the	the	DET
bjos-8668473	74	82	positive	positive	ADJ
bjos-8668473	74	83	ion	ion	NOUN
bjos-8668473	74	84	mode	mode	NOUN
bjos-8668473	74	85	.	.	PUNCT
bjos-8668473	75	1	for	for	ADP
bjos-8668473	75	2	the	the	DET
bjos-8668473	75	3	analysis	analysis	NOUN
bjos-8668473	75	4	of	of	ADP
bjos-8668473	75	5	the	the	DET
bjos-8668473	75	6	raw	raw	ADJ
bjos-8668473	75	7	data	datum	NOUN
bjos-8668473	75	8	,	,	PUNCT
bjos-8668473	75	9	an	an	DET
bjos-8668473	75	10	agilent	agilent	PROPN
bjos-8668473	75	11	mass	mass	PROPN
bjos-8668473	75	12	hunter	hunter	PROPN
bjos-8668473	75	13	data	datum	NOUN
bjos-8668473	75	14	acquisition	acquisition	NOUN
bjos-8668473	75	15	and	and	CCONJ
bjos-8668473	75	16	processing	processing	NOUN
bjos-8668473	75	17	was	be	AUX
bjos-8668473	75	18	used	use	VERB
bjos-8668473	75	19	for	for	ADP
bjos-8668473	75	20	the	the	DET
bjos-8668473	75	21	qualitative	qualitative	ADJ
bjos-8668473	75	22	and	and	CCONJ
bjos-8668473	75	23	quantitative	quantitative	ADJ
bjos-8668473	75	24	analyses	analysis	NOUN
bjos-8668473	75	25	.	.	PUNCT
bjos-8668473	76	1	in	in	ADP
bjos-8668473	76	2	this	this	DET
bjos-8668473	76	3	study	study	NOUN
bjos-8668473	76	4	,	,	PUNCT
bjos-8668473	76	5	independent	independent	ADJ
bjos-8668473	76	6	reference	reference	NOUN
bjos-8668473	76	7	lock	lock	NOUN
bjos-8668473	76	8	-	-	PUNCT
bjos-8668473	76	9	mass	mass	NOUN
bjos-8668473	76	10	ions	ion	NOUN
bjos-8668473	76	11	were	be	AUX
bjos-8668473	76	12	obtained	obtain	VERB
bjos-8668473	76	13	in	in	ADP
bjos-8668473	76	14	previous	previous	ADJ
bjos-8668473	76	15	validation	validation	NOUN
bjos-8668473	76	16	via	via	ADP
bjos-8668473	76	17	an	an	DET
bjos-8668473	76	18	electrospray	electrospray	NOUN
bjos-8668473	76	19	source	source	NOUN
bjos-8668473	76	20	interface	interface	NOUN
bjos-8668473	76	21	to	to	PART
bjos-8668473	76	22	ensure	ensure	VERB
bjos-8668473	76	23	mass	mass	ADJ
bjos-8668473	76	24	accuracy	accuracy	NOUN
bjos-8668473	76	25	during	during	ADP
bjos-8668473	76	26	data	data	NOUN
bjos-8668473	76	27	acquisition	acquisition	NOUN
bjos-8668473	76	28	.	.	PUNCT
bjos-8668473	77	1	the	the	DET
bjos-8668473	77	2	accuracy	accuracy	NOUN
bjos-8668473	77	3	of	of	ADP
bjos-8668473	77	4	the	the	DET
bjos-8668473	77	5	obtained	obtain	VERB
bjos-8668473	77	6	mass	mass	NOUN
bjos-8668473	77	7	ions	ion	NOUN
bjos-8668473	77	8	is	be	AUX
bjos-8668473	77	9	0.1	0.1	NUM
bjos-8668473	77	10	atomic	atomic	ADJ
bjos-8668473	77	11	mass	mass	NOUN
bjos-8668473	77	12	units	unit	NOUN
bjos-8668473	77	13	.	.	PUNCT
bjos-8668473	78	1	pipecolic	pipecolic	PROPN
bjos-8668473	78	2	acid	acid	PROPN
bjos-8668473	78	3	(	(	PUNCT
bjos-8668473	78	4	sigma	sigma	PROPN
bjos-8668473	78	5	;	;	PUNCT
bjos-8668473	78	6	st	st	PROPN
bjos-8668473	78	7	.	.	PROPN
bjos-8668473	78	8	louis	louis	PROPN
bjos-8668473	78	9	,	,	PUNCT
bjos-8668473	78	10	mo	mo	PROPN
bjos-8668473	78	11	,	,	PUNCT
bjos-8668473	78	12	usa	usa	PROPN
bjos-8668473	78	13	)	)	PUNCT
bjos-8668473	78	14	;	;	PUNCT
bjos-8668473	79	1	[	[	X
bjos-8668473	79	2	pa	pa	X
bjos-8668473	79	3	+	+	PROPN
bjos-8668473	79	4	h]+	h]+	PROPN
bjos-8668473	79	5	,	,	PUNCT
bjos-8668473	79	6	m	m	NOUN
bjos-8668473	79	7	/	/	SYM
bjos-8668473	79	8	z	z	PROPN
bjos-8668473	79	9	130.157	130.157	NUM
bjos-8668473	79	10	)	)	PUNCT
bjos-8668473	79	11	was	be	AUX
bjos-8668473	79	12	used	use	VERB
bjos-8668473	79	13	as	as	ADP
bjos-8668473	79	14	the	the	DET
bjos-8668473	79	15	standard	standard	ADJ
bjos-8668473	79	16	compound	compound	NOUN
bjos-8668473	79	17	.	.	PUNCT
bjos-8668473	80	1	multiple	multiple	ADJ
bjos-8668473	80	2	reaction	reaction	NOUN
bjos-8668473	80	3	monitoring	monitoring	NOUN
bjos-8668473	80	4	was	be	AUX
bjos-8668473	80	5	conducted	conduct	VERB
bjos-8668473	80	6	to	to	PART
bjos-8668473	80	7	optimize	optimize	VERB
bjos-8668473	80	8	the	the	DET
bjos-8668473	80	9	fragmentation	fragmentation	NOUN
bjos-8668473	80	10	conditions	condition	NOUN
bjos-8668473	80	11	and	and	CCONJ
bjos-8668473	80	12	identify	identify	VERB
bjos-8668473	80	13	the	the	DET
bjos-8668473	80	14	best	good	ADJ
bjos-8668473	80	15	precursor	precursor	NOUN
bjos-8668473	80	16	/	/	SYM
bjos-8668473	80	17	product	product	NOUN
bjos-8668473	80	18	transitions	transition	NOUN
bjos-8668473	80	19	for	for	ADP
bjos-8668473	80	20	quantitation	quantitation	NOUN
bjos-8668473	80	21	and	and	CCONJ
bjos-8668473	80	22	confirmation	confirmation	NOUN
bjos-8668473	80	23	.	.	PUNCT
bjos-8668473	81	1	the	the	DET
bjos-8668473	81	2	analysis	analysis	NOUN
bjos-8668473	81	3	was	be	AUX
bjos-8668473	81	4	performed	perform	VERB
bjos-8668473	81	5	in	in	ADP
bjos-8668473	81	6	the	the	DET
bjos-8668473	81	7	selected	select	VERB
bjos-8668473	81	8	-	-	PUNCT
bjos-8668473	81	9	reaction	reaction	NOUN
bjos-8668473	81	10	monitoring	monitoring	NOUN
bjos-8668473	81	11	mode	mode	NOUN
bjos-8668473	81	12	using	use	VERB
bjos-8668473	81	13	two	two	NUM
bjos-8668473	81	14	transitions	transition	NOUN
bjos-8668473	81	15	:	:	PUNCT
bjos-8668473	81	16	m	m	X
bjos-8668473	81	17	/	/	SYM
bjos-8668473	81	18	z	z	PROPN
bjos-8668473	81	19	130.1	130.1	NUM
bjos-8668473	81	20	-	-	PUNCT
bjos-8668473	81	21	->m	->m	NOUN
bjos-8668473	81	22	/	/	SYM
bjos-8668473	81	23	z	z	NOUN
bjos-8668473	81	24	84.1	84.1	NUM
bjos-8668473	81	25	,	,	PUNCT
bjos-8668473	81	26	collision	collision	VERB
bjos-8668473	81	27	energy	energy	NOUN
bjos-8668473	81	28	of	of	ADP
bjos-8668473	81	29	15	15	NUM
bjos-8668473	81	30	ev	ev	NOUN
bjos-8668473	81	31	.	.	PROPN
bjos-8668473	81	32	5	5	NUM
bjos-8668473	81	33	ferrazzo	ferrazzo	VERB
bjos-8668473	82	1	et	et	PROPN
bjos-8668473	82	2	al	al	PROPN
bjos-8668473	82	3	.	.	PROPN
bjos-8668473	82	4	braz	braz	PROPN
bjos-8668473	82	5	j	j	PROPN
bjos-8668473	82	6	oral	oral	PROPN
bjos-8668473	82	7	sci	sci	PROPN
bjos-8668473	82	8	.	.	PUNCT
bjos-8668473	83	1	2023;22	2023;22	NUM
bjos-8668473	83	2	:	:	PUNCT
bjos-8668473	83	3	e238473	e238473	NUM
bjos-8668473	83	4	statistical	statistical	ADJ
bjos-8668473	83	5	analysis	analysis	NOUN
bjos-8668473	83	6	the	the	DET
bjos-8668473	83	7	data	datum	NOUN
bjos-8668473	83	8	were	be	AUX
bjos-8668473	83	9	analyzed	analyze	VERB
bjos-8668473	83	10	descriptively	descriptively	ADV
bjos-8668473	83	11	and	and	CCONJ
bjos-8668473	83	12	expressed	express	VERB
bjos-8668473	83	13	as	as	ADP
bjos-8668473	83	14	mean	mean	ADJ
bjos-8668473	83	15	,	,	PUNCT
bjos-8668473	83	16	standard	standard	ADJ
bjos-8668473	83	17	deviation	deviation	NOUN
bjos-8668473	83	18	and	and	CCONJ
bjos-8668473	83	19	median	median	ADJ
bjos-8668473	83	20	values	value	NOUN
bjos-8668473	83	21	.	.	PUNCT
bjos-8668473	84	1	the	the	DET
bjos-8668473	84	2	outcome	outcome	NOUN
bjos-8668473	84	3	was	be	AUX
bjos-8668473	84	4	pipecolic	pipecolic	ADJ
bjos-8668473	84	5	acid	acid	PROPN
bjos-8668473	84	6	determined	determine	VERB
bjos-8668473	84	7	in	in	ADP
bjos-8668473	84	8	ng	ng	PROPN
bjos-8668473	84	9	/	/	SYM
bjos-8668473	84	10	ml	ml	PROPN
bjos-8668473	84	11	.	.	PUNCT
bjos-8668473	85	1	the	the	DET
bjos-8668473	85	2	categorical	categorical	ADJ
bjos-8668473	85	3	covariables	covariable	NOUN
bjos-8668473	85	4	were	be	AUX
bjos-8668473	85	5	sex	sex	NOUN
bjos-8668473	85	6	,	,	PUNCT
bjos-8668473	85	7	age	age	NOUN
bjos-8668473	85	8	,	,	PUNCT
bjos-8668473	85	9	schooling	schooling	NOUN
bjos-8668473	85	10	,	,	PUNCT
bjos-8668473	85	11	smoking	smoking	NOUN
bjos-8668473	85	12	status	status	NOUN
bjos-8668473	85	13	and	and	CCONJ
bjos-8668473	85	14	cumulative	cumulative	ADJ
bjos-8668473	85	15	tobacco	tobacco	NOUN
bjos-8668473	85	16	dose	dose	NOUN
bjos-8668473	85	17	(	(	PUNCT
bjos-8668473	85	18	pack	pack	NOUN
bjos-8668473	85	19	-	-	PUNCT
bjos-8668473	85	20	years	year	NOUN
bjos-8668473	85	21	)	)	PUNCT
bjos-8668473	85	22	.	.	PUNCT
bjos-8668473	86	1	for	for	ADP
bjos-8668473	86	2	the	the	DET
bjos-8668473	86	3	purposes	purpose	NOUN
bjos-8668473	86	4	of	of	ADP
bjos-8668473	86	5	statistical	statistical	ADJ
bjos-8668473	86	6	analysis	analysis	NOUN
bjos-8668473	86	7	,	,	PUNCT
bjos-8668473	86	8	age	age	NOUN
bjos-8668473	86	9	,	,	PUNCT
bjos-8668473	86	10	schooling	schooling	NOUN
bjos-8668473	86	11	and	and	CCONJ
bjos-8668473	86	12	pack	pack	NOUN
bjos-8668473	86	13	-	-	PUNCT
bjos-8668473	86	14	years	year	NOUN
bjos-8668473	86	15	were	be	AUX
bjos-8668473	86	16	dichotomized	dichotomize	VERB
bjos-8668473	86	17	by	by	ADP
bjos-8668473	86	18	the	the	DET
bjos-8668473	86	19	median	median	NOUN
bjos-8668473	86	20	of	of	ADP
bjos-8668473	86	21	the	the	DET
bjos-8668473	86	22	entire	entire	ADJ
bjos-8668473	86	23	sample	sample	NOUN
bjos-8668473	86	24	.	.	PUNCT
bjos-8668473	87	1	a	a	DET
bjos-8668473	87	2	variable	variable	ADJ
bjos-8668473	87	3	denominated	denominate	VERB
bjos-8668473	87	4	comorbidity	comorbidity	NOUN
bjos-8668473	87	5	was	be	AUX
bjos-8668473	87	6	created	create	VERB
bjos-8668473	87	7	to	to	PART
bjos-8668473	87	8	analyze	analyze	VERB
bjos-8668473	87	9	individual	individual	ADJ
bjos-8668473	87	10	patients	patient	NOUN
bjos-8668473	87	11	using	use	VERB
bjos-8668473	87	12	oral	oral	ADJ
bjos-8668473	87	13	hypoglycemic	hypoglycemic	ADJ
bjos-8668473	87	14	drugs	drug	NOUN
bjos-8668473	87	15	.	.	PUNCT
bjos-8668473	88	1	to	to	PART
bjos-8668473	88	2	determine	determine	VERB
bjos-8668473	88	3	pipecolic	pipecolic	NOUN
bjos-8668473	88	4	acid	acid	NOUN
bjos-8668473	88	5	levels	level	NOUN
bjos-8668473	88	6	in	in	ADP
bjos-8668473	88	7	relation	relation	NOUN
bjos-8668473	88	8	to	to	ADP
bjos-8668473	88	9	the	the	DET
bjos-8668473	88	10	stage	stage	NOUN
bjos-8668473	88	11	of	of	ADP
bjos-8668473	88	12	the	the	DET
bjos-8668473	88	13	disease	disease	NOUN
bjos-8668473	88	14	,	,	PUNCT
bjos-8668473	88	15	the	the	DET
bjos-8668473	88	16	case	case	NOUN
bjos-8668473	88	17	group	group	NOUN
bjos-8668473	88	18	was	be	AUX
bjos-8668473	88	19	subdivided	subdivide	VERB
bjos-8668473	88	20	into	into	ADP
bjos-8668473	88	21	case	case	NOUN
bjos-8668473	88	22	group	group	NOUN
bjos-8668473	88	23	1	1	NUM
bjos-8668473	88	24	(	(	PUNCT
bjos-8668473	88	25	stages	stage	NOUN
bjos-8668473	88	26	i	i	PRON
bjos-8668473	88	27	and	and	CCONJ
bjos-8668473	88	28	ii	ii	NOUN
bjos-8668473	88	29	)	)	PUNCT
bjos-8668473	88	30	and	and	CCONJ
bjos-8668473	88	31	case	case	NOUN
bjos-8668473	88	32	group	group	NOUN
bjos-8668473	88	33	2	2	NUM
bjos-8668473	88	34	(	(	PUNCT
bjos-8668473	88	35	stages	stage	NOUN
bjos-8668473	88	36	iii	iii	NOUN
bjos-8668473	88	37	and	and	CCONJ
bjos-8668473	88	38	iv	iv	NUM
bjos-8668473	88	39	)	)	PUNCT
bjos-8668473	88	40	.	.	PUNCT
bjos-8668473	89	1	the	the	DET
bjos-8668473	89	2	shapiro	shapiro	PROPN
bjos-8668473	89	3	-	-	PUNCT
bjos-8668473	89	4	wilk	wilk	NOUN
bjos-8668473	89	5	test	test	NOUN
bjos-8668473	89	6	was	be	AUX
bjos-8668473	89	7	used	use	VERB
bjos-8668473	89	8	to	to	PART
bjos-8668473	89	9	determine	determine	VERB
bjos-8668473	89	10	the	the	DET
bjos-8668473	89	11	normality	normality	NOUN
bjos-8668473	89	12	of	of	ADP
bjos-8668473	89	13	the	the	DET
bjos-8668473	89	14	variables	variable	NOUN
bjos-8668473	89	15	.	.	PUNCT
bjos-8668473	90	1	the	the	DET
bjos-8668473	90	2	student	student	NOUN
bjos-8668473	90	3	’s	’s	PART
bjos-8668473	90	4	t	t	PROPN
bjos-8668473	90	5	-	-	PUNCT
bjos-8668473	90	6	test	test	NOUN
bjos-8668473	90	7	and	and	CCONJ
bjos-8668473	90	8	mann	mann	PROPN
bjos-8668473	90	9	-	-	PUNCT
bjos-8668473	90	10	whitney	whitney	PROPN
bjos-8668473	90	11	test	test	NOUN
bjos-8668473	90	12	were	be	AUX
bjos-8668473	90	13	used	use	VERB
bjos-8668473	90	14	for	for	ADP
bjos-8668473	90	15	the	the	DET
bjos-8668473	90	16	comparisons	comparison	NOUN
bjos-8668473	90	17	of	of	ADP
bjos-8668473	90	18	mean	mean	ADJ
bjos-8668473	90	19	pipecolic	pipecolic	NOUN
bjos-8668473	90	20	acid	acid	NOUN
bjos-8668473	90	21	levels	level	NOUN
bjos-8668473	90	22	between	between	ADP
bjos-8668473	90	23	the	the	DET
bjos-8668473	90	24	case	case	NOUN
bjos-8668473	90	25	and	and	CCONJ
bjos-8668473	90	26	control	control	NOUN
bjos-8668473	90	27	groups	group	NOUN
bjos-8668473	90	28	as	as	ADV
bjos-8668473	90	29	well	well	ADV
bjos-8668473	90	30	as	as	ADP
bjos-8668473	90	31	among	among	ADP
bjos-8668473	90	32	the	the	DET
bjos-8668473	90	33	clinical	clinical	ADJ
bjos-8668473	90	34	and	and	CCONJ
bjos-8668473	90	35	demographic	demographic	ADJ
bjos-8668473	90	36	variables	variable	NOUN
bjos-8668473	90	37	.	.	PUNCT
bjos-8668473	91	1	the	the	DET
bjos-8668473	91	2	level	level	NOUN
bjos-8668473	91	3	of	of	ADP
bjos-8668473	91	4	significance	significance	NOUN
bjos-8668473	91	5	was	be	AUX
bjos-8668473	91	6	set	set	VERB
bjos-8668473	91	7	to	to	ADP
bjos-8668473	91	8	5	5	NUM
bjos-8668473	91	9	%	%	NOUN
bjos-8668473	91	10	(	(	PUNCT
bjos-8668473	91	11	p	p	X
bjos-8668473	91	12	<	<	X
bjos-8668473	91	13	0.05	0.05	NUM
bjos-8668473	91	14	)	)	PUNCT
bjos-8668473	91	15	.	.	PUNCT
bjos-8668473	92	1	the	the	DET
bjos-8668473	92	2	sensitivity	sensitivity	NOUN
bjos-8668473	92	3	and	and	CCONJ
bjos-8668473	92	4	specificity	specificity	NOUN
bjos-8668473	92	5	of	of	ADP
bjos-8668473	92	6	pipecolic	pipecolic	NOUN
bjos-8668473	92	7	acid	acid	NOUN
bjos-8668473	92	8	were	be	AUX
bjos-8668473	92	9	tested	test	VERB
bjos-8668473	92	10	.	.	PUNCT
bjos-8668473	93	1	for	for	ADP
bjos-8668473	93	2	such	such	ADJ
bjos-8668473	93	3	,	,	PUNCT
bjos-8668473	93	4	a	a	DET
bjos-8668473	93	5	receiver	receiver	NOUN
bjos-8668473	93	6	operating	operate	VERB
bjos-8668473	93	7	characteristic	characteristic	NOUN
bjos-8668473	93	8	(	(	PUNCT
bjos-8668473	93	9	roc	roc	PROPN
bjos-8668473	93	10	)	)	PUNCT
bjos-8668473	93	11	curve	curve	NOUN
bjos-8668473	93	12	was	be	AUX
bjos-8668473	93	13	created	create	VERB
bjos-8668473	93	14	and	and	CCONJ
bjos-8668473	93	15	the	the	DET
bjos-8668473	93	16	area	area	NOUN
bjos-8668473	93	17	under	under	ADP
bjos-8668473	93	18	the	the	DET
bjos-8668473	93	19	curve	curve	NOUN
bjos-8668473	93	20	(	(	PUNCT
bjos-8668473	93	21	auc	auc	NOUN
bjos-8668473	93	22	)	)	PUNCT
bjos-8668473	93	23	was	be	AUX
bjos-8668473	93	24	determined	determine	VERB
bjos-8668473	93	25	.	.	PUNCT
bjos-8668473	94	1	all	all	DET
bjos-8668473	94	2	statistical	statistical	ADJ
bjos-8668473	94	3	tests	test	NOUN
bjos-8668473	94	4	were	be	AUX
bjos-8668473	94	5	performed	perform	VERB
bjos-8668473	94	6	using	use	VERB
bjos-8668473	94	7	ibm	ibm	PROPN
bjos-8668473	94	8	spss	spss	PROPN
bjos-8668473	94	9	statistics	statistic	NOUN
bjos-8668473	94	10	for	for	ADP
bjos-8668473	94	11	windows	window	NOUN
bjos-8668473	94	12	,	,	PUNCT
bjos-8668473	94	13	version	version	NOUN
bjos-8668473	94	14	21.0	21.0	NUM
bjos-8668473	94	15	(	(	PUNCT
bjos-8668473	94	16	armonk	armonk	PROPN
bjos-8668473	94	17	,	,	PUNCT
bjos-8668473	94	18	ny	ny	PROPN
bjos-8668473	94	19	:	:	PROPN
bjos-8668473	94	20	ibm	ibm	PROPN
bjos-8668473	94	21	corp	corp	PROPN
bjos-8668473	94	22	)	)	PUNCT
bjos-8668473	94	23	.	.	PUNCT
bjos-8668473	95	1	results	result	VERB
bjos-8668473	95	2	the	the	DET
bjos-8668473	95	3	sample	sample	NOUN
bjos-8668473	95	4	consisted	consist	VERB
bjos-8668473	95	5	of	of	ADP
bjos-8668473	95	6	40	40	NUM
bjos-8668473	95	7	individuals	individual	NOUN
bjos-8668473	95	8	:	:	PUNCT
bjos-8668473	95	9	20	20	NUM
bjos-8668473	95	10	in	in	ADP
bjos-8668473	95	11	the	the	DET
bjos-8668473	95	12	control	control	NOUN
bjos-8668473	95	13	group	group	NOUN
bjos-8668473	95	14	(	(	PUNCT
bjos-8668473	95	15	mean	mean	INTJ
bjos-8668473	95	16	age	age	NOUN
bjos-8668473	95	17	:	:	PUNCT
bjos-8668473	95	18	52.45	52.45	NUM
bjos-8668473	95	19	±	±	NUM
bjos-8668473	95	20	11.30	11.30	NUM
bjos-8668473	95	21	years	year	NOUN
bjos-8668473	95	22	)	)	PUNCT
bjos-8668473	95	23	and	and	CCONJ
bjos-8668473	95	24	20	20	NUM
bjos-8668473	95	25	in	in	ADP
bjos-8668473	95	26	the	the	DET
bjos-8668473	95	27	case	case	NOUN
bjos-8668473	95	28	group	group	NOUN
bjos-8668473	95	29	(	(	PUNCT
bjos-8668473	95	30	mean	mean	INTJ
bjos-8668473	95	31	age	age	NOUN
bjos-8668473	95	32	:	:	PUNCT
bjos-8668473	95	33	62.95	62.95	NUM
bjos-8668473	95	34	±	±	NUM
bjos-8668473	95	35	10.33	10.33	NUM
bjos-8668473	95	36	years	year	NOUN
bjos-8668473	95	37	)	)	PUNCT
bjos-8668473	95	38	.	.	PUNCT
bjos-8668473	96	1	the	the	DET
bjos-8668473	96	2	two	two	NUM
bjos-8668473	96	3	groups	group	NOUN
bjos-8668473	96	4	were	be	AUX
bjos-8668473	96	5	matched	match	VERB
bjos-8668473	96	6	for	for	ADP
bjos-8668473	96	7	sex	sex	NOUN
bjos-8668473	96	8	and	and	CCONJ
bjos-8668473	96	9	comorbidity	comorbidity	NOUN
bjos-8668473	96	10	.	.	PUNCT
bjos-8668473	97	1	table	table	NOUN
bjos-8668473	97	2	1	1	NUM
bjos-8668473	97	3	gives	give	VERB
bjos-8668473	97	4	a	a	DET
bjos-8668473	97	5	complete	complete	ADJ
bjos-8668473	97	6	description	description	NOUN
bjos-8668473	97	7	of	of	ADP
bjos-8668473	97	8	the	the	DET
bjos-8668473	97	9	sample	sample	NOUN
bjos-8668473	97	10	.	.	PUNCT
bjos-8668473	98	1	table	table	NOUN
bjos-8668473	98	2	1	1	NUM
bjos-8668473	98	3	.	.	PUNCT
bjos-8668473	99	1	demographic	demographic	ADJ
bjos-8668473	99	2	,	,	PUNCT
bjos-8668473	99	3	behavioral	behavioral	ADJ
bjos-8668473	99	4	and	and	CCONJ
bjos-8668473	99	5	clinical	clinical	ADJ
bjos-8668473	99	6	characteristics	characteristic	NOUN
bjos-8668473	99	7	of	of	ADP
bjos-8668473	99	8	sample	sample	NOUN
bjos-8668473	99	9	variables	variable	NOUN
bjos-8668473	99	10	n	n	CCONJ
bjos-8668473	99	11	(	(	PUNCT
bjos-8668473	99	12	%	%	INTJ
bjos-8668473	99	13	)	)	PUNCT
bjos-8668473	99	14	control	control	NOUN
bjos-8668473	99	15	group	group	NOUN
bjos-8668473	99	16	(	(	PUNCT
bjos-8668473	99	17	without	without	ADP
bjos-8668473	99	18	disease	disease	NOUN
bjos-8668473	99	19	)	)	PUNCT
bjos-8668473	99	20	case	case	NOUN
bjos-8668473	99	21	group	group	NOUN
bjos-8668473	99	22	(	(	PUNCT
bjos-8668473	99	23	with	with	ADP
bjos-8668473	99	24	disease	disease	NOUN
bjos-8668473	99	25	)	)	PUNCT
bjos-8668473	99	26	sex	sex	NOUN
bjos-8668473	99	27	male	male	NOUN
bjos-8668473	99	28	18	18	NUM
bjos-8668473	99	29	(	(	PUNCT
bjos-8668473	99	30	90	90	NUM
bjos-8668473	99	31	%	%	NOUN
bjos-8668473	99	32	)	)	PUNCT
bjos-8668473	99	33	18	18	NUM
bjos-8668473	99	34	(	(	PUNCT
bjos-8668473	99	35	90	90	NUM
bjos-8668473	99	36	%	%	NOUN
bjos-8668473	99	37	)	)	PUNCT
bjos-8668473	99	38	female	female	ADJ
bjos-8668473	99	39	2	2	NUM
bjos-8668473	99	40	(	(	PUNCT
bjos-8668473	99	41	10	10	NUM
bjos-8668473	99	42	%	%	NOUN
bjos-8668473	99	43	)	)	PUNCT
bjos-8668473	99	44	2	2	NUM
bjos-8668473	99	45	(	(	PUNCT
bjos-8668473	99	46	10	10	NUM
bjos-8668473	99	47	%	%	NOUN
bjos-8668473	99	48	)	)	PUNCT
bjos-8668473	99	49	schooling	school	VERB
bjos-8668473	99	50	<	<	X
bjos-8668473	99	51	5	5	NUM
bjos-8668473	99	52	years	year	NOUN
bjos-8668473	99	53	4	4	NUM
bjos-8668473	99	54	(	(	PUNCT
bjos-8668473	99	55	20	20	NUM
bjos-8668473	99	56	%	%	NOUN
bjos-8668473	99	57	)	)	PUNCT
bjos-8668473	99	58	10	10	NUM
bjos-8668473	99	59	(	(	PUNCT
bjos-8668473	99	60	50	50	NUM
bjos-8668473	99	61	%	%	NOUN
bjos-8668473	99	62	)	)	PUNCT
bjos-8668473	99	63	5	5	NUM
bjos-8668473	99	64	-	-	SYM
bjos-8668473	99	65	8	8	NUM
bjos-8668473	99	66	years	year	NOUN
bjos-8668473	99	67	4	4	NUM
bjos-8668473	99	68	(	(	PUNCT
bjos-8668473	99	69	20	20	NUM
bjos-8668473	99	70	%	%	NOUN
bjos-8668473	99	71	)	)	PUNCT
bjos-8668473	99	72	6	6	NUM
bjos-8668473	99	73	(	(	PUNCT
bjos-8668473	99	74	30	30	NUM
bjos-8668473	99	75	%	%	NOUN
bjos-8668473	99	76	)	)	PUNCT
bjos-8668473	99	77	>	>	SYM
bjos-8668473	99	78	8	8	NUM
bjos-8668473	99	79	years	year	NOUN
bjos-8668473	99	80	12	12	NUM
bjos-8668473	99	81	(	(	PUNCT
bjos-8668473	99	82	60	60	NUM
bjos-8668473	99	83	%	%	NOUN
bjos-8668473	99	84	)	)	PUNCT
bjos-8668473	99	85	4	4	NUM
bjos-8668473	99	86	(	(	PUNCT
bjos-8668473	99	87	20	20	NUM
bjos-8668473	99	88	%	%	NOUN
bjos-8668473	99	89	)	)	PUNCT
bjos-8668473	99	90	smoking	smoking	NOUN
bjos-8668473	99	91	status	status	NOUN
bjos-8668473	99	92	non	non	ADJ
bjos-8668473	99	93	-	-	ADJ
bjos-8668473	99	94	smoker	smoker	ADJ
bjos-8668473	99	95	10	10	NUM
bjos-8668473	99	96	(	(	PUNCT
bjos-8668473	99	97	50	50	NUM
bjos-8668473	99	98	%	%	NOUN
bjos-8668473	99	99	)	)	PUNCT
bjos-8668473	99	100	2	2	NUM
bjos-8668473	99	101	(	(	PUNCT
bjos-8668473	99	102	10	10	NUM
bjos-8668473	99	103	%	%	NOUN
bjos-8668473	99	104	)	)	PUNCT
bjos-8668473	99	105	current	current	ADJ
bjos-8668473	99	106	smoker	smoker	NOUN
bjos-8668473	99	107	2	2	NUM
bjos-8668473	99	108	(	(	PUNCT
bjos-8668473	99	109	10	10	NUM
bjos-8668473	99	110	%	%	NOUN
bjos-8668473	99	111	)	)	PUNCT
bjos-8668473	99	112	13	13	NUM
bjos-8668473	99	113	(	(	PUNCT
bjos-8668473	99	114	65	65	NUM
bjos-8668473	99	115	%	%	NOUN
bjos-8668473	99	116	)	)	PUNCT
bjos-8668473	100	1	ex	ex	NOUN
bjos-8668473	100	2	-	-	NOUN
bjos-8668473	100	3	smoker	smoker	ADJ
bjos-8668473	100	4	8	8	NUM
bjos-8668473	100	5	(	(	PUNCT
bjos-8668473	100	6	40	40	NUM
bjos-8668473	100	7	%	%	NOUN
bjos-8668473	100	8	)	)	PUNCT
bjos-8668473	100	9	5	5	NUM
bjos-8668473	100	10	(	(	PUNCT
bjos-8668473	100	11	25	25	NUM
bjos-8668473	100	12	%	%	NOUN
bjos-8668473	100	13	)	)	PUNCT
bjos-8668473	100	14	smoking	smoking	NOUN
bjos-8668473	100	15	cessation	cessation	NOUN
bjos-8668473	100	16	time	time	NOUN
bjos-8668473	100	17	1	1	NUM
bjos-8668473	100	18	-	-	SYM
bjos-8668473	100	19	4	4	NUM
bjos-8668473	100	20	years	year	NOUN
bjos-8668473	100	21	4	4	NUM
bjos-8668473	100	22	(	(	PUNCT
bjos-8668473	100	23	20	20	NUM
bjos-8668473	100	24	%	%	NOUN
bjos-8668473	100	25	)	)	PUNCT
bjos-8668473	100	26	2	2	NUM
bjos-8668473	100	27	(	(	PUNCT
bjos-8668473	100	28	10	10	NUM
bjos-8668473	100	29	%	%	NOUN
bjos-8668473	100	30	)	)	PUNCT
bjos-8668473	100	31	continue	continue	VERB
bjos-8668473	100	32	6	6	NUM
bjos-8668473	100	33	ferrazzo	ferrazzo	VERB
bjos-8668473	101	1	et	et	PROPN
bjos-8668473	101	2	al	al	PROPN
bjos-8668473	101	3	.	.	PROPN
bjos-8668473	101	4	braz	braz	PROPN
bjos-8668473	101	5	j	j	PROPN
bjos-8668473	101	6	oral	oral	PROPN
bjos-8668473	101	7	sci	sci	PROPN
bjos-8668473	101	8	.	.	PUNCT
bjos-8668473	102	1	2023;22	2023;22	NUM
bjos-8668473	102	2	:	:	PUNCT
bjos-8668473	102	3	e238473	e238473	NUM
bjos-8668473	102	4	continuation	continuation	NOUN
bjos-8668473	102	5	5	5	NUM
bjos-8668473	102	6	-	-	SYM
bjos-8668473	102	7	9	9	NUM
bjos-8668473	102	8	years	year	NOUN
bjos-8668473	102	9	1	1	NUM
bjos-8668473	102	10	(	(	PUNCT
bjos-8668473	102	11	5	5	NUM
bjos-8668473	102	12	%	%	NOUN
bjos-8668473	102	13	)	)	PUNCT
bjos-8668473	102	14	10	10	NUM
bjos-8668473	102	15	-	-	SYM
bjos-8668473	102	16	19	19	NUM
bjos-8668473	102	17	years	year	NOUN
bjos-8668473	102	18	1	1	NUM
bjos-8668473	102	19	(	(	PUNCT
bjos-8668473	102	20	5	5	NUM
bjos-8668473	102	21	%	%	NOUN
bjos-8668473	102	22	)	)	PUNCT
bjos-8668473	102	23	2	2	NUM
bjos-8668473	102	24	(	(	PUNCT
bjos-8668473	102	25	10	10	NUM
bjos-8668473	102	26	%	%	NOUN
bjos-8668473	102	27	)	)	PUNCT
bjos-8668473	102	28	≥	≥	NOUN
bjos-8668473	102	29	20	20	NUM
bjos-8668473	102	30	years	year	NOUN
bjos-8668473	102	31	2	2	NUM
bjos-8668473	102	32	(	(	PUNCT
bjos-8668473	102	33	10	10	NUM
bjos-8668473	102	34	%	%	NOUN
bjos-8668473	102	35	)	)	PUNCT
bjos-8668473	102	36	1	1	NUM
bjos-8668473	102	37	(	(	PUNCT
bjos-8668473	102	38	5	5	NUM
bjos-8668473	102	39	%	%	NOUN
bjos-8668473	102	40	)	)	PUNCT
bjos-8668473	102	41	comorbidity	comorbidity	NOUN
bjos-8668473	102	42	(	(	PUNCT
bjos-8668473	102	43	oral	oral	ADJ
bjos-8668473	102	44	hypoglycemic	hypoglycemic	ADJ
bjos-8668473	102	45	drug	drug	NOUN
bjos-8668473	102	46	)	)	PUNCT
bjos-8668473	103	1	no	no	DET
bjos-8668473	103	2	17	17	NUM
bjos-8668473	103	3	(	(	PUNCT
bjos-8668473	103	4	80	80	NUM
bjos-8668473	103	5	%	%	NOUN
bjos-8668473	103	6	)	)	PUNCT
bjos-8668473	103	7	17	17	NUM
bjos-8668473	103	8	(	(	PUNCT
bjos-8668473	103	9	80	80	NUM
bjos-8668473	103	10	%	%	NOUN
bjos-8668473	103	11	)	)	PUNCT
bjos-8668473	104	1	yes	yes	INTJ
bjos-8668473	104	2	3	3	NUM
bjos-8668473	104	3	(	(	PUNCT
bjos-8668473	104	4	20	20	NUM
bjos-8668473	104	5	%	%	NOUN
bjos-8668473	104	6	)	)	PUNCT
bjos-8668473	104	7	3	3	NUM
bjos-8668473	104	8	(	(	PUNCT
bjos-8668473	104	9	20	20	NUM
bjos-8668473	104	10	%	%	NOUN
bjos-8668473	104	11	)	)	PUNCT
bjos-8668473	104	12	no	no	DET
bjos-8668473	104	13	statistically	statistically	ADV
bjos-8668473	104	14	significant	significant	ADJ
bjos-8668473	104	15	differences	difference	NOUN
bjos-8668473	104	16	in	in	ADP
bjos-8668473	104	17	pipecolic	pipecolic	NOUN
bjos-8668473	104	18	acid	acid	NOUN
bjos-8668473	104	19	levels	level	NOUN
bjos-8668473	104	20	were	be	AUX
bjos-8668473	104	21	found	find	VERB
bjos-8668473	104	22	in	in	ADP
bjos-8668473	104	23	relation	relation	NOUN
bjos-8668473	104	24	to	to	ADP
bjos-8668473	104	25	sex	sex	NOUN
bjos-8668473	104	26	,	,	PUNCT
bjos-8668473	104	27	age	age	NOUN
bjos-8668473	104	28	,	,	PUNCT
bjos-8668473	104	29	schooling	schooling	NOUN
bjos-8668473	104	30	or	or	CCONJ
bjos-8668473	104	31	smoking	smoking	NOUN
bjos-8668473	104	32	/	/	SYM
bjos-8668473	104	33	pack	pack	NOUN
bjos-8668473	104	34	-	-	PUNCT
bjos-8668473	104	35	years	year	NOUN
bjos-8668473	104	36	.	.	PUNCT
bjos-8668473	105	1	patients	patient	NOUN
bjos-8668473	105	2	with	with	ADP
bjos-8668473	105	3	comorbidity	comorbidity	NOUN
bjos-8668473	105	4	(	(	PUNCT
bjos-8668473	105	5	who	who	PRON
bjos-8668473	105	6	took	take	VERB
bjos-8668473	105	7	oral	oral	ADJ
bjos-8668473	105	8	hypoglycemic	hypoglycemic	ADJ
bjos-8668473	105	9	drugs	drug	NOUN
bjos-8668473	105	10	)	)	PUNCT
bjos-8668473	105	11	had	have	VERB
bjos-8668473	105	12	higher	high	ADJ
bjos-8668473	105	13	salivary	salivary	ADJ
bjos-8668473	105	14	levels	level	NOUN
bjos-8668473	105	15	of	of	ADP
bjos-8668473	105	16	pipecolic	pipecolic	NOUN
bjos-8668473	105	17	acid	acid	NOUN
bjos-8668473	105	18	and	and	CCONJ
bjos-8668473	105	19	significant	significant	ADJ
bjos-8668473	105	20	differences	difference	NOUN
bjos-8668473	105	21	were	be	AUX
bjos-8668473	105	22	found	find	VERB
bjos-8668473	105	23	between	between	ADP
bjos-8668473	105	24	those	those	PRON
bjos-8668473	105	25	who	who	PRON
bjos-8668473	105	26	took	take	VERB
bjos-8668473	105	27	such	such	ADJ
bjos-8668473	105	28	medication	medication	NOUN
bjos-8668473	105	29	and	and	CCONJ
bjos-8668473	105	30	those	those	PRON
bjos-8668473	105	31	who	who	PRON
bjos-8668473	105	32	did	do	VERB
bjos-8668473	105	33	not	not	PART
bjos-8668473	105	34	in	in	ADP
bjos-8668473	105	35	both	both	DET
bjos-8668473	105	36	groups	group	NOUN
bjos-8668473	105	37	(	(	PUNCT
bjos-8668473	105	38	p	p	X
bjos-8668473	105	39	<	<	X
bjos-8668473	105	40	0.001	0.001	NUM
bjos-8668473	105	41	)	)	PUNCT
bjos-8668473	105	42	(	(	PUNCT
bjos-8668473	105	43	table	table	NOUN
bjos-8668473	105	44	2	2	NUM
bjos-8668473	105	45	)	)	PUNCT
bjos-8668473	105	46	.	.	PUNCT
bjos-8668473	106	1	table	table	NOUN
bjos-8668473	107	1	2	2	NUM
bjos-8668473	107	2	.	.	PUNCT
bjos-8668473	107	3	mean	mean	VERB
bjos-8668473	107	4	salivary	salivary	ADJ
bjos-8668473	107	5	pipecolic	pipecolic	NOUN
bjos-8668473	107	6	acid	acid	NOUN
bjos-8668473	107	7	levels	level	NOUN
bjos-8668473	107	8	in	in	ADP
bjos-8668473	107	9	case	case	NOUN
bjos-8668473	107	10	and	and	CCONJ
bjos-8668473	107	11	control	control	NOUN
bjos-8668473	107	12	groups	group	NOUN
bjos-8668473	107	13	according	accord	VERB
bjos-8668473	107	14	to	to	ADP
bjos-8668473	107	15	demographic	demographic	ADJ
bjos-8668473	107	16	,	,	PUNCT
bjos-8668473	107	17	behavioral	behavioral	ADJ
bjos-8668473	107	18	and	and	CCONJ
bjos-8668473	107	19	clinical	clinical	ADJ
bjos-8668473	107	20	variables	variable	NOUN
bjos-8668473	107	21	variable	variable	ADJ
bjos-8668473	107	22	control	control	NOUN
bjos-8668473	107	23	group	group	NOUN
bjos-8668473	107	24	(	(	PUNCT
bjos-8668473	107	25	without	without	ADP
bjos-8668473	107	26	disease	disease	NOUN
bjos-8668473	107	27	)	)	PUNCT
bjos-8668473	107	28	case	case	NOUN
bjos-8668473	107	29	group	group	NOUN
bjos-8668473	107	30	(	(	PUNCT
bjos-8668473	107	31	with	with	ADP
bjos-8668473	107	32	disease	disease	NOUN
bjos-8668473	107	33	)	)	PUNCT
bjos-8668473	107	34	pipecolic	pipecolic	NOUN
bjos-8668473	107	35	acid	acid	NOUN
bjos-8668473	107	36	level	level	NOUN
bjos-8668473	107	37	(	(	PUNCT
bjos-8668473	107	38	ng	ng	NOUN
bjos-8668473	107	39	/	/	SYM
bjos-8668473	107	40	ml	ml	NOUN
bjos-8668473	107	41	)	)	PUNCT
bjos-8668473	107	42	mean	mean	NOUN
bjos-8668473	107	43	(	(	PUNCT
bjos-8668473	107	44	±	±	NOUN
bjos-8668473	107	45	standard	standard	ADJ
bjos-8668473	107	46	deviation	deviation	NOUN
bjos-8668473	107	47	)	)	PUNCT
bjos-8668473	107	48	sex	sex	NOUN
bjos-8668473	107	49	male	male	NOUN
bjos-8668473	107	50	117.65	117.65	NUM
bjos-8668473	107	51	(	(	PUNCT
bjos-8668473	107	52	±	±	NOUN
bjos-8668473	107	53	33.37	33.37	NUM
bjos-8668473	107	54	)	)	PUNCT
bjos-8668473	107	55	166.40	166.40	NUM
bjos-8668473	107	56	(	(	PUNCT
bjos-8668473	107	57	±	±	NOUN
bjos-8668473	107	58	49.09	49.09	NUM
bjos-8668473	107	59	)	)	PUNCT
bjos-8668473	107	60	female	female	NOUN
bjos-8668473	107	61	87.68	87.68	NUM
bjos-8668473	107	62	(	(	PUNCT
bjos-8668473	107	63	±	±	NOUN
bjos-8668473	107	64	22.35	22.35	NUM
bjos-8668473	107	65	)	)	PUNCT
bjos-8668473	107	66	196.26	196.26	NUM
bjos-8668473	107	67	(	(	PUNCT
bjos-8668473	107	68	±	±	NOUN
bjos-8668473	107	69	102.51	102.51	NUM
bjos-8668473	107	70	)	)	PUNCT
bjos-8668473	107	71	p	p	NOUN
bjos-8668473	107	72	-	-	PUNCT
bjos-8668473	107	73	value	value	NOUN
bjos-8668473	107	74	0.257	0.257	NUM
bjos-8668473	107	75	a	a	DET
bjos-8668473	107	76	0.801	0.801	NUM
bjos-8668473	107	77	a	a	DET
bjos-8668473	107	78	age	age	NOUN
bjos-8668473	107	79	*	*	PUNCT
bjos-8668473	107	80	≤	≤	NUM
bjos-8668473	107	81	58	58	NUM
bjos-8668473	107	82	years	year	NOUN
bjos-8668473	107	83	115.58	115.58	NUM
bjos-8668473	107	84	(	(	PUNCT
bjos-8668473	107	85	±	±	NOUN
bjos-8668473	107	86	31.25	31.25	NUM
bjos-8668473	107	87	)	)	PUNCT
bjos-8668473	107	88	165.97	165.97	NUM
bjos-8668473	107	89	(	(	PUNCT
bjos-8668473	107	90	±	±	NOUN
bjos-8668473	107	91	21.70	21.70	NUM
bjos-8668473	107	92	)	)	PUNCT
bjos-8668473	107	93	>	>	X
bjos-8668473	107	94	58	58	NUM
bjos-8668473	107	95	years	year	NOUN
bjos-8668473	107	96	111.89	111.89	NUM
bjos-8668473	107	97	(	(	PUNCT
bjos-8668473	107	98	±	±	NOUN
bjos-8668473	107	99	42.79	42.79	NUM
bjos-8668473	107	100	)	)	PUNCT
bjos-8668473	107	101	170.52	170.52	NUM
bjos-8668473	107	102	(	(	PUNCT
bjos-8668473	107	103	±	±	NOUN
bjos-8668473	107	104	60.43	60.43	NUM
bjos-8668473	107	105	)	)	PUNCT
bjos-8668473	107	106	p	p	NOUN
bjos-8668473	107	107	-	-	PUNCT
bjos-8668473	107	108	value	value	NOUN
bjos-8668473	107	109	0.694	0.694	NUM
bjos-8668473	107	110	a	a	DET
bjos-8668473	107	111	0.694	0.694	NUM
bjos-8668473	107	112	a	a	DET
bjos-8668473	107	113	years	year	NOUN
bjos-8668473	107	114	of	of	ADP
bjos-8668473	107	115	schooling	schooling	NOUN
bjos-8668473	107	116	*	*	PUNCT
bjos-8668473	107	117	≤	≤	NUM
bjos-8668473	107	118	7	7	NUM
bjos-8668473	107	119	years	year	NOUN
bjos-8668473	107	120	130.64	130.64	NUM
bjos-8668473	107	121	(	(	PUNCT
bjos-8668473	107	122	±	±	NUM
bjos-8668473	107	123	40.29	40.29	NUM
bjos-8668473	107	124	)	)	PUNCT
bjos-8668473	107	125	173.39	173.39	NUM
bjos-8668473	107	126	(	(	PUNCT
bjos-8668473	107	127	±	±	NOUN
bjos-8668473	107	128	56.62	56.62	NUM
bjos-8668473	107	129	)	)	PUNCT
bjos-8668473	107	130	>	>	X
bjos-8668473	107	131	7	7	NUM
bjos-8668473	107	132	years	year	NOUN
bjos-8668473	107	133	107.80	107.80	NUM
bjos-8668473	107	134	(	(	PUNCT
bjos-8668473	107	135	±	±	NOUN
bjos-8668473	107	136	28.74	28.74	NUM
bjos-8668473	107	137	)	)	PUNCT
bjos-8668473	107	138	153.35	153.35	NUM
bjos-8668473	107	139	(	(	PUNCT
bjos-8668473	107	140	±	±	NUM
bjos-8668473	107	141	35.13	35.13	NUM
bjos-8668473	107	142	)	)	PUNCT
bjos-8668473	108	1	p	p	NOUN
bjos-8668473	108	2	-	-	PUNCT
bjos-8668473	108	3	value	value	NOUN
bjos-8668473	108	4	0.165	0.165	NUM
bjos-8668473	108	5	b	b	NUM
bjos-8668473	108	6	0.512	0.512	NUM
bjos-8668473	108	7	b	b	NOUN
bjos-8668473	108	8	smoking	smoking	NOUN
bjos-8668473	108	9	status	status	NOUN
bjos-8668473	108	10	normal	normal	ADJ
bjos-8668473	108	11	non	non	ADJ
bjos-8668473	108	12	-	-	ADJ
bjos-8668473	108	13	smoker	smoker	ADJ
bjos-8668473	108	14	109.85	109.85	NUM
bjos-8668473	108	15	(	(	PUNCT
bjos-8668473	108	16	±	±	NOUN
bjos-8668473	108	17	30.67	30.67	NUM
bjos-8668473	108	18	)	)	PUNCT
bjos-8668473	108	19	123.10	123.10	NUM
bjos-8668473	108	20	(	(	PUNCT
bjos-8668473	108	21	±	±	NOUN
bjos-8668473	108	22	0.95	0.95	NUM
bjos-8668473	108	23	)	)	PUNCT
bjos-8668473	108	24	ex-	ex-	NOUN
bjos-8668473	108	25	,	,	PUNCT
bjos-8668473	108	26	current	current	ADJ
bjos-8668473	108	27	smoker	smoker	NOUN
bjos-8668473	108	28	119.46	119.46	NUM
bjos-8668473	108	29	(	(	PUNCT
bjos-8668473	108	30	±	±	NOUN
bjos-8668473	108	31	36.70	36.70	NUM
bjos-8668473	108	32	)	)	PUNCT
bjos-8668473	108	33	174.53	174.53	NUM
bjos-8668473	108	34	(	(	PUNCT
bjos-8668473	108	35	±	±	NOUN
bjos-8668473	108	36	53.31	53.31	NUM
bjos-8668473	108	37	)	)	PUNCT
bjos-8668473	108	38	p	p	NOUN
bjos-8668473	108	39	-	-	PUNCT
bjos-8668473	108	40	value	value	NOUN
bjos-8668473	108	41	0.533	0.533	NUM
bjos-8668473	108	42	b	b	NOUN
bjos-8668473	108	43	0.200	0.200	NUM
bjos-8668473	108	44	b	b	NOUN
bjos-8668473	108	45	pack	pack	NOUN
bjos-8668473	108	46	-	-	PUNCT
bjos-8668473	108	47	years	year	NOUN
bjos-8668473	108	48	*	*	PUNCT
bjos-8668473	108	49	≤	≤	NUM
bjos-8668473	108	50	23	23	NUM
bjos-8668473	108	51	108.00	108.00	NUM
bjos-8668473	108	52	(	(	PUNCT
bjos-8668473	108	53	±	±	NOUN
bjos-8668473	108	54	28.79	28.79	NUM
bjos-8668473	108	55	)	)	PUNCT
bjos-8668473	108	56	172.95	172.95	NUM
bjos-8668473	108	57	(	(	PUNCT
bjos-8668473	108	58	±	±	NOUN
bjos-8668473	108	59	57.48	57.48	NUM
bjos-8668473	108	60	)	)	PUNCT
bjos-8668473	108	61	>	>	X
bjos-8668473	108	62	23	23	NUM
bjos-8668473	108	63	134.62	134.62	NUM
bjos-8668473	108	64	(	(	PUNCT
bjos-8668473	108	65	±	±	NOUN
bjos-8668473	108	66	41.18	41.18	NUM
bjos-8668473	108	67	)	)	PUNCT
bjos-8668473	108	68	167.86	167.86	NUM
bjos-8668473	108	69	(	(	PUNCT
bjos-8668473	108	70	±	±	NOUN
bjos-8668473	108	71	52.95	52.95	NUM
bjos-8668473	108	72	)	)	PUNCT
bjos-8668473	108	73	p	p	NOUN
bjos-8668473	108	74	-	-	PUNCT
bjos-8668473	108	75	value	value	NOUN
bjos-8668473	108	76	0.206	0.206	NUM
bjos-8668473	108	77	a	a	DET
bjos-8668473	108	78	0.850	0.850	NUM
bjos-8668473	108	79	a	a	DET
bjos-8668473	108	80	continue	continue	NOUN
bjos-8668473	108	81	7	7	NUM
bjos-8668473	108	82	ferrazzo	ferrazzo	VERB
bjos-8668473	109	1	et	et	PROPN
bjos-8668473	109	2	al	al	PROPN
bjos-8668473	109	3	.	.	PROPN
bjos-8668473	109	4	braz	braz	PROPN
bjos-8668473	109	5	j	j	PROPN
bjos-8668473	109	6	oral	oral	PROPN
bjos-8668473	109	7	sci	sci	PROPN
bjos-8668473	109	8	.	.	PUNCT
bjos-8668473	110	1	2023;22	2023;22	NUM
bjos-8668473	110	2	:	:	PUNCT
bjos-8668473	110	3	e238473	e238473	NUM
bjos-8668473	110	4	continuation	continuation	NOUN
bjos-8668473	110	5	comorbidity	comorbidity	NOUN
bjos-8668473	110	6	(	(	PUNCT
bjos-8668473	110	7	oral	oral	ADJ
bjos-8668473	110	8	hypoglycemic	hypoglycemic	ADJ
bjos-8668473	110	9	drug	drug	NOUN
bjos-8668473	110	10	)	)	PUNCT
bjos-8668473	111	1	no	no	DET
bjos-8668473	111	2	104.13	104.13	NUM
bjos-8668473	111	3	(	(	PUNCT
bjos-8668473	111	4	±	±	NUM
bjos-8668473	111	5	23.03	23.03	NUM
bjos-8668473	111	6	)	)	PUNCT
bjos-8668473	111	7	153.23	153.23	NUM
bjos-8668473	111	8	(	(	PUNCT
bjos-8668473	111	9	±	±	NOUN
bjos-8668473	111	10	32.78	32.78	NUM
bjos-8668473	111	11	)	)	PUNCT
bjos-8668473	111	12	yes	ye	NOUN
bjos-8668473	111	13	174.29	174.29	NUM
bjos-8668473	111	14	(	(	PUNCT
bjos-8668473	111	15	±	±	NOUN
bjos-8668473	111	16	2.20	2.20	NUM
bjos-8668473	111	17	)	)	PUNCT
bjos-8668473	111	18	260.94	260.94	NUM
bjos-8668473	111	19	(	(	PUNCT
bjos-8668473	111	20	±	±	NOUN
bjos-8668473	111	21	56.12	56.12	NUM
bjos-8668473	111	22	)	)	PUNCT
bjos-8668473	111	23	p	p	NOUN
bjos-8668473	111	24	-	-	PUNCT
bjos-8668473	111	25	value	value	NOUN
bjos-8668473	111	26	<	<	X
bjos-8668473	111	27	0.001	0.001	NUM
bjos-8668473	111	28	b	b	NOUN
bjos-8668473	111	29	<	<	X
bjos-8668473	111	30	0.001	0.001	NUM
bjos-8668473	111	31	b	b	SYM
bjos-8668473	111	32	*	*	PUNCT
bjos-8668473	111	33	variables	variable	NOUN
bjos-8668473	111	34	dichotomized	dichotomize	VERB
bjos-8668473	111	35	by	by	ADP
bjos-8668473	111	36	median	median	PROPN
bjos-8668473	111	37	;	;	PUNCT
bjos-8668473	111	38	a	a	DET
bjos-8668473	111	39	mann	mann	PROPN
bjos-8668473	111	40	-	-	PUNCT
bjos-8668473	111	41	whitney	whitney	PROPN
bjos-8668473	111	42	;	;	PUNCT
bjos-8668473	111	43	b	b	X
bjos-8668473	111	44	student	student	NOUN
bjos-8668473	111	45	’s	’s	PART
bjos-8668473	111	46	t	t	PROPN
bjos-8668473	111	47	-	-	PUNCT
bjos-8668473	111	48	test	test	NOUN
bjos-8668473	111	49	the	the	DET
bjos-8668473	111	50	case	case	NOUN
bjos-8668473	111	51	group	group	NOUN
bjos-8668473	111	52	was	be	AUX
bjos-8668473	111	53	composed	compose	VERB
bjos-8668473	111	54	of	of	ADP
bjos-8668473	111	55	12	12	NUM
bjos-8668473	111	56	individuals	individual	NOUN
bjos-8668473	111	57	with	with	ADP
bjos-8668473	111	58	squamous	squamous	ADJ
bjos-8668473	111	59	cell	cell	NOUN
bjos-8668473	111	60	carcinoma	carcinoma	NOUN
bjos-8668473	111	61	in	in	ADP
bjos-8668473	111	62	the	the	DET
bjos-8668473	111	63	oral	oral	ADJ
bjos-8668473	111	64	cavity	cavity	NOUN
bjos-8668473	111	65	and/or	and/or	CCONJ
bjos-8668473	111	66	oropharynx	oropharynx	NOUN
bjos-8668473	111	67	and	and	CCONJ
bjos-8668473	111	68	eight	eight	NUM
bjos-8668473	111	69	in	in	ADP
bjos-8668473	111	70	the	the	DET
bjos-8668473	111	71	hypopharynx	hypopharynx	NOUN
bjos-8668473	111	72	and/or	and/or	CCONJ
bjos-8668473	111	73	larynx	larynx	NOUN
bjos-8668473	111	74	,	,	PUNCT
bjos-8668473	111	75	most	most	ADJ
bjos-8668473	111	76	of	of	ADP
bjos-8668473	111	77	whom	whom	PRON
bjos-8668473	111	78	(	(	PUNCT
bjos-8668473	111	79	55	55	NUM
bjos-8668473	111	80	%	%	NOUN
bjos-8668473	111	81	)	)	PUNCT
bjos-8668473	111	82	were	be	AUX
bjos-8668473	111	83	in	in	ADP
bjos-8668473	111	84	the	the	DET
bjos-8668473	111	85	advanced	advanced	ADJ
bjos-8668473	111	86	stage	stage	NOUN
bjos-8668473	111	87	(	(	PUNCT
bjos-8668473	111	88	iii	iii	NOUN
bjos-8668473	111	89	and	and	CCONJ
bjos-8668473	111	90	iv	iv	NUM
bjos-8668473	111	91	)	)	PUNCT
bjos-8668473	111	92	.	.	PUNCT
bjos-8668473	112	1	mean	mean	VERB
bjos-8668473	112	2	pipecolic	pipecolic	NOUN
bjos-8668473	112	3	acid	acid	NOUN
bjos-8668473	112	4	levels	level	NOUN
bjos-8668473	112	5	were	be	AUX
bjos-8668473	112	6	114.66	114.66	NUM
bjos-8668473	112	7	±	±	NUM
bjos-8668473	112	8	33.28	33.28	NUM
bjos-8668473	112	9	ng	ng	PROPN
bjos-8668473	112	10	/	/	SYM
bjos-8668473	112	11	ml	ml	NOUN
bjos-8668473	112	12	in	in	ADP
bjos-8668473	112	13	the	the	DET
bjos-8668473	112	14	control	control	NOUN
bjos-8668473	112	15	group	group	NOUN
bjos-8668473	112	16	and	and	CCONJ
bjos-8668473	112	17	169.38	169.38	NUM
bjos-8668473	112	18	±	±	NUM
bjos-8668473	112	19	52.85	52.85	NUM
bjos-8668473	112	20	ng	ng	NOUN
bjos-8668473	112	21	/	/	SYM
bjos-8668473	112	22	ml	ml	NOUN
bjos-8668473	112	23	in	in	ADP
bjos-8668473	112	24	the	the	DET
bjos-8668473	112	25	case	case	NOUN
bjos-8668473	112	26	group	group	NOUN
bjos-8668473	112	27	(	(	PUNCT
bjos-8668473	112	28	p	p	X
bjos-8668473	112	29	<	<	X
bjos-8668473	112	30	0.001	0.001	NUM
bjos-8668473	112	31	)	)	PUNCT
bjos-8668473	112	32	.	.	PUNCT
bjos-8668473	113	1	statistically	statistically	ADV
bjos-8668473	113	2	significant	significant	ADJ
bjos-8668473	113	3	differences	difference	NOUN
bjos-8668473	113	4	in	in	ADP
bjos-8668473	113	5	pipecolic	pipecolic	NOUN
bjos-8668473	113	6	acid	acid	NOUN
bjos-8668473	113	7	levels	level	NOUN
bjos-8668473	113	8	were	be	AUX
bjos-8668473	113	9	found	find	VERB
bjos-8668473	113	10	between	between	ADP
bjos-8668473	113	11	the	the	DET
bjos-8668473	113	12	control	control	NOUN
bjos-8668473	113	13	group	group	NOUN
bjos-8668473	113	14	and	and	CCONJ
bjos-8668473	113	15	both	both	DET
bjos-8668473	113	16	case	case	NOUN
bjos-8668473	113	17	group	group	NOUN
bjos-8668473	113	18	1	1	NUM
bjos-8668473	113	19	(	(	PUNCT
bjos-8668473	113	20	early	early	ADJ
bjos-8668473	113	21	phase	phase	NOUN
bjos-8668473	113	22	of	of	ADP
bjos-8668473	113	23	the	the	DET
bjos-8668473	113	24	disease	disease	NOUN
bjos-8668473	113	25	)	)	PUNCT
bjos-8668473	113	26	(	(	PUNCT
bjos-8668473	113	27	p	p	X
bjos-8668473	113	28	=	=	NOUN
bjos-8668473	113	29	0.008	0.008	NUM
bjos-8668473	113	30	)	)	PUNCT
bjos-8668473	113	31	and	and	CCONJ
bjos-8668473	113	32	case	case	NOUN
bjos-8668473	113	33	group	group	NOUN
bjos-8668473	113	34	2	2	NUM
bjos-8668473	113	35	(	(	PUNCT
bjos-8668473	113	36	advanced	advanced	ADJ
bjos-8668473	113	37	stage	stage	NOUN
bjos-8668473	113	38	of	of	ADP
bjos-8668473	113	39	the	the	DET
bjos-8668473	113	40	disease	disease	NOUN
bjos-8668473	113	41	)	)	PUNCT
bjos-8668473	113	42	(	(	PUNCT
bjos-8668473	113	43	p	p	X
bjos-8668473	113	44	<	<	X
bjos-8668473	113	45	0.001	0.001	NUM
bjos-8668473	113	46	)	)	PUNCT
bjos-8668473	113	47	(	(	PUNCT
bjos-8668473	113	48	table	table	NOUN
bjos-8668473	113	49	3	3	NUM
bjos-8668473	113	50	)	)	PUNCT
bjos-8668473	113	51	.	.	PUNCT
bjos-8668473	114	1	no	no	DET
bjos-8668473	114	2	significant	significant	ADJ
bjos-8668473	114	3	differences	difference	NOUN
bjos-8668473	114	4	in	in	ADP
bjos-8668473	114	5	pipecolic	pipecolic	NOUN
bjos-8668473	114	6	acid	acid	NOUN
bjos-8668473	114	7	levels	level	NOUN
bjos-8668473	114	8	were	be	AUX
bjos-8668473	114	9	found	find	VERB
bjos-8668473	114	10	with	with	ADP
bjos-8668473	114	11	regards	regard	NOUN
bjos-8668473	114	12	to	to	ADP
bjos-8668473	114	13	the	the	DET
bjos-8668473	114	14	clinical	clinical	ADJ
bjos-8668473	114	15	characteristics	characteristic	NOUN
bjos-8668473	114	16	of	of	ADP
bjos-8668473	114	17	the	the	DET
bjos-8668473	114	18	tumor	tumor	NOUN
bjos-8668473	114	19	(	(	PUNCT
bjos-8668473	114	20	table	table	NOUN
bjos-8668473	114	21	4	4	NUM
bjos-8668473	114	22	)	)	PUNCT
bjos-8668473	114	23	.	.	PUNCT
bjos-8668473	115	1	table	table	NOUN
bjos-8668473	116	1	3	3	NUM
bjos-8668473	116	2	.	.	PUNCT
bjos-8668473	117	1	mean	mean	PROPN
bjos-8668473	117	2	pipecolic	pipecolic	NOUN
bjos-8668473	117	3	acid	acid	NOUN
bjos-8668473	117	4	levels	level	NOUN
bjos-8668473	117	5	in	in	ADP
bjos-8668473	117	6	control	control	NOUN
bjos-8668473	117	7	and	and	CCONJ
bjos-8668473	117	8	case	case	NOUN
bjos-8668473	117	9	groups	group	NOUN
bjos-8668473	117	10	groups	group	NOUN
bjos-8668473	117	11	n	n	CCONJ
bjos-8668473	117	12	pipecolic	pipecolic	NOUN
bjos-8668473	117	13	acid	acid	NOUN
bjos-8668473	117	14	level	level	NOUN
bjos-8668473	117	15	(	(	PUNCT
bjos-8668473	117	16	ng	ng	NOUN
bjos-8668473	117	17	/	/	SYM
bjos-8668473	117	18	ml	ml	NOUN
bjos-8668473	117	19	)	)	PUNCT
bjos-8668473	117	20	mean	mean	NOUN
bjos-8668473	117	21	(	(	PUNCT
bjos-8668473	117	22	±	±	NOUN
bjos-8668473	117	23	sd	sd	NOUN
bjos-8668473	117	24	)	)	PUNCT
bjos-8668473	117	25	p	p	NOUN
bjos-8668473	117	26	-	-	PUNCT
bjos-8668473	117	27	value	value	NOUN
bjos-8668473	117	28	control	control	NOUN
bjos-8668473	117	29	(	(	PUNCT
bjos-8668473	117	30	without	without	ADP
bjos-8668473	117	31	disease	disease	NOUN
bjos-8668473	117	32	)	)	PUNCT
bjos-8668473	117	33	20	20	NUM
bjos-8668473	117	34	114.66	114.66	NUM
bjos-8668473	117	35	(	(	PUNCT
bjos-8668473	117	36	±	±	NUM
bjos-8668473	117	37	33.28	33.28	NUM
bjos-8668473	117	38	)	)	PUNCT
bjos-8668473	117	39	case	case	NOUN
bjos-8668473	117	40	(	(	PUNCT
bjos-8668473	117	41	with	with	ADP
bjos-8668473	117	42	disease	disease	NOUN
bjos-8668473	117	43	)	)	PUNCT
bjos-8668473	117	44	20	20	NUM
bjos-8668473	117	45	169.38	169.38	NUM
bjos-8668473	117	46	(	(	PUNCT
bjos-8668473	117	47	±	±	NOUN
bjos-8668473	117	48	52.85	52.85	NUM
bjos-8668473	117	49	)	)	PUNCT
bjos-8668473	117	50	<	<	X
bjos-8668473	117	51	0.001	0.001	NUM
bjos-8668473	117	52	a	a	DET
bjos-8668473	117	53	control	control	NOUN
bjos-8668473	117	54	(	(	PUNCT
bjos-8668473	117	55	without	without	ADP
bjos-8668473	117	56	disease	disease	NOUN
bjos-8668473	117	57	)	)	PUNCT
bjos-8668473	117	58	20	20	NUM
bjos-8668473	117	59	114.66	114.66	NUM
bjos-8668473	117	60	(	(	PUNCT
bjos-8668473	117	61	±	±	NUM
bjos-8668473	117	62	33.28	33.28	NUM
bjos-8668473	117	63	)	)	PUNCT
bjos-8668473	117	64	0.008	0.008	NUM
bjos-8668473	117	65	b	b	NOUN
bjos-8668473	117	66	case	case	NOUN
bjos-8668473	117	67	1	1	NUM
bjos-8668473	117	68	(	(	PUNCT
bjos-8668473	117	69	early	early	ADJ
bjos-8668473	117	70	stage	stage	NOUN
bjos-8668473	117	71	of	of	ADP
bjos-8668473	117	72	disease	disease	NOUN
bjos-8668473	117	73	)	)	PUNCT
bjos-8668473	117	74	9	9	NUM
bjos-8668473	117	75	158.54	158.54	NUM
bjos-8668473	117	76	(	(	PUNCT
bjos-8668473	117	77	±	±	NUM
bjos-8668473	117	78	48.65	48.65	NUM
bjos-8668473	117	79	)	)	PUNCT
bjos-8668473	117	80	control	control	NOUN
bjos-8668473	117	81	(	(	PUNCT
bjos-8668473	117	82	without	without	ADP
bjos-8668473	117	83	disease	disease	NOUN
bjos-8668473	117	84	)	)	PUNCT
bjos-8668473	117	85	20	20	NUM
bjos-8668473	117	86	114.66	114.66	NUM
bjos-8668473	117	87	(	(	PUNCT
bjos-8668473	117	88	±	±	NUM
bjos-8668473	117	89	33.28	33.28	NUM
bjos-8668473	117	90	)	)	PUNCT
bjos-8668473	117	91	<	<	X
bjos-8668473	117	92	0.001	0.001	NUM
bjos-8668473	117	93	a	a	DET
bjos-8668473	117	94	case	case	NOUN
bjos-8668473	117	95	2	2	NUM
bjos-8668473	117	96	(	(	PUNCT
bjos-8668473	117	97	advanced	advanced	ADJ
bjos-8668473	117	98	stage	stage	NOUN
bjos-8668473	117	99	of	of	ADP
bjos-8668473	117	100	disease	disease	NOUN
bjos-8668473	117	101	)	)	PUNCT
bjos-8668473	117	102	11	11	NUM
bjos-8668473	117	103	178.26	178.26	NUM
bjos-8668473	117	104	(	(	PUNCT
bjos-8668473	117	105	±	±	NUM
bjos-8668473	117	106	56.76	56.76	NUM
bjos-8668473	117	107	)	)	PUNCT
bjos-8668473	117	108	a	a	DET
bjos-8668473	117	109	student	student	NOUN
bjos-8668473	117	110	’s	’s	PART
bjos-8668473	117	111	t	t	PROPN
bjos-8668473	117	112	-	-	PUNCT
bjos-8668473	117	113	test	test	NOUN
bjos-8668473	117	114	;	;	PUNCT
bjos-8668473	117	115	b	b	X
bjos-8668473	117	116	mann	mann	PROPN
bjos-8668473	117	117	-	-	PUNCT
bjos-8668473	117	118	whitney	whitney	PROPN
bjos-8668473	117	119	test	test	NOUN
bjos-8668473	117	120	table	table	NOUN
bjos-8668473	117	121	4	4	NUM
bjos-8668473	117	122	.	.	PUNCT
bjos-8668473	118	1	mean	mean	ADJ
bjos-8668473	118	2	levels	level	NOUN
bjos-8668473	118	3	of	of	ADP
bjos-8668473	118	4	pipecolic	pipecolic	NOUN
bjos-8668473	118	5	acid	acid	NOUN
bjos-8668473	118	6	according	accord	VERB
bjos-8668473	118	7	to	to	ADP
bjos-8668473	118	8	clinical	clinical	ADJ
bjos-8668473	118	9	characteristics	characteristic	NOUN
bjos-8668473	118	10	of	of	ADP
bjos-8668473	118	11	case	case	NOUN
bjos-8668473	118	12	group	group	NOUN
bjos-8668473	118	13	clinical	clinical	ADJ
bjos-8668473	118	14	variables	variable	NOUN
bjos-8668473	118	15	n	n	PROPN
bjos-8668473	118	16	(	(	PUNCT
bjos-8668473	118	17	%	%	INTJ
bjos-8668473	118	18	)	)	PUNCT
bjos-8668473	118	19	pipecolic	pipecolic	NOUN
bjos-8668473	118	20	acid	acid	NOUN
bjos-8668473	118	21	level	level	NOUN
bjos-8668473	118	22	(	(	PUNCT
bjos-8668473	118	23	ng	ng	NOUN
bjos-8668473	118	24	/	/	SYM
bjos-8668473	118	25	ml	ml	NOUN
bjos-8668473	118	26	)	)	PUNCT
bjos-8668473	118	27	mean	mean	NOUN
bjos-8668473	118	28	(	(	PUNCT
bjos-8668473	118	29	±	±	NOUN
bjos-8668473	118	30	sd	sd	NOUN
bjos-8668473	118	31	)	)	PUNCT
bjos-8668473	118	32	p	p	NOUN
bjos-8668473	118	33	-	-	PUNCT
bjos-8668473	118	34	value	value	NOUN
bjos-8668473	118	35	location	location	NOUN
bjos-8668473	118	36	of	of	ADP
bjos-8668473	118	37	tumor	tumor	NOUN
bjos-8668473	118	38	oral	oral	ADJ
bjos-8668473	118	39	cavity	cavity	NOUN
bjos-8668473	118	40	and	and	CCONJ
bjos-8668473	118	41	oropharynx	oropharynx	NOUN
bjos-8668473	118	42	12	12	NUM
bjos-8668473	118	43	(	(	PUNCT
bjos-8668473	118	44	60	60	NUM
bjos-8668473	118	45	%	%	NOUN
bjos-8668473	118	46	)	)	PUNCT
bjos-8668473	118	47	177.37	177.37	NUM
bjos-8668473	118	48	(	(	PUNCT
bjos-8668473	118	49	±	±	NOUN
bjos-8668473	118	50	59.73	59.73	NUM
bjos-8668473	118	51	)	)	PUNCT
bjos-8668473	118	52	0.589	0.589	NUM
bjos-8668473	118	53	a	a	DET
bjos-8668473	118	54	hypopharynx	hypopharynx	NOUN
bjos-8668473	118	55	and	and	CCONJ
bjos-8668473	118	56	larynx	larynx	NOUN
bjos-8668473	118	57	8	8	NUM
bjos-8668473	118	58	(	(	PUNCT
bjos-8668473	118	59	40	40	NUM
bjos-8668473	118	60	%	%	NOUN
bjos-8668473	118	61	)	)	PUNCT
bjos-8668473	118	62	157.40	157.40	NUM
bjos-8668473	118	63	(	(	PUNCT
bjos-8668473	118	64	±	±	NOUN
bjos-8668473	118	65	41.26	41.26	NUM
bjos-8668473	118	66	)	)	PUNCT
bjos-8668473	119	1	stage	stage	NOUN
bjos-8668473	119	2	initial	initial	NOUN
bjos-8668473	119	3	(	(	PUNCT
bjos-8668473	119	4	i	i	NOUN
bjos-8668473	119	5	and	and	CCONJ
bjos-8668473	119	6	ii	ii	NOUN
bjos-8668473	119	7	)	)	PUNCT
bjos-8668473	119	8	9	9	NUM
bjos-8668473	119	9	(	(	PUNCT
bjos-8668473	119	10	45	45	NUM
bjos-8668473	119	11	%	%	NOUN
bjos-8668473	119	12	)	)	PUNCT
bjos-8668473	119	13	158.54	158.54	NUM
bjos-8668473	119	14	(	(	PUNCT
bjos-8668473	119	15	±	±	NUM
bjos-8668473	119	16	48.65	48.65	NUM
bjos-8668473	119	17	)	)	PUNCT
bjos-8668473	119	18	0.305	0.305	NUM
bjos-8668473	119	19	a	a	DET
bjos-8668473	119	20	advanced	advanced	ADJ
bjos-8668473	119	21	(	(	PUNCT
bjos-8668473	119	22	iii	iii	NUM
bjos-8668473	119	23	and	and	CCONJ
bjos-8668473	119	24	iv	iv	X
bjos-8668473	119	25	)	)	PUNCT
bjos-8668473	119	26	11	11	NUM
bjos-8668473	119	27	(	(	PUNCT
bjos-8668473	119	28	55	55	NUM
bjos-8668473	119	29	%	%	NOUN
bjos-8668473	119	30	)	)	PUNCT
bjos-8668473	119	31	178.26	178.26	NUM
bjos-8668473	119	32	(	(	PUNCT
bjos-8668473	119	33	±	±	NUM
bjos-8668473	119	34	56.76	56.76	NUM
bjos-8668473	119	35	)	)	PUNCT
bjos-8668473	119	36	tumor	tumor	NOUN
bjos-8668473	119	37	size	size	NOUN
bjos-8668473	119	38	t1	t1	NOUN
bjos-8668473	119	39	and	and	CCONJ
bjos-8668473	119	40	t2	t2	PROPN
bjos-8668473	119	41	14	14	NUM
bjos-8668473	119	42	(	(	PUNCT
bjos-8668473	119	43	70	70	NUM
bjos-8668473	119	44	%	%	NOUN
bjos-8668473	119	45	)	)	PUNCT
bjos-8668473	119	46	165.31	165.31	NUM
bjos-8668473	119	47	(	(	PUNCT
bjos-8668473	119	48	±	±	NOUN
bjos-8668473	119	49	44.67	44.67	NUM
bjos-8668473	119	50	)	)	PUNCT
bjos-8668473	120	1	0.612	0.612	NUM
bjos-8668473	120	2	b	b	NOUN
bjos-8668473	120	3	t3	t3	PROPN
bjos-8668473	120	4	and	and	CCONJ
bjos-8668473	120	5	t4	t4	PROPN
bjos-8668473	120	6	6	6	NUM
bjos-8668473	120	7	(	(	PUNCT
bjos-8668473	120	8	30	30	NUM
bjos-8668473	120	9	%	%	NOUN
bjos-8668473	120	10	)	)	PUNCT
bjos-8668473	120	11	178.89	178.89	NUM
bjos-8668473	120	12	(	(	PUNCT
bjos-8668473	120	13	±	±	NUM
bjos-8668473	120	14	72.61	72.61	NUM
bjos-8668473	120	15	)	)	PUNCT
bjos-8668473	121	1	metastasis	metastasis	NOUN
bjos-8668473	121	2	to	to	AUX
bjos-8668473	121	3	lymph	lymph	NOUN
bjos-8668473	121	4	nodes	node	NOUN
bjos-8668473	121	5	no	no	DET
bjos-8668473	121	6	12	12	NUM
bjos-8668473	121	7	(	(	PUNCT
bjos-8668473	121	8	60	60	NUM
bjos-8668473	121	9	%	%	NOUN
bjos-8668473	121	10	)	)	PUNCT
bjos-8668473	121	11	157.81	157.81	NUM
bjos-8668473	121	12	(	(	PUNCT
bjos-8668473	121	13	±	±	NOUN
bjos-8668473	121	14	46.32	46.32	NUM
bjos-8668473	121	15	)	)	PUNCT
bjos-8668473	122	1	0.240	0.240	NUM
bjos-8668473	123	1	b	b	NOUN
bjos-8668473	124	1	yes	yes	INTJ
bjos-8668473	124	2	8	8	NUM
bjos-8668473	124	3	(	(	PUNCT
bjos-8668473	124	4	40	40	NUM
bjos-8668473	124	5	%	%	NOUN
bjos-8668473	124	6	)	)	PUNCT
bjos-8668473	125	1	186.75	186.75	NUM
bjos-8668473	125	2	(	(	PUNCT
bjos-8668473	125	3	±	±	NOUN
bjos-8668473	125	4	60.31	60.31	NUM
bjos-8668473	125	5	)	)	PUNCT
bjos-8668473	125	6	a	a	DET
bjos-8668473	125	7	mann	mann	PROPN
bjos-8668473	125	8	-	-	PUNCT
bjos-8668473	125	9	whitney	whitney	PROPN
bjos-8668473	125	10	;	;	PUNCT
bjos-8668473	125	11	b	b	X
bjos-8668473	125	12	student	student	NOUN
bjos-8668473	125	13	’s	’s	PART
bjos-8668473	125	14	t	t	PROPN
bjos-8668473	125	15	-	-	PUNCT
bjos-8668473	125	16	test	test	NOUN
bjos-8668473	125	17	8	8	NUM
bjos-8668473	125	18	ferrazzo	ferrazzo	VERB
bjos-8668473	125	19	et	et	PROPN
bjos-8668473	125	20	al	al	PROPN
bjos-8668473	125	21	.	.	PROPN
bjos-8668473	126	1	braz	braz	PROPN
bjos-8668473	126	2	j	j	PROPN
bjos-8668473	126	3	oral	oral	PROPN
bjos-8668473	126	4	sci	sci	PROPN
bjos-8668473	126	5	.	.	PUNCT
bjos-8668473	127	1	2023;22	2023;22	NUM
bjos-8668473	127	2	:	:	PUNCT
bjos-8668473	127	3	e238473	e238473	NUM
bjos-8668473	127	4	based	base	VERB
bjos-8668473	127	5	on	on	ADP
bjos-8668473	127	6	the	the	DET
bjos-8668473	127	7	roc	roc	PROPN
bjos-8668473	127	8	curve	curve	NOUN
bjos-8668473	127	9	,	,	PUNCT
bjos-8668473	127	10	pipecolic	pipecolic	NOUN
bjos-8668473	127	11	acid	acid	NOUN
bjos-8668473	127	12	had	have	VERB
bjos-8668473	127	13	90	90	NUM
bjos-8668473	127	14	%	%	NOUN
bjos-8668473	127	15	sensitivity	sensitivity	NOUN
bjos-8668473	127	16	and	and	CCONJ
bjos-8668473	127	17	65	65	NUM
bjos-8668473	127	18	%	%	NOUN
bjos-8668473	127	19	specificity	specificity	NOUN
bjos-8668473	127	20	for	for	ADP
bjos-8668473	127	21	predicting	predict	VERB
bjos-8668473	127	22	whether	whether	SCONJ
bjos-8668473	127	23	a	a	DET
bjos-8668473	127	24	patient	patient	NOUN
bjos-8668473	127	25	has	have	VERB
bjos-8668473	127	26	scc	scc	NOUN
bjos-8668473	127	27	of	of	ADP
bjos-8668473	127	28	the	the	DET
bjos-8668473	127	29	head	head	NOUN
bjos-8668473	127	30	and	and	CCONJ
bjos-8668473	127	31	neck	neck	NOUN
bjos-8668473	127	32	,	,	PUNCT
bjos-8668473	127	33	with	with	ADP
bjos-8668473	127	34	an	an	DET
bjos-8668473	127	35	auc	auc	NOUN
bjos-8668473	127	36	of	of	ADP
bjos-8668473	127	37	0.838	0.838	NUM
bjos-8668473	127	38	(	(	PUNCT
bjos-8668473	127	39	p	p	X
bjos-8668473	127	40	<	<	X
bjos-8668473	127	41	0.001	0.001	NUM
bjos-8668473	127	42	;	;	PUNCT
bjos-8668473	127	43	95	95	NUM
bjos-8668473	127	44	%	%	NOUN
bjos-8668473	127	45	confidence	confidence	NOUN
bjos-8668473	127	46	interval	interval	NOUN
bjos-8668473	127	47	:	:	PUNCT
bjos-8668473	127	48	0.716	0.716	NUM
bjos-8668473	127	49	0.959	0.959	NUM
bjos-8668473	127	50	)	)	PUNCT
bjos-8668473	127	51	and	and	CCONJ
bjos-8668473	127	52	a	a	DET
bjos-8668473	127	53	cutoff	cutoff	NOUN
bjos-8668473	127	54	point	point	NOUN
bjos-8668473	127	55	of	of	ADP
bjos-8668473	127	56	121.77	121.77	NUM
bjos-8668473	127	57	ng	ng	PROPN
bjos-8668473	127	58	/	/	SYM
bjos-8668473	127	59	ml	ml	PROPN
bjos-8668473	127	60	.	.	PUNCT
bjos-8668473	128	1	in	in	ADP
bjos-8668473	128	2	the	the	DET
bjos-8668473	128	3	analysis	analysis	NOUN
bjos-8668473	128	4	stratified	stratify	VERB
bjos-8668473	128	5	by	by	ADP
bjos-8668473	128	6	disease	disease	NOUN
bjos-8668473	128	7	stage	stage	NOUN
bjos-8668473	128	8	,	,	PUNCT
bjos-8668473	128	9	sensitivity	sensitivity	NOUN
bjos-8668473	128	10	was	be	AUX
bjos-8668473	128	11	100	100	NUM
bjos-8668473	128	12	%	%	NOUN
bjos-8668473	128	13	and	and	CCONJ
bjos-8668473	128	14	specificity	specificity	NOUN
bjos-8668473	128	15	was	be	AUX
bjos-8668473	128	16	65	65	NUM
bjos-8668473	128	17	%	%	NOUN
bjos-8668473	128	18	(	(	PUNCT
bjos-8668473	128	19	auc	auc	NOUN
bjos-8668473	128	20	=	=	SYM
bjos-8668473	128	21	0.811	0.811	NUM
bjos-8668473	128	22	;	;	PUNCT
bjos-8668473	128	23	p	p	X
bjos-8668473	128	24	=	=	NOUN
bjos-8668473	128	25	0.008	0.008	NUM
bjos-8668473	128	26	;	;	PUNCT
bjos-8668473	128	27	95	95	NUM
bjos-8668473	128	28	%	%	NOUN
bjos-8668473	128	29	confidence	confidence	NOUN
bjos-8668473	128	30	interval	interval	NOUN
bjos-8668473	128	31	:	:	PUNCT
bjos-8668473	128	32	0.655	0.655	NUM
bjos-8668473	128	33	0.967	0.967	NUM
bjos-8668473	128	34	)	)	PUNCT
bjos-8668473	128	35	for	for	ADP
bjos-8668473	128	36	the	the	DET
bjos-8668473	128	37	detection	detection	NOUN
bjos-8668473	128	38	of	of	ADP
bjos-8668473	128	39	the	the	DET
bjos-8668473	128	40	early	early	ADJ
bjos-8668473	128	41	stage	stage	NOUN
bjos-8668473	128	42	of	of	ADP
bjos-8668473	128	43	the	the	DET
bjos-8668473	128	44	disease	disease	NOUN
bjos-8668473	128	45	,	,	PUNCT
bjos-8668473	128	46	whereas	whereas	SCONJ
bjos-8668473	128	47	sensitivity	sensitivity	NOUN
bjos-8668473	128	48	was	be	AUX
bjos-8668473	128	49	91	91	NUM
bjos-8668473	128	50	%	%	NOUN
bjos-8668473	128	51	and	and	CCONJ
bjos-8668473	128	52	specificity	specificity	NOUN
bjos-8668473	128	53	was	be	AUX
bjos-8668473	128	54	60	60	NUM
bjos-8668473	128	55	%	%	NOUN
bjos-8668473	128	56	(	(	PUNCT
bjos-8668473	128	57	auc	auc	NOUN
bjos-8668473	128	58	=	=	SYM
bjos-8668473	128	59	0.859	0.859	NUM
bjos-8668473	128	60	;	;	PUNCT
bjos-8668473	128	61	p	p	PROPN
bjos-8668473	128	62	=	=	NOUN
bjos-8668473	128	63	0.001	0.001	NUM
bjos-8668473	128	64	;	;	PUNCT
bjos-8668473	128	65	95	95	NUM
bjos-8668473	128	66	%	%	NOUN
bjos-8668473	128	67	confidence	confidence	NOUN
bjos-8668473	128	68	interval	interval	NOUN
bjos-8668473	128	69	:	:	PUNCT
bjos-8668473	128	70	0.727	0.727	NUM
bjos-8668473	128	71	0.991	0.991	NUM
bjos-8668473	128	72	)	)	PUNCT
bjos-8668473	128	73	for	for	ADP
bjos-8668473	128	74	detection	detection	NOUN
bjos-8668473	128	75	of	of	ADP
bjos-8668473	128	76	the	the	DET
bjos-8668473	128	77	advanced	advanced	ADJ
bjos-8668473	128	78	stage	stage	NOUN
bjos-8668473	128	79	of	of	ADP
bjos-8668473	128	80	the	the	DET
bjos-8668473	128	81	disease	disease	NOUN
bjos-8668473	128	82	.	.	PUNCT
bjos-8668473	129	1	cutoff	cutoff	NOUN
bjos-8668473	129	2	points	point	NOUN
bjos-8668473	129	3	for	for	ADP
bjos-8668473	129	4	early	early	ADJ
bjos-8668473	129	5	and	and	CCONJ
bjos-8668473	129	6	advanced	advanced	ADJ
bjos-8668473	129	7	stages	stage	NOUN
bjos-8668473	129	8	were	be	AUX
bjos-8668473	129	9	121.77	121.77	NUM
bjos-8668473	129	10	ng	ng	NOUN
bjos-8668473	129	11	/	/	SYM
bjos-8668473	129	12	ml	ml	PROPN
bjos-8668473	129	13	and	and	CCONJ
bjos-8668473	129	14	120.79	120.79	NUM
bjos-8668473	129	15	ng	ng	NOUN
bjos-8668473	129	16	/	/	SYM
bjos-8668473	129	17	ml	ml	PROPN
bjos-8668473	129	18	,	,	PUNCT
bjos-8668473	129	19	respectively	respectively	ADV
bjos-8668473	129	20	(	(	PUNCT
bjos-8668473	129	21	figure	figure	NOUN
bjos-8668473	129	22	1	1	NUM
bjos-8668473	129	23	)	)	PUNCT
bjos-8668473	129	24	.	.	PUNCT
bjos-8668473	130	1	(	(	PUNCT
bjos-8668473	130	2	a	a	X
bjos-8668473	130	3	)	)	PUNCT
bjos-8668473	130	4	1.0	1.0	NUM
bjos-8668473	130	5	0.8	0.8	NUM
bjos-8668473	130	6	0.6	0.6	NUM
bjos-8668473	130	7	0.4	0.4	NUM
bjos-8668473	130	8	0.2	0.2	NUM
bjos-8668473	130	9	0.0	0.0	NUM
bjos-8668473	130	10	0.0	0.0	NUM
bjos-8668473	130	11	0.2	0.2	NUM
bjos-8668473	130	12	0.4	0.4	NUM
bjos-8668473	130	13	0.6	0.6	NUM
bjos-8668473	130	14	0.8	0.8	NUM
bjos-8668473	130	15	1.0	1.0	NUM
bjos-8668473	130	16	1	1	NUM
bjos-8668473	130	17	–	–	PUNCT
bjos-8668473	130	18	specificity	specificity	NOUN
bjos-8668473	130	19	se	se	X
bjos-8668473	130	20	ns	ns	PROPN
bjos-8668473	130	21	ib	ib	PROPN
bjos-8668473	130	22	ili	ili	PROPN
bjos-8668473	131	1	ty	ty	INTJ
bjos-8668473	131	2	control	control	NOUN
bjos-8668473	131	3	versus	versus	ADP
bjos-8668473	131	4	case	case	NOUN
bjos-8668473	131	5	auc	auc	NOUN
bjos-8668473	131	6	=	=	PUNCT
bjos-8668473	131	7	0.838	0.838	NUM
bjos-8668473	131	8	p	p	X
bjos-8668473	131	9	<	<	X
bjos-8668473	131	10	0.001	0.001	NUM
bjos-8668473	131	11	(	(	PUNCT
bjos-8668473	131	12	b	b	NOUN
bjos-8668473	131	13	)	)	PUNCT
bjos-8668473	131	14	1.0	1.0	NUM
bjos-8668473	131	15	0.8	0.8	NUM
bjos-8668473	131	16	0.6	0.6	NUM
bjos-8668473	131	17	0.4	0.4	NUM
bjos-8668473	131	18	0.2	0.2	NUM
bjos-8668473	131	19	0.0	0.0	NUM
bjos-8668473	131	20	0.0	0.0	NUM
bjos-8668473	131	21	0.2	0.2	NUM
bjos-8668473	131	22	0.4	0.4	NUM
bjos-8668473	131	23	0.6	0.6	NUM
bjos-8668473	131	24	0.8	0.8	NUM
bjos-8668473	131	25	1.0	1.0	NUM
bjos-8668473	131	26	1	1	NUM
bjos-8668473	131	27	–	–	PUNCT
bjos-8668473	131	28	specificity	specificity	NOUN
bjos-8668473	131	29	se	se	X
bjos-8668473	131	30	ns	ns	PROPN
bjos-8668473	131	31	ib	ib	PROPN
bjos-8668473	131	32	ili	ili	PROPN
bjos-8668473	132	1	ty	ty	INTJ
bjos-8668473	132	2	control	control	NOUN
bjos-8668473	132	3	versus	versus	ADP
bjos-8668473	132	4	case	case	NOUN
bjos-8668473	132	5	1	1	NUM
bjos-8668473	132	6	auc	auc	NOUN
bjos-8668473	132	7	=	=	NOUN
bjos-8668473	132	8	0.811	0.811	NUM
bjos-8668473	132	9	p	p	NOUN
bjos-8668473	132	10	=	=	NOUN
bjos-8668473	132	11	0.008	0.008	NUM
bjos-8668473	132	12	(	(	PUNCT
bjos-8668473	132	13	c	c	NOUN
bjos-8668473	132	14	)	)	PUNCT
bjos-8668473	132	15	1.0	1.0	NUM
bjos-8668473	132	16	0.8	0.8	NUM
bjos-8668473	132	17	0.6	0.6	NUM
bjos-8668473	132	18	0.4	0.4	NUM
bjos-8668473	132	19	0.2	0.2	NUM
bjos-8668473	132	20	0.0	0.0	NUM
bjos-8668473	132	21	0.0	0.0	NUM
bjos-8668473	132	22	0.2	0.2	NUM
bjos-8668473	132	23	0.4	0.4	NUM
bjos-8668473	132	24	0.6	0.6	NUM
bjos-8668473	132	25	0.8	0.8	NUM
bjos-8668473	132	26	1.0	1.0	NUM
bjos-8668473	132	27	1	1	NUM
bjos-8668473	132	28	–	–	PUNCT
bjos-8668473	132	29	specificity	specificity	NOUN
bjos-8668473	132	30	se	se	X
bjos-8668473	132	31	ns	ns	PROPN
bjos-8668473	132	32	ib	ib	PROPN
bjos-8668473	132	33	ili	ili	PROPN
bjos-8668473	133	1	ty	ty	INTJ
bjos-8668473	133	2	control	control	NOUN
bjos-8668473	133	3	versus	versus	ADP
bjos-8668473	133	4	case	case	NOUN
bjos-8668473	133	5	2	2	NUM
bjos-8668473	133	6	auc	auc	NOUN
bjos-8668473	133	7	=	=	NOUN
bjos-8668473	133	8	0.859	0.859	NUM
bjos-8668473	133	9	p	p	NOUN
bjos-8668473	133	10	=	=	NOUN
bjos-8668473	133	11	0.001	0.001	NUM
bjos-8668473	133	12	figure	figure	NOUN
bjos-8668473	133	13	1	1	NUM
bjos-8668473	133	14	.	.	PUNCT
bjos-8668473	133	15	analysis	analysis	NOUN
bjos-8668473	133	16	of	of	ADP
bjos-8668473	133	17	roc	roc	PROPN
bjos-8668473	133	18	curve	curve	NOUN
bjos-8668473	133	19	for	for	ADP
bjos-8668473	133	20	determination	determination	NOUN
bjos-8668473	133	21	of	of	ADP
bjos-8668473	133	22	sensitivity	sensitivity	NOUN
bjos-8668473	133	23	and	and	CCONJ
bjos-8668473	133	24	specificity	specificity	NOUN
bjos-8668473	133	25	of	of	ADP
bjos-8668473	133	26	pipecolic	pipecolic	NOUN
bjos-8668473	133	27	acid	acid	NOUN
bjos-8668473	133	28	for	for	ADP
bjos-8668473	133	29	prediction	prediction	NOUN
bjos-8668473	133	30	of	of	ADP
bjos-8668473	133	31	head	head	NOUN
bjos-8668473	133	32	and	and	CCONJ
bjos-8668473	133	33	neck	neck	VERB
bjos-8668473	133	34	squamous	squamous	ADJ
bjos-8668473	133	35	cell	cell	NOUN
bjos-8668473	133	36	carcinoma	carcinoma	NOUN
bjos-8668473	133	37	.	.	PUNCT
bjos-8668473	134	1	(	(	PUNCT
bjos-8668473	134	2	a	a	X
bjos-8668473	134	3	)	)	PUNCT
bjos-8668473	134	4	control	control	NOUN
bjos-8668473	134	5	versus	versus	ADP
bjos-8668473	134	6	case	case	NOUN
bjos-8668473	134	7	;	;	PUNCT
bjos-8668473	134	8	(	(	PUNCT
bjos-8668473	134	9	b	b	X
bjos-8668473	134	10	)	)	PUNCT
bjos-8668473	134	11	control	control	NOUN
bjos-8668473	134	12	versus	versus	ADP
bjos-8668473	134	13	case	case	NOUN
bjos-8668473	134	14	1	1	NUM
bjos-8668473	134	15	(	(	PUNCT
bjos-8668473	134	16	initial	initial	ADJ
bjos-8668473	134	17	stage	stage	NOUN
bjos-8668473	134	18	of	of	ADP
bjos-8668473	134	19	disease	disease	NOUN
bjos-8668473	134	20	)	)	PUNCT
bjos-8668473	134	21	;	;	PUNCT
bjos-8668473	134	22	(	(	PUNCT
bjos-8668473	134	23	c	c	X
bjos-8668473	134	24	)	)	PUNCT
bjos-8668473	134	25	control	control	NOUN
bjos-8668473	134	26	versus	versus	ADP
bjos-8668473	134	27	case	case	NOUN
bjos-8668473	134	28	2	2	NUM
bjos-8668473	134	29	(	(	PUNCT
bjos-8668473	134	30	advanced	advanced	ADJ
bjos-8668473	134	31	stage	stage	NOUN
bjos-8668473	134	32	of	of	ADP
bjos-8668473	134	33	disease	disease	NOUN
bjos-8668473	134	34	)	)	PUNCT
bjos-8668473	134	35	.	.	PUNCT
bjos-8668473	135	1	9	9	NUM
bjos-8668473	135	2	ferrazzo	ferrazzo	VERB
bjos-8668473	135	3	et	et	PROPN
bjos-8668473	135	4	al	al	PROPN
bjos-8668473	135	5	.	.	PROPN
bjos-8668473	136	1	braz	braz	PROPN
bjos-8668473	136	2	j	j	PROPN
bjos-8668473	136	3	oral	oral	PROPN
bjos-8668473	136	4	sci	sci	PROPN
bjos-8668473	136	5	.	.	PUNCT
bjos-8668473	137	1	2023;22	2023;22	NUM
bjos-8668473	137	2	:	:	PUNCT
bjos-8668473	137	3	e238473	e238473	NUM
bjos-8668473	137	4	discussion	discussion	NOUN
bjos-8668473	137	5	in	in	ADP
bjos-8668473	137	6	the	the	DET
bjos-8668473	137	7	present	present	ADJ
bjos-8668473	137	8	study	study	NOUN
bjos-8668473	137	9	,	,	PUNCT
bjos-8668473	137	10	a	a	DET
bjos-8668473	137	11	significant	significant	ADJ
bjos-8668473	137	12	difference	difference	NOUN
bjos-8668473	137	13	in	in	ADP
bjos-8668473	137	14	salivary	salivary	ADJ
bjos-8668473	137	15	levels	level	NOUN
bjos-8668473	137	16	of	of	ADP
bjos-8668473	137	17	pipecolic	pipecolic	NOUN
bjos-8668473	137	18	acid	acid	NOUN
bjos-8668473	137	19	was	be	AUX
bjos-8668473	137	20	found	find	VERB
bjos-8668473	137	21	between	between	ADP
bjos-8668473	137	22	individuals	individual	NOUN
bjos-8668473	137	23	without	without	ADP
bjos-8668473	137	24	cancer	cancer	NOUN
bjos-8668473	137	25	and	and	CCONJ
bjos-8668473	137	26	patients	patient	NOUN
bjos-8668473	137	27	with	with	ADP
bjos-8668473	137	28	hnscc	hnscc	NOUN
bjos-8668473	137	29	in	in	ADP
bjos-8668473	137	30	both	both	CCONJ
bjos-8668473	137	31	the	the	DET
bjos-8668473	137	32	early	early	ADJ
bjos-8668473	137	33	stages	stage	NOUN
bjos-8668473	137	34	and	and	CCONJ
bjos-8668473	137	35	advanced	advanced	ADJ
bjos-8668473	137	36	stages	stage	NOUN
bjos-8668473	137	37	.	.	PUNCT
bjos-8668473	138	1	this	this	DET
bjos-8668473	138	2	finding	finding	NOUN
bjos-8668473	138	3	is	be	AUX
bjos-8668473	138	4	important	important	ADJ
bjos-8668473	138	5	,	,	PUNCT
bjos-8668473	138	6	as	as	ADV
bjos-8668473	138	7	well	well	ADV
bjos-8668473	138	8	-	-	PUNCT
bjos-8668473	138	9	designed	design	VERB
bjos-8668473	138	10	studies	study	NOUN
bjos-8668473	138	11	that	that	PRON
bjos-8668473	138	12	investigate	investigate	VERB
bjos-8668473	138	13	this	this	DET
bjos-8668473	138	14	association	association	NOUN
bjos-8668473	138	15	are	be	AUX
bjos-8668473	138	16	scarce	scarce	ADJ
bjos-8668473	138	17	in	in	ADP
bjos-8668473	138	18	the	the	DET
bjos-8668473	138	19	literature	literature	NOUN
bjos-8668473	138	20	according	accord	VERB
bjos-8668473	138	21	to	to	ADP
bjos-8668473	138	22	a	a	DET
bjos-8668473	138	23	recent	recent	ADJ
bjos-8668473	138	24	systematic	systematic	ADJ
bjos-8668473	138	25	review27	review27	NOUN
bjos-8668473	138	26	.	.	PUNCT
bjos-8668473	139	1	an	an	DET
bjos-8668473	139	2	important	important	ADJ
bjos-8668473	139	3	result	result	NOUN
bjos-8668473	139	4	found	find	VERB
bjos-8668473	139	5	in	in	ADP
bjos-8668473	139	6	this	this	DET
bjos-8668473	139	7	paper	paper	NOUN
bjos-8668473	139	8	was	be	AUX
bjos-8668473	139	9	that	that	SCONJ
bjos-8668473	139	10	individuals	individual	NOUN
bjos-8668473	139	11	with	with	ADP
bjos-8668473	139	12	higher	high	ADJ
bjos-8668473	139	13	levels	level	NOUN
bjos-8668473	139	14	of	of	ADP
bjos-8668473	139	15	pipecolic	pipecolic	NOUN
bjos-8668473	139	16	acid	acid	NOUN
bjos-8668473	139	17	in	in	ADP
bjos-8668473	139	18	both	both	CCONJ
bjos-8668473	139	19	the	the	DET
bjos-8668473	139	20	case	case	NOUN
bjos-8668473	139	21	and	and	CCONJ
bjos-8668473	139	22	control	control	NOUN
bjos-8668473	139	23	groups	group	NOUN
bjos-8668473	139	24	made	make	VERB
bjos-8668473	139	25	daily	daily	ADJ
bjos-8668473	139	26	use	use	NOUN
bjos-8668473	139	27	of	of	ADP
bjos-8668473	139	28	some	some	DET
bjos-8668473	139	29	oral	oral	ADJ
bjos-8668473	139	30	hypoglycemic	hypoglycemic	ADJ
bjos-8668473	139	31	drug	drug	NOUN
bjos-8668473	139	32	.	.	PUNCT
bjos-8668473	140	1	the	the	DET
bjos-8668473	140	2	test	test	NOUN
bjos-8668473	140	3	and	and	CCONJ
bjos-8668473	140	4	control	control	NOUN
bjos-8668473	140	5	groups	group	NOUN
bjos-8668473	140	6	were	be	AUX
bjos-8668473	140	7	matched	match	VERB
bjos-8668473	140	8	regarding	regard	VERB
bjos-8668473	140	9	the	the	DET
bjos-8668473	140	10	use	use	NOUN
bjos-8668473	140	11	of	of	ADP
bjos-8668473	140	12	oral	oral	ADJ
bjos-8668473	140	13	hypoglycemic	hypoglycemic	ADJ
bjos-8668473	140	14	agents	agent	NOUN
bjos-8668473	140	15	to	to	PART
bjos-8668473	140	16	reduce	reduce	VERB
bjos-8668473	140	17	the	the	DET
bjos-8668473	140	18	possibility	possibility	NOUN
bjos-8668473	140	19	of	of	ADP
bjos-8668473	140	20	a	a	DET
bjos-8668473	140	21	confounding	confound	VERB
bjos-8668473	140	22	factor	factor	NOUN
bjos-8668473	140	23	.	.	PUNCT
bjos-8668473	141	1	in	in	ADP
bjos-8668473	141	2	a	a	DET
bjos-8668473	141	3	previous	previous	ADJ
bjos-8668473	141	4	study	study	NOUN
bjos-8668473	141	5	,	,	PUNCT
bjos-8668473	141	6	pipecolic	pipecolic	NOUN
bjos-8668473	141	7	acid	acid	PROPN
bjos-8668473	141	8	exhibited	exhibit	VERB
bjos-8668473	141	9	sensitivity	sensitivity	NOUN
bjos-8668473	141	10	and	and	CCONJ
bjos-8668473	141	11	specificity	specificity	NOUN
bjos-8668473	141	12	higher	high	ADJ
bjos-8668473	141	13	than	than	ADP
bjos-8668473	141	14	90	90	NUM
bjos-8668473	141	15	%	%	NOUN
bjos-8668473	141	16	for	for	ADP
bjos-8668473	141	17	the	the	DET
bjos-8668473	141	18	early	early	ADJ
bjos-8668473	141	19	detection	detection	NOUN
bjos-8668473	141	20	of	of	ADP
bjos-8668473	141	21	squamous	squamous	ADJ
bjos-8668473	141	22	cell	cell	NOUN
bjos-8668473	141	23	carcinoma	carcinoma	NOUN
bjos-8668473	141	24	of	of	ADP
bjos-8668473	141	25	the	the	DET
bjos-8668473	141	26	oral	oral	ADJ
bjos-8668473	141	27	cavity18	cavity18	NOUN
bjos-8668473	141	28	.	.	PUNCT
bjos-8668473	142	1	in	in	ADP
bjos-8668473	142	2	the	the	DET
bjos-8668473	142	3	present	present	ADJ
bjos-8668473	142	4	study	study	NOUN
bjos-8668473	142	5	,	,	PUNCT
bjos-8668473	142	6	sensitivity	sensitivity	NOUN
bjos-8668473	142	7	and	and	CCONJ
bjos-8668473	142	8	specificity	specificity	NOUN
bjos-8668473	142	9	were	be	AUX
bjos-8668473	142	10	respectively	respectively	ADV
bjos-8668473	142	11	90	90	NUM
bjos-8668473	142	12	%	%	NOUN
bjos-8668473	142	13	and	and	CCONJ
bjos-8668473	142	14	65	65	NUM
bjos-8668473	142	15	%	%	NOUN
bjos-8668473	142	16	.	.	PUNCT
bjos-8668473	143	1	the	the	DET
bjos-8668473	143	2	lower	low	ADJ
bjos-8668473	143	3	specificity	specificity	NOUN
bjos-8668473	143	4	in	in	ADP
bjos-8668473	143	5	this	this	DET
bjos-8668473	143	6	investigation	investigation	NOUN
bjos-8668473	143	7	compared	compare	VERB
bjos-8668473	143	8	to	to	ADP
bjos-8668473	143	9	the	the	DET
bjos-8668473	143	10	study	study	NOUN
bjos-8668473	143	11	cited	cite	VERB
bjos-8668473	143	12	may	may	AUX
bjos-8668473	143	13	be	be	AUX
bjos-8668473	143	14	due	due	ADJ
bjos-8668473	143	15	to	to	ADP
bjos-8668473	143	16	the	the	DET
bjos-8668473	143	17	small	small	ADJ
bjos-8668473	143	18	sample	sample	NOUN
bjos-8668473	143	19	size	size	NOUN
bjos-8668473	143	20	.	.	PUNCT
bjos-8668473	144	1	however	however	ADV
bjos-8668473	144	2	,	,	PUNCT
bjos-8668473	144	3	pipecolic	pipecolic	ADJ
bjos-8668473	144	4	acid	acid	NOUN
bjos-8668473	144	5	levels	level	NOUN
bjos-8668473	144	6	appear	appear	VERB
bjos-8668473	144	7	also	also	ADV
bjos-8668473	144	8	to	to	PART
bjos-8668473	144	9	be	be	AUX
bjos-8668473	144	10	associated	associate	VERB
bjos-8668473	144	11	with	with	ADP
bjos-8668473	144	12	glucose	glucose	NOUN
bjos-8668473	144	13	homeostasis	homeostasis	NOUN
bjos-8668473	144	14	,	,	PUNCT
bjos-8668473	144	15	as	as	SCONJ
bjos-8668473	144	16	demonstrated	demonstrate	VERB
bjos-8668473	144	17	by	by	ADP
bjos-8668473	144	18	other	other	ADJ
bjos-8668473	144	19	authors19,20	authors19,20	PROPN
bjos-8668473	144	20	.	.	PUNCT
bjos-8668473	144	21	lysine	lysine	NOUN
bjos-8668473	144	22	metabolites	metabolite	NOUN
bjos-8668473	144	23	,	,	PUNCT
bjos-8668473	144	24	including	include	VERB
bjos-8668473	144	25	pipecolic	pipecolic	NOUN
bjos-8668473	144	26	acid	acid	NOUN
bjos-8668473	144	27	,	,	PUNCT
bjos-8668473	144	28	have	have	AUX
bjos-8668473	144	29	been	be	AUX
bjos-8668473	144	30	associated	associate	VERB
bjos-8668473	144	31	with	with	ADP
bjos-8668473	144	32	an	an	DET
bjos-8668473	144	33	increased	increase	VERB
bjos-8668473	144	34	risk	risk	NOUN
bjos-8668473	144	35	of	of	ADP
bjos-8668473	144	36	type	type	NOUN
bjos-8668473	144	37	ii	ii	PROPN
bjos-8668473	144	38	diabetes21,28	diabetes21,28	PROPN
bjos-8668473	144	39	.	.	PUNCT
bjos-8668473	145	1	the	the	DET
bjos-8668473	145	2	development	development	NOUN
bjos-8668473	145	3	mechanism	mechanism	NOUN
bjos-8668473	145	4	of	of	ADP
bjos-8668473	145	5	this	this	DET
bjos-8668473	145	6	pathway	pathway	NOUN
bjos-8668473	145	7	is	be	AUX
bjos-8668473	145	8	not	not	PART
bjos-8668473	145	9	yet	yet	ADV
bjos-8668473	145	10	well	well	ADV
bjos-8668473	145	11	understood	understand	VERB
bjos-8668473	145	12	.	.	PUNCT
bjos-8668473	146	1	lysine	lysine	NOUN
bjos-8668473	146	2	metabolites	metabolite	NOUN
bjos-8668473	146	3	are	be	AUX
bjos-8668473	146	4	believed	believe	VERB
bjos-8668473	146	5	to	to	PART
bjos-8668473	146	6	positively	positively	ADV
bjos-8668473	146	7	regulate	regulate	VERB
bjos-8668473	146	8	insulin	insulin	NOUN
bjos-8668473	146	9	secretion	secretion	NOUN
bjos-8668473	146	10	in	in	ADP
bjos-8668473	146	11	order	order	NOUN
bjos-8668473	146	12	to	to	PART
bjos-8668473	146	13	maintain	maintain	VERB
bjos-8668473	146	14	glucose	glucose	NOUN
bjos-8668473	146	15	homeostasis	homeostasis	NOUN
bjos-8668473	146	16	in	in	ADP
bjos-8668473	146	17	patients	patient	NOUN
bjos-8668473	146	18	with	with	ADP
bjos-8668473	146	19	insulin	insulin	NOUN
bjos-8668473	146	20	resistance28	resistance28	NOUN
bjos-8668473	146	21	.	.	PUNCT
bjos-8668473	147	1	wang	wang	PROPN
bjos-8668473	147	2	et	et	PROPN
bjos-8668473	147	3	al.18	al.18	PROPN
bjos-8668473	147	4	(	(	PUNCT
bjos-8668473	147	5	2014	2014	NUM
bjos-8668473	147	6	)	)	PUNCT
bjos-8668473	147	7	demonstrated	demonstrate	VERB
bjos-8668473	147	8	that	that	SCONJ
bjos-8668473	147	9	salivary	salivary	ADJ
bjos-8668473	147	10	levels	level	NOUN
bjos-8668473	147	11	of	of	ADP
bjos-8668473	147	12	pipecolic	pipecolic	NOUN
bjos-8668473	147	13	acid	acid	NOUN
bjos-8668473	147	14	were	be	AUX
bjos-8668473	147	15	increased	increase	VERB
bjos-8668473	147	16	in	in	ADP
bjos-8668473	147	17	patients	patient	NOUN
bjos-8668473	147	18	with	with	ADP
bjos-8668473	147	19	oral	oral	ADJ
bjos-8668473	147	20	squamous	squamous	ADJ
bjos-8668473	147	21	cell	cell	NOUN
bjos-8668473	147	22	carcinoma	carcinoma	NOUN
bjos-8668473	147	23	compared	compare	VERB
bjos-8668473	147	24	to	to	ADP
bjos-8668473	147	25	healthy	healthy	ADJ
bjos-8668473	147	26	individuals	individual	NOUN
bjos-8668473	147	27	and	and	CCONJ
bjos-8668473	147	28	also	also	ADV
bjos-8668473	147	29	found	find	VERB
bjos-8668473	147	30	higher	high	ADJ
bjos-8668473	147	31	salivary	salivary	ADJ
bjos-8668473	147	32	levels	level	NOUN
bjos-8668473	147	33	of	of	ADP
bjos-8668473	147	34	this	this	DET
bjos-8668473	147	35	biomarker	biomarker	NOUN
bjos-8668473	147	36	in	in	ADP
bjos-8668473	147	37	patients	patient	NOUN
bjos-8668473	147	38	with	with	ADP
bjos-8668473	147	39	late	late	ADJ
bjos-8668473	147	40	-	-	PUNCT
bjos-8668473	147	41	stage	stage	NOUN
bjos-8668473	147	42	tumors	tumor	NOUN
bjos-8668473	147	43	,	,	PUNCT
bjos-8668473	147	44	with	with	ADP
bjos-8668473	147	45	a	a	DET
bjos-8668473	147	46	statistically	statistically	ADV
bjos-8668473	147	47	significant	significant	ADJ
bjos-8668473	147	48	difference	difference	NOUN
bjos-8668473	147	49	between	between	ADP
bjos-8668473	147	50	the	the	DET
bjos-8668473	147	51	stages	stage	NOUN
bjos-8668473	147	52	of	of	ADP
bjos-8668473	147	53	the	the	DET
bjos-8668473	147	54	disease	disease	NOUN
bjos-8668473	147	55	.	.	PUNCT
bjos-8668473	148	1	in	in	ADP
bjos-8668473	148	2	the	the	DET
bjos-8668473	148	3	present	present	ADJ
bjos-8668473	148	4	study	study	NOUN
bjos-8668473	148	5	,	,	PUNCT
bjos-8668473	148	6	although	although	SCONJ
bjos-8668473	148	7	significant	significant	ADJ
bjos-8668473	148	8	differences	difference	NOUN
bjos-8668473	148	9	were	be	AUX
bjos-8668473	148	10	found	find	VERB
bjos-8668473	148	11	between	between	ADP
bjos-8668473	148	12	individuals	individual	NOUN
bjos-8668473	148	13	without	without	ADP
bjos-8668473	148	14	cancer	cancer	NOUN
bjos-8668473	148	15	and	and	CCONJ
bjos-8668473	148	16	those	those	PRON
bjos-8668473	148	17	in	in	ADP
bjos-8668473	148	18	both	both	CCONJ
bjos-8668473	148	19	the	the	DET
bjos-8668473	148	20	early	early	ADJ
bjos-8668473	148	21	(	(	PUNCT
bjos-8668473	148	22	i	i	NOUN
bjos-8668473	148	23	and	and	CCONJ
bjos-8668473	148	24	ii	ii	NOUN
bjos-8668473	148	25	)	)	PUNCT
bjos-8668473	148	26	and	and	CCONJ
bjos-8668473	148	27	advanced	advanced	ADJ
bjos-8668473	148	28	(	(	PUNCT
bjos-8668473	148	29	iii	iii	X
bjos-8668473	148	30	and	and	CCONJ
bjos-8668473	148	31	iv	iv	NUM
bjos-8668473	148	32	)	)	PUNCT
bjos-8668473	148	33	stages	stage	NOUN
bjos-8668473	148	34	of	of	ADP
bjos-8668473	148	35	the	the	DET
bjos-8668473	148	36	disease	disease	NOUN
bjos-8668473	148	37	,	,	PUNCT
bjos-8668473	148	38	no	no	DET
bjos-8668473	148	39	statistically	statistically	ADV
bjos-8668473	148	40	significant	significant	ADJ
bjos-8668473	148	41	difference	difference	NOUN
bjos-8668473	148	42	in	in	ADP
bjos-8668473	148	43	pipecolic	pipecolic	NOUN
bjos-8668473	148	44	acid	acid	NOUN
bjos-8668473	148	45	was	be	AUX
bjos-8668473	148	46	found	find	VERB
bjos-8668473	148	47	between	between	ADP
bjos-8668473	148	48	the	the	DET
bjos-8668473	148	49	stages	stage	NOUN
bjos-8668473	148	50	.	.	PUNCT
bjos-8668473	149	1	this	this	PRON
bjos-8668473	149	2	may	may	AUX
bjos-8668473	149	3	be	be	AUX
bjos-8668473	149	4	explained	explain	VERB
bjos-8668473	149	5	by	by	ADP
bjos-8668473	149	6	the	the	DET
bjos-8668473	149	7	small	small	ADJ
bjos-8668473	149	8	sample	sample	NOUN
bjos-8668473	149	9	size	size	NOUN
bjos-8668473	149	10	.	.	PUNCT
bjos-8668473	150	1	accumulated	accumulate	VERB
bjos-8668473	150	2	evidence	evidence	NOUN
bjos-8668473	150	3	has	have	AUX
bjos-8668473	150	4	demonstrated	demonstrate	VERB
bjos-8668473	150	5	an	an	DET
bjos-8668473	150	6	increase	increase	NOUN
bjos-8668473	150	7	in	in	ADP
bjos-8668473	150	8	salivary	salivary	ADJ
bjos-8668473	150	9	pipecolic	pipecolic	NOUN
bjos-8668473	150	10	acid	acid	NOUN
bjos-8668473	150	11	in	in	ADP
bjos-8668473	150	12	cases	case	NOUN
bjos-8668473	150	13	of	of	ADP
bjos-8668473	150	14	hnscc3,6,18	hnscc3,6,18	NOUN
bjos-8668473	150	15	,	,	PUNCT
bjos-8668473	150	16	but	but	CCONJ
bjos-8668473	150	17	the	the	DET
bjos-8668473	150	18	role	role	NOUN
bjos-8668473	150	19	of	of	ADP
bjos-8668473	150	20	this	this	DET
bjos-8668473	150	21	metabolite	metabolite	NOUN
bjos-8668473	150	22	in	in	ADP
bjos-8668473	150	23	carcinogenesis	carcinogenesis	NOUN
bjos-8668473	150	24	remains	remain	VERB
bjos-8668473	150	25	unclear13	unclear13	NOUN
bjos-8668473	150	26	.	.	PUNCT
bjos-8668473	151	1	wang	wang	PROPN
bjos-8668473	151	2	et	et	PROPN
bjos-8668473	151	3	al.18	al.18	PROPN
bjos-8668473	151	4	(	(	PUNCT
bjos-8668473	151	5	2014	2014	NUM
bjos-8668473	151	6	)	)	PUNCT
bjos-8668473	151	7	suggest	suggest	VERB
bjos-8668473	151	8	that	that	SCONJ
bjos-8668473	151	9	the	the	DET
bjos-8668473	151	10	increase	increase	NOUN
bjos-8668473	151	11	in	in	ADP
bjos-8668473	151	12	pipecolic	pipecolic	NOUN
bjos-8668473	151	13	acid	acid	NOUN
bjos-8668473	151	14	in	in	ADP
bjos-8668473	151	15	the	the	DET
bjos-8668473	151	16	presence	presence	NOUN
bjos-8668473	151	17	of	of	ADP
bjos-8668473	151	18	these	these	DET
bjos-8668473	151	19	tumors	tumor	NOUN
bjos-8668473	151	20	is	be	AUX
bjos-8668473	151	21	likely	likely	ADJ
bjos-8668473	151	22	due	due	ADP
bjos-8668473	151	23	to	to	ADP
bjos-8668473	151	24	the	the	DET
bjos-8668473	151	25	fact	fact	NOUN
bjos-8668473	151	26	that	that	SCONJ
bjos-8668473	151	27	the	the	DET
bjos-8668473	151	28	metabolism	metabolism	NOUN
bjos-8668473	151	29	of	of	ADP
bjos-8668473	151	30	lysine	lysine	NOUN
bjos-8668473	151	31	is	be	AUX
bjos-8668473	151	32	overregulated	overregulate	VERB
bjos-8668473	151	33	in	in	ADP
bjos-8668473	151	34	the	the	DET
bjos-8668473	151	35	neoplastic	neoplastic	ADJ
bjos-8668473	151	36	cells	cell	NOUN
bjos-8668473	151	37	of	of	ADP
bjos-8668473	151	38	the	the	DET
bjos-8668473	151	39	tumor	tumor	NOUN
bjos-8668473	151	40	.	.	PUNCT
bjos-8668473	152	1	lysine	lysine	NOUN
bjos-8668473	152	2	is	be	AUX
bjos-8668473	152	3	an	an	DET
bjos-8668473	152	4	important	important	ADJ
bjos-8668473	152	5	constituent	constituent	NOUN
bjos-8668473	152	6	of	of	ADP
bjos-8668473	152	7	histones	histone	NOUN
bjos-8668473	152	8	,	,	PUNCT
bjos-8668473	152	9	which	which	PRON
bjos-8668473	152	10	can	can	AUX
bjos-8668473	152	11	undergo	undergo	VERB
bjos-8668473	152	12	alterations	alteration	NOUN
bjos-8668473	152	13	,	,	PUNCT
bjos-8668473	152	14	the	the	DET
bjos-8668473	152	15	most	most	ADV
bjos-8668473	152	16	widely	widely	ADV
bjos-8668473	152	17	studied	study	VERB
bjos-8668473	152	18	of	of	ADP
bjos-8668473	152	19	which	which	PRON
bjos-8668473	152	20	are	be	AUX
bjos-8668473	152	21	the	the	DET
bjos-8668473	152	22	hypermethylation	hypermethylation	NOUN
bjos-8668473	152	23	and	and	CCONJ
bjos-8668473	152	24	acetylation	acetylation	NOUN
bjos-8668473	152	25	of	of	ADP
bjos-8668473	152	26	lysine	lysine	NOUN
bjos-8668473	152	27	.	.	PUNCT
bjos-8668473	153	1	when	when	SCONJ
bjos-8668473	153	2	altered	alter	VERB
bjos-8668473	153	3	,	,	PUNCT
bjos-8668473	153	4	histones	histone	NOUN
bjos-8668473	153	5	exert	exert	VERB
bjos-8668473	153	6	an	an	DET
bjos-8668473	153	7	influence	influence	NOUN
bjos-8668473	153	8	on	on	ADP
bjos-8668473	153	9	the	the	DET
bjos-8668473	153	10	methylation	methylation	NOUN
bjos-8668473	153	11	of	of	ADP
bjos-8668473	153	12	dna	dna	PROPN
bjos-8668473	153	13	,	,	PUNCT
bjos-8668473	153	14	which	which	PRON
bjos-8668473	153	15	can	can	AUX
bjos-8668473	153	16	contribute	contribute	VERB
bjos-8668473	153	17	to	to	ADP
bjos-8668473	153	18	the	the	DET
bjos-8668473	153	19	development	development	NOUN
bjos-8668473	153	20	of	of	ADP
bjos-8668473	153	21	tumors29,30	tumors29,30	PROPN
bjos-8668473	153	22	.	.	PUNCT
bjos-8668473	154	1	the	the	DET
bjos-8668473	154	2	present	present	ADJ
bjos-8668473	154	3	study	study	NOUN
bjos-8668473	154	4	has	have	VERB
bjos-8668473	154	5	limitations	limitation	NOUN
bjos-8668473	154	6	that	that	PRON
bjos-8668473	154	7	should	should	AUX
bjos-8668473	154	8	be	be	AUX
bjos-8668473	154	9	considered	consider	VERB
bjos-8668473	154	10	.	.	PUNCT
bjos-8668473	155	1	salivary	salivary	ADJ
bjos-8668473	155	2	levels	level	NOUN
bjos-8668473	155	3	of	of	ADP
bjos-8668473	155	4	pipecolic	pipecolic	NOUN
bjos-8668473	155	5	acid	acid	NOUN
bjos-8668473	155	6	in	in	ADP
bjos-8668473	155	7	the	the	DET
bjos-8668473	155	8	present	present	ADJ
bjos-8668473	155	9	study	study	NOUN
bjos-8668473	155	10	were	be	AUX
bjos-8668473	155	11	slightly	slightly	ADV
bjos-8668473	155	12	higher	high	ADJ
bjos-8668473	155	13	in	in	ADP
bjos-8668473	155	14	the	the	DET
bjos-8668473	155	15	control	control	NOUN
bjos-8668473	155	16	group	group	NOUN
bjos-8668473	155	17	compared	compare	VERB
bjos-8668473	155	18	to	to	ADP
bjos-8668473	155	19	reports	report	NOUN
bjos-8668473	155	20	in	in	ADP
bjos-8668473	155	21	the	the	DET
bjos-8668473	155	22	literature18	literature18	NOUN
bjos-8668473	155	23	.	.	PUNCT
bjos-8668473	156	1	this	this	DET
bjos-8668473	156	2	divergence	divergence	NOUN
bjos-8668473	156	3	may	may	AUX
bjos-8668473	156	4	be	be	AUX
bjos-8668473	156	5	explained	explain	VERB
bjos-8668473	156	6	by	by	ADP
bjos-8668473	156	7	the	the	DET
bjos-8668473	156	8	time	time	NOUN
bjos-8668473	156	9	of	of	ADP
bjos-8668473	156	10	the	the	DET
bjos-8668473	156	11	day	day	NOUN
bjos-8668473	156	12	at	at	ADP
bjos-8668473	156	13	which	which	PRON
bjos-8668473	156	14	the	the	DET
bjos-8668473	156	15	saliva	saliva	NOUN
bjos-8668473	156	16	samples	sample	NOUN
bjos-8668473	156	17	were	be	AUX
bjos-8668473	156	18	collected	collect	VERB
bjos-8668473	156	19	in	in	ADP
bjos-8668473	156	20	the	the	DET
bjos-8668473	156	21	present	present	ADJ
bjos-8668473	156	22	investigation	investigation	NOUN
bjos-8668473	156	23	.	.	PUNCT
bjos-8668473	157	1	due	due	ADP
bjos-8668473	157	2	to	to	ADP
bjos-8668473	157	3	the	the	DET
bjos-8668473	157	4	office	office	NOUN
bjos-8668473	157	5	hours	hour	NOUN
bjos-8668473	157	6	of	of	ADP
bjos-8668473	157	7	the	the	DET
bjos-8668473	157	8	clinic	clinic	NOUN
bjos-8668473	157	9	,	,	PUNCT
bjos-8668473	157	10	it	it	PRON
bjos-8668473	157	11	was	be	AUX
bjos-8668473	157	12	necessary	necessary	ADJ
bjos-8668473	157	13	to	to	PART
bjos-8668473	157	14	collect	collect	VERB
bjos-8668473	157	15	samples	sample	NOUN
bjos-8668473	157	16	in	in	ADP
bjos-8668473	157	17	the	the	DET
bjos-8668473	157	18	afternoon	afternoon	NOUN
bjos-8668473	157	19	.	.	PUNCT
bjos-8668473	158	1	components	component	NOUN
bjos-8668473	158	2	of	of	ADP
bjos-8668473	158	3	saliva	saliva	NOUN
bjos-8668473	158	4	,	,	PUNCT
bjos-8668473	158	5	especially	especially	ADV
bjos-8668473	158	6	metabolites	metabolite	NOUN
bjos-8668473	158	7	,	,	PUNCT
bjos-8668473	158	8	are	be	AUX
bjos-8668473	158	9	known	know	VERB
bjos-8668473	158	10	to	to	PART
bjos-8668473	158	11	be	be	AUX
bjos-8668473	158	12	influenced	influence	VERB
bjos-8668473	158	13	by	by	ADP
bjos-8668473	158	14	diet	diet	PROPN
bjos-8668473	158	15	,	,	PUNCT
bjos-8668473	158	16	the	the	DET
bjos-8668473	158	17	circadian	circadian	ADJ
bjos-8668473	158	18	rhythm	rhythm	NOUN
bjos-8668473	158	19	,	,	PUNCT
bjos-8668473	158	20	etc.31,32	etc.31,32	PROPN
bjos-8668473	158	21	.	.	PROPN
bjos-8668473	158	22	to	to	PART
bjos-8668473	158	23	minimize	minimize	VERB
bjos-8668473	158	24	this	this	DET
bjos-8668473	158	25	bias	bias	NOUN
bjos-8668473	158	26	,	,	PUNCT
bjos-8668473	158	27	we	we	PRON
bjos-8668473	158	28	standardized	standardize	VERB
bjos-8668473	158	29	the	the	DET
bjos-8668473	158	30	collection	collection	NOUN
bjos-8668473	158	31	in	in	ADP
bjos-8668473	158	32	the	the	DET
bjos-8668473	158	33	same	same	ADJ
bjos-8668473	158	34	time	time	NOUN
bjos-8668473	158	35	interval	interval	NOUN
bjos-8668473	158	36	and	and	CCONJ
bjos-8668473	158	37	required	require	VERB
bjos-8668473	158	38	at	at	ADP
bjos-8668473	158	39	least	least	ADV
bjos-8668473	158	40	two	two	NUM
bjos-8668473	158	41	hours	hour	NOUN
bjos-8668473	158	42	of	of	ADP
bjos-8668473	158	43	fasting	fast	VERB
bjos-8668473	158	44	prior	prior	ADV
bjos-8668473	158	45	to	to	ADP
bjos-8668473	158	46	collection	collection	NOUN
bjos-8668473	158	47	.	.	PUNCT
bjos-8668473	159	1	10	10	NUM
bjos-8668473	159	2	ferrazzo	ferrazzo	VERB
bjos-8668473	159	3	et	et	PROPN
bjos-8668473	159	4	al	al	PROPN
bjos-8668473	159	5	.	.	PROPN
bjos-8668473	160	1	braz	braz	PROPN
bjos-8668473	160	2	j	j	PROPN
bjos-8668473	160	3	oral	oral	PROPN
bjos-8668473	160	4	sci	sci	PROPN
bjos-8668473	160	5	.	.	PUNCT
bjos-8668473	161	1	2023;22	2023;22	NUM
bjos-8668473	161	2	:	:	PUNCT
bjos-8668473	161	3	e238473	e238473	NUM
bjos-8668473	161	4	the	the	DET
bjos-8668473	161	5	study	study	NOUN
bjos-8668473	161	6	of	of	ADP
bjos-8668473	161	7	salivary	salivary	ADJ
bjos-8668473	161	8	biomarkers	biomarker	NOUN
bjos-8668473	161	9	for	for	ADP
bjos-8668473	161	10	different	different	ADJ
bjos-8668473	161	11	types	type	NOUN
bjos-8668473	161	12	of	of	ADP
bjos-8668473	161	13	systemic	systemic	ADJ
bjos-8668473	161	14	diseases	disease	NOUN
bjos-8668473	161	15	has	have	AUX
bjos-8668473	161	16	grown	grow	VERB
bjos-8668473	161	17	considerably	considerably	ADV
bjos-8668473	161	18	in	in	ADP
bjos-8668473	161	19	the	the	DET
bjos-8668473	161	20	last	last	ADJ
bjos-8668473	161	21	decade8	decade8	PROPN
bjos-8668473	161	22	.	.	PUNCT
bjos-8668473	162	1	saliva	saliva	NOUN
bjos-8668473	162	2	has	have	VERB
bjos-8668473	162	3	advantages	advantage	NOUN
bjos-8668473	162	4	over	over	ADP
bjos-8668473	162	5	other	other	ADJ
bjos-8668473	162	6	body	body	NOUN
bjos-8668473	162	7	fluids	fluid	NOUN
bjos-8668473	162	8	,	,	PUNCT
bjos-8668473	162	9	such	such	ADJ
bjos-8668473	162	10	as	as	ADP
bjos-8668473	162	11	plasma	plasma	NOUN
bjos-8668473	162	12	,	,	PUNCT
bjos-8668473	162	13	as	as	SCONJ
bjos-8668473	162	14	its	its	PRON
bjos-8668473	162	15	collection	collection	NOUN
bjos-8668473	162	16	is	be	AUX
bjos-8668473	162	17	quick	quick	ADJ
bjos-8668473	162	18	,	,	PUNCT
bjos-8668473	162	19	easy	easy	ADJ
bjos-8668473	162	20	and	and	CCONJ
bjos-8668473	162	21	non	non	ADJ
bjos-8668473	162	22	-	-	ADJ
bjos-8668473	162	23	invasive	invasive	ADJ
bjos-8668473	162	24	,	,	PUNCT
bjos-8668473	162	25	has	have	VERB
bjos-8668473	162	26	a	a	DET
bjos-8668473	162	27	good	good	ADJ
bjos-8668473	162	28	cost	cost	NOUN
bjos-8668473	162	29	-	-	PUNCT
bjos-8668473	162	30	effectiveness	effectiveness	NOUN
bjos-8668473	162	31	ratio	ratio	NOUN
bjos-8668473	162	32	and	and	CCONJ
bjos-8668473	162	33	does	do	AUX
bjos-8668473	162	34	not	not	PART
bjos-8668473	162	35	cause	cause	VERB
bjos-8668473	162	36	stress	stress	NOUN
bjos-8668473	162	37	to	to	ADP
bjos-8668473	162	38	patients	patient	NOUN
bjos-8668473	162	39	,	,	PUNCT
bjos-8668473	162	40	as	as	SCONJ
bjos-8668473	162	41	it	it	PRON
bjos-8668473	162	42	does	do	AUX
bjos-8668473	162	43	not	not	PART
bjos-8668473	162	44	require	require	VERB
bjos-8668473	162	45	needles33	needles33	NOUN
bjos-8668473	162	46	.	.	PUNCT
bjos-8668473	163	1	another	another	DET
bjos-8668473	163	2	advantage	advantage	NOUN
bjos-8668473	163	3	of	of	ADP
bjos-8668473	163	4	saliva	saliva	NOUN
bjos-8668473	163	5	over	over	ADP
bjos-8668473	163	6	plasma	plasma	NOUN
bjos-8668473	163	7	is	be	AUX
bjos-8668473	163	8	the	the	DET
bjos-8668473	163	9	fact	fact	NOUN
bjos-8668473	163	10	that	that	SCONJ
bjos-8668473	163	11	saliva	saliva	NOUN
bjos-8668473	163	12	contains	contain	VERB
bjos-8668473	163	13	a	a	DET
bjos-8668473	163	14	lower	low	ADJ
bjos-8668473	163	15	amount	amount	NOUN
bjos-8668473	163	16	of	of	ADP
bjos-8668473	163	17	proteins	protein	NOUN
bjos-8668473	163	18	,	,	PUNCT
bjos-8668473	163	19	some	some	PRON
bjos-8668473	163	20	of	of	ADP
bjos-8668473	163	21	which	which	PRON
bjos-8668473	163	22	are	be	AUX
bjos-8668473	163	23	unique	unique	ADJ
bjos-8668473	163	24	to	to	ADP
bjos-8668473	163	25	saliva	saliva	NOUN
bjos-8668473	163	26	,	,	PUNCT
bjos-8668473	163	27	which	which	PRON
bjos-8668473	163	28	reduces	reduce	VERB
bjos-8668473	163	29	nonspecific	nonspecific	ADJ
bjos-8668473	163	30	interactions	interaction	NOUN
bjos-8668473	163	31	and	and	CCONJ
bjos-8668473	163	32	makes	make	VERB
bjos-8668473	163	33	saliva	saliva	NOUN
bjos-8668473	163	34	a	a	DET
bjos-8668473	163	35	more	more	ADV
bjos-8668473	163	36	sensitive	sensitive	ADJ
bjos-8668473	163	37	and	and	CCONJ
bjos-8668473	163	38	specific	specific	ADJ
bjos-8668473	163	39	biomarker8	biomarker8	NOUN
bjos-8668473	163	40	.	.	PUNCT
bjos-8668473	164	1	although	although	SCONJ
bjos-8668473	164	2	numerous	numerous	ADJ
bjos-8668473	164	3	salivary	salivary	ADJ
bjos-8668473	164	4	biomarkers	biomarker	NOUN
bjos-8668473	164	5	have	have	AUX
bjos-8668473	164	6	been	be	AUX
bjos-8668473	164	7	discovered	discover	VERB
bjos-8668473	164	8	,	,	PUNCT
bjos-8668473	164	9	the	the	DET
bjos-8668473	164	10	literature	literature	NOUN
bjos-8668473	164	11	is	be	AUX
bjos-8668473	164	12	unanimous	unanimous	ADJ
bjos-8668473	164	13	in	in	ADP
bjos-8668473	164	14	stating	state	VERB
bjos-8668473	164	15	that	that	SCONJ
bjos-8668473	164	16	further	further	ADJ
bjos-8668473	164	17	studies	study	NOUN
bjos-8668473	164	18	are	be	AUX
bjos-8668473	164	19	needed	need	VERB
bjos-8668473	164	20	before	before	SCONJ
bjos-8668473	164	21	any	any	DET
bjos-8668473	164	22	biomarker	biomarker	NOUN
bjos-8668473	164	23	can	can	AUX
bjos-8668473	164	24	be	be	AUX
bjos-8668473	164	25	consolidated	consolidate	VERB
bjos-8668473	164	26	as	as	ADP
bjos-8668473	164	27	a	a	DET
bjos-8668473	164	28	diagnostic	diagnostic	ADJ
bjos-8668473	164	29	test	test	NOUN
bjos-8668473	164	30	with	with	ADP
bjos-8668473	164	31	the	the	DET
bjos-8668473	164	32	sensitivity	sensitivity	NOUN
bjos-8668473	164	33	and	and	CCONJ
bjos-8668473	164	34	specificity	specificity	NOUN
bjos-8668473	164	35	required	require	VERB
bjos-8668473	164	36	for	for	ADP
bjos-8668473	164	37	a	a	DET
bjos-8668473	164	38	biomarker13	biomarker13	NOUN
bjos-8668473	164	39	.	.	PUNCT
bjos-8668473	165	1	a	a	DET
bjos-8668473	165	2	good	good	ADJ
bjos-8668473	165	3	biomarker	biomarker	NOUN
bjos-8668473	165	4	candidate	candidate	NOUN
bjos-8668473	165	5	must	must	AUX
bjos-8668473	165	6	have	have	VERB
bjos-8668473	165	7	diagnostic	diagnostic	ADJ
bjos-8668473	165	8	precision	precision	NOUN
bjos-8668473	165	9	and	and	CCONJ
bjos-8668473	165	10	predictability34	predictability34	NOUN
bjos-8668473	165	11	.	.	PUNCT
bjos-8668473	166	1	although	although	SCONJ
bjos-8668473	166	2	the	the	DET
bjos-8668473	166	3	present	present	ADJ
bjos-8668473	166	4	preliminary	preliminary	ADJ
bjos-8668473	166	5	study	study	NOUN
bjos-8668473	166	6	showed	show	VERB
bjos-8668473	166	7	positive	positive	ADJ
bjos-8668473	166	8	results	result	NOUN
bjos-8668473	166	9	with	with	ADP
bjos-8668473	166	10	the	the	DET
bjos-8668473	166	11	level	level	NOUN
bjos-8668473	166	12	of	of	ADP
bjos-8668473	166	13	pipecolic	pipecolic	NOUN
bjos-8668473	166	14	acid	acid	NOUN
bjos-8668473	166	15	for	for	ADP
bjos-8668473	166	16	the	the	DET
bjos-8668473	166	17	prediction	prediction	NOUN
bjos-8668473	166	18	of	of	ADP
bjos-8668473	166	19	hnscc	hnscc	NOUN
bjos-8668473	166	20	,	,	PUNCT
bjos-8668473	166	21	the	the	DET
bjos-8668473	166	22	analysis	analysis	NOUN
bjos-8668473	166	23	of	of	ADP
bjos-8668473	166	24	salivary	salivary	ADJ
bjos-8668473	166	25	biomarkers	biomarker	NOUN
bjos-8668473	166	26	must	must	AUX
bjos-8668473	166	27	be	be	AUX
bjos-8668473	166	28	allied	ally	VERB
bjos-8668473	166	29	with	with	ADP
bjos-8668473	166	30	a	a	DET
bjos-8668473	166	31	rigorous	rigorous	ADJ
bjos-8668473	166	32	oral	oral	ADJ
bjos-8668473	166	33	clinical	clinical	ADJ
bjos-8668473	166	34	examination	examination	NOUN
bjos-8668473	166	35	as	as	ADP
bjos-8668473	166	36	a	a	DET
bjos-8668473	166	37	strategy	strategy	NOUN
bjos-8668473	166	38	for	for	ADP
bjos-8668473	166	39	the	the	DET
bjos-8668473	166	40	detection	detection	NOUN
bjos-8668473	166	41	of	of	ADP
bjos-8668473	166	42	hnscc	hnscc	NOUN
bjos-8668473	166	43	,	,	PUNCT
bjos-8668473	166	44	especially	especially	ADV
bjos-8668473	166	45	in	in	ADP
bjos-8668473	166	46	the	the	DET
bjos-8668473	166	47	early	early	ADJ
bjos-8668473	166	48	stages	stage	NOUN
bjos-8668473	166	49	of	of	ADP
bjos-8668473	166	50	the	the	DET
bjos-8668473	166	51	disease	disease	NOUN
bjos-8668473	166	52	,	,	PUNCT
bjos-8668473	166	53	which	which	PRON
bjos-8668473	166	54	will	will	AUX
bjos-8668473	166	55	potentially	potentially	ADV
bjos-8668473	166	56	lead	lead	VERB
bjos-8668473	166	57	to	to	ADP
bjos-8668473	166	58	a	a	DET
bjos-8668473	166	59	better	well	ADJ
bjos-8668473	166	60	quality	quality	NOUN
bjos-8668473	166	61	of	of	ADP
bjos-8668473	166	62	life	life	NOUN
bjos-8668473	166	63	for	for	ADP
bjos-8668473	166	64	patients	patient	NOUN
bjos-8668473	166	65	.	.	PUNCT
bjos-8668473	167	1	conclusion	conclusion	NOUN
bjos-8668473	167	2	the	the	DET
bjos-8668473	167	3	present	present	ADJ
bjos-8668473	167	4	findings	finding	NOUN
bjos-8668473	167	5	are	be	AUX
bjos-8668473	167	6	relevant	relevant	ADJ
bjos-8668473	167	7	and	and	CCONJ
bjos-8668473	167	8	add	add	VERB
bjos-8668473	167	9	novel	novel	ADJ
bjos-8668473	167	10	information	information	NOUN
bjos-8668473	167	11	related	relate	VERB
bjos-8668473	167	12	to	to	ADP
bjos-8668473	167	13	salivary	salivary	ADJ
bjos-8668473	167	14	levels	level	NOUN
bjos-8668473	167	15	of	of	ADP
bjos-8668473	167	16	pipecolic	pipecolic	NOUN
bjos-8668473	167	17	acid	acid	NOUN
bjos-8668473	167	18	in	in	ADP
bjos-8668473	167	19	cases	case	NOUN
bjos-8668473	167	20	of	of	ADP
bjos-8668473	167	21	hnscc	hnscc	NOUN
bjos-8668473	167	22	,	,	PUNCT
bjos-8668473	167	23	suggesting	suggest	VERB
bjos-8668473	167	24	the	the	DET
bjos-8668473	167	25	high	high	ADJ
bjos-8668473	167	26	sensitivity	sensitivity	NOUN
bjos-8668473	167	27	of	of	ADP
bjos-8668473	167	28	this	this	DET
bjos-8668473	167	29	metabolite	metabolite	NOUN
bjos-8668473	167	30	in	in	ADP
bjos-8668473	167	31	predicting	predict	VERB
bjos-8668473	167	32	the	the	DET
bjos-8668473	167	33	disease	disease	NOUN
bjos-8668473	167	34	,	,	PUNCT
bjos-8668473	167	35	even	even	ADV
bjos-8668473	167	36	in	in	ADP
bjos-8668473	167	37	the	the	DET
bjos-8668473	167	38	early	early	ADJ
bjos-8668473	167	39	stages	stage	NOUN
bjos-8668473	167	40	.	.	PUNCT
bjos-8668473	168	1	however	however	ADV
bjos-8668473	168	2	,	,	PUNCT
bjos-8668473	168	3	the	the	DET
bjos-8668473	168	4	specificity	specificity	NOUN
bjos-8668473	168	5	of	of	ADP
bjos-8668473	168	6	pipecolic	pipecolic	NOUN
bjos-8668473	168	7	acid	acid	NOUN
bjos-8668473	168	8	for	for	ADP
bjos-8668473	168	9	hnscc	hnscc	NOUN
bjos-8668473	168	10	needs	need	NOUN
bjos-8668473	168	11	to	to	PART
bjos-8668473	168	12	be	be	AUX
bjos-8668473	168	13	investigated	investigate	VERB
bjos-8668473	168	14	further	far	ADV
bjos-8668473	168	15	in	in	ADP
bjos-8668473	168	16	larger	large	ADJ
bjos-8668473	168	17	samples	sample	NOUN
bjos-8668473	168	18	.	.	PUNCT
bjos-8668473	169	1	acknowledgement	acknowledgement	NOUN
bjos-8668473	169	2	the	the	DET
bjos-8668473	169	3	research	research	NOUN
bjos-8668473	169	4	was	be	AUX
bjos-8668473	169	5	partially	partially	ADV
bjos-8668473	169	6	supported	support	VERB
bjos-8668473	169	7	by	by	ADP
bjos-8668473	169	8	the	the	DET
bjos-8668473	169	9	research	research	NOUN
bjos-8668473	169	10	incentive	incentive	NOUN
bjos-8668473	169	11	fund	fund	NOUN
bjos-8668473	169	12	(	(	PUNCT
bjos-8668473	169	13	fipe	fipe	NOUN
bjos-8668473	169	14	)	)	PUNCT
bjos-8668473	169	15	of	of	ADP
bjos-8668473	169	16	the	the	DET
bjos-8668473	169	17	federal	federal	ADJ
bjos-8668473	169	18	university	university	PROPN
bjos-8668473	169	19	of	of	ADP
bjos-8668473	169	20	santa	santa	PROPN
bjos-8668473	169	21	maria	maria	PROPN
bjos-8668473	169	22	.	.	PUNCT
bjos-8668473	170	1	conflict	conflict	NOUN
bjos-8668473	170	2	of	of	ADP
bjos-8668473	170	3	interest	interest	NOUN
bjos-8668473	170	4	none	none	NOUN
bjos-8668473	170	5	.	.	PUNCT
bjos-8668473	171	1	ethics	ethic	NOUN
bjos-8668473	171	2	approval	approval	VERB
bjos-8668473	171	3	the	the	DET
bjos-8668473	171	4	present	present	ADJ
bjos-8668473	171	5	study	study	NOUN
bjos-8668473	171	6	was	be	AUX
bjos-8668473	171	7	conducted	conduct	VERB
bjos-8668473	171	8	at	at	ADP
bjos-8668473	171	9	a	a	DET
bjos-8668473	171	10	university	university	NOUN
bjos-8668473	171	11	hospital	hospital	NOUN
bjos-8668473	171	12	of	of	ADP
bjos-8668473	171	13	the	the	DET
bjos-8668473	171	14	public	public	ADJ
bjos-8668473	171	15	education	education	NOUN
bjos-8668473	171	16	system	system	NOUN
bjos-8668473	171	17	in	in	ADP
bjos-8668473	171	18	southern	southern	ADJ
bjos-8668473	171	19	brazil	brazil	PROPN
bjos-8668473	171	20	,	,	PUNCT
bjos-8668473	171	21	in	in	ADP
bjos-8668473	171	22	accordance	accordance	NOUN
bjos-8668473	171	23	with	with	ADP
bjos-8668473	171	24	the	the	DET
bjos-8668473	171	25	precepts	precept	NOUN
bjos-8668473	171	26	stipulated	stipulate	VERB
bjos-8668473	171	27	in	in	ADP
bjos-8668473	171	28	the	the	DET
bjos-8668473	171	29	declaration	declaration	NOUN
bjos-8668473	171	30	of	of	ADP
bjos-8668473	171	31	helsinki	helsinki	PROPN
bjos-8668473	171	32	,	,	PUNCT
bjos-8668473	171	33	and	and	CCONJ
bjos-8668473	171	34	received	receive	VERB
bjos-8668473	171	35	approval	approval	NOUN
bjos-8668473	171	36	from	from	ADP
bjos-8668473	171	37	the	the	DET
bjos-8668473	171	38	local	local	ADJ
bjos-8668473	171	39	human	human	ADJ
bjos-8668473	171	40	research	research	PROPN
bjos-8668473	171	41	ethics	ethic	NOUN
bjos-8668473	171	42	committee	committee	PROPN
bjos-8668473	171	43	(	(	PUNCT
bjos-8668473	171	44	certificate	certificate	NOUN
bjos-8668473	171	45	number	number	NOUN
bjos-8668473	171	46	:	:	PUNCT
bjos-8668473	171	47	63198116.3.0000.5346/1.889.748	63198116.3.0000.5346/1.889.748	NOUN
bjos-8668473	171	48	)	)	PUNCT
bjos-8668473	171	49	.	.	PUNCT
bjos-8668473	172	1	data	datum	NOUN
bjos-8668473	172	2	availability	availability	NOUN
bjos-8668473	172	3	datasets	dataset	NOUN
bjos-8668473	172	4	related	relate	VERB
bjos-8668473	172	5	to	to	ADP
bjos-8668473	172	6	this	this	DET
bjos-8668473	172	7	article	article	NOUN
bjos-8668473	172	8	will	will	AUX
bjos-8668473	172	9	be	be	AUX
bjos-8668473	172	10	available	available	ADJ
bjos-8668473	172	11	upon	upon	SCONJ
bjos-8668473	172	12	request	request	NOUN
bjos-8668473	172	13	to	to	ADP
bjos-8668473	172	14	the	the	DET
bjos-8668473	172	15	corresponding	corresponding	ADJ
bjos-8668473	172	16	author	author	NOUN
bjos-8668473	172	17	.	.	PUNCT
bjos-8668473	173	1	author	author	NOUN
bjos-8668473	173	2	contributions	contribution	NOUN
bjos-8668473	173	3	kívia	kívia	PROPN
bjos-8668473	173	4	linhares	linhare	NOUN
bjos-8668473	173	5	ferrazzo	ferrazzo	VERB
bjos-8668473	173	6	:	:	PUNCT
bjos-8668473	173	7	conceptualization	conceptualization	NOUN
bjos-8668473	173	8	and	and	CCONJ
bjos-8668473	173	9	design	design	NOUN
bjos-8668473	173	10	of	of	ADP
bjos-8668473	173	11	the	the	DET
bjos-8668473	173	12	manuscript	manuscript	NOUN
bjos-8668473	173	13	,	,	PUNCT
bjos-8668473	173	14	data	data	NOUN
bjos-8668473	173	15	acquisition	acquisition	NOUN
bjos-8668473	173	16	,	,	PUNCT
bjos-8668473	173	17	formal	formal	ADJ
bjos-8668473	173	18	data	datum	NOUN
bjos-8668473	173	19	analysis	analysis	NOUN
bjos-8668473	173	20	and	and	CCONJ
bjos-8668473	173	21	writing	write	VERB
bjos-8668473	173	22	the	the	DET
bjos-8668473	173	23	manuscripit	manuscripit	NOUN
bjos-8668473	173	24	–	–	PUNCT
bjos-8668473	173	25	original	original	ADJ
bjos-8668473	173	26	draft	draft	NOUN
bjos-8668473	173	27	,	,	PUNCT
bjos-8668473	173	28	review	review	VERB
bjos-8668473	173	29	11	11	NUM
bjos-8668473	173	30	ferrazzo	ferrazzo	VERB
bjos-8668473	173	31	et	et	PROPN
bjos-8668473	174	1	al	al	PROPN
bjos-8668473	174	2	.	.	PROPN
bjos-8668473	174	3	braz	braz	PROPN
bjos-8668473	174	4	j	j	PROPN
bjos-8668473	174	5	oral	oral	PROPN
bjos-8668473	174	6	sci	sci	PROPN
bjos-8668473	174	7	.	.	PUNCT
bjos-8668473	175	1	2023;22	2023;22	NUM
bjos-8668473	175	2	:	:	PUNCT
bjos-8668473	175	3	e238473	e238473	NOUN
bjos-8668473	175	4	and	and	CCONJ
bjos-8668473	175	5	editing	editing	NOUN
bjos-8668473	175	6	.	.	PUNCT
bjos-8668473	176	1	larissa	larissa	PROPN
bjos-8668473	176	2	daiane	daiane	PROPN
bjos-8668473	176	3	w.	w.	PROPN
bjos-8668473	176	4	de	de	PROPN
bjos-8668473	176	5	melo	melo	PROPN
bjos-8668473	176	6	:	:	PUNCT
bjos-8668473	176	7	data	data	NOUN
bjos-8668473	176	8	acquisition	acquisition	NOUN
bjos-8668473	176	9	,	,	PUNCT
bjos-8668473	176	10	formal	formal	ADJ
bjos-8668473	176	11	analysis	analysis	NOUN
bjos-8668473	176	12	,	,	PUNCT
bjos-8668473	176	13	writing	writing	NOUN
bjos-8668473	176	14	–	–	PUNCT
bjos-8668473	176	15	original	original	ADJ
bjos-8668473	176	16	draft	draft	NOUN
bjos-8668473	176	17	.	.	PUNCT
bjos-8668473	177	1	cristiane	cristiane	PROPN
bjos-8668473	177	2	cademartori	cademartori	PROPN
bjos-8668473	177	3	danesi	danesi	PROPN
bjos-8668473	177	4	:	:	PUNCT
bjos-8668473	177	5	formal	formal	ADJ
bjos-8668473	177	6	data	datum	NOUN
bjos-8668473	177	7	analysis	analysis	NOUN
bjos-8668473	177	8	,	,	PUNCT
bjos-8668473	177	9	writing	writing	NOUN
bjos-8668473	177	10	–	–	PUNCT
bjos-8668473	177	11	review	review	NOUN
bjos-8668473	177	12	and	and	CCONJ
bjos-8668473	177	13	editing	editing	NOUN
bjos-8668473	177	14	.	.	PUNCT
bjos-8668473	178	1	alexander	alexander	PROPN
bjos-8668473	178	2	thomas	thomas	PROPN
bjos-8668473	178	3	:	:	PUNCT
bjos-8668473	178	4	formal	formal	ADJ
bjos-8668473	178	5	data	datum	NOUN
bjos-8668473	178	6	analysis	analysis	NOUN
bjos-8668473	178	7	and	and	CCONJ
bjos-8668473	178	8	writing	writing	NOUN
bjos-8668473	178	9	–	–	PUNCT
bjos-8668473	178	10	original	original	ADJ
bjos-8668473	178	11	draft	draft	NOUN
bjos-8668473	178	12	.	.	PUNCT
bjos-8668473	179	1	laura	laura	PROPN
bjos-8668473	179	2	izabel	izabel	PROPN
bjos-8668473	179	3	lampert	lampert	PROPN
bjos-8668473	179	4	bonzanini	bonzanini	PROPN
bjos-8668473	179	5	:	:	PUNCT
bjos-8668473	179	6	review	review	NOUN
bjos-8668473	179	7	and	and	CCONJ
bjos-8668473	179	8	editing	editing	NOUN
bjos-8668473	179	9	.	.	PUNCT
bjos-8668473	180	1	nilo	nilo	PROPN
bjos-8668473	180	2	zanatta	zanatta	PROPN
bjos-8668473	180	3	:	:	PUNCT
bjos-8668473	180	4	data	data	PROPN
bjos-8668473	180	5	acquisition	acquisition	NOUN
bjos-8668473	180	6	,	,	PUNCT
bjos-8668473	180	7	data	datum	NOUN
bjos-8668473	180	8	analysis	analysis	NOUN
bjos-8668473	180	9	,	,	PUNCT
bjos-8668473	180	10	writing	write	VERB
bjos-8668473	180	11	–	–	PUNCT
bjos-8668473	180	12	original	original	ADJ
bjos-8668473	180	13	draft	draft	NOUN
bjos-8668473	180	14	and	and	CCONJ
bjos-8668473	180	15	review	review	NOUN
bjos-8668473	180	16	.	.	PUNCT
bjos-8668473	181	1	all	all	DET
bjos-8668473	181	2	authors	author	NOUN
bjos-8668473	181	3	gave	give	VERB
bjos-8668473	181	4	final	final	ADJ
bjos-8668473	181	5	approval	approval	NOUN
bjos-8668473	181	6	of	of	ADP
bjos-8668473	181	7	the	the	DET
bjos-8668473	181	8	work	work	NOUN
bjos-8668473	181	9	.	.	PUNCT
bjos-8668473	182	1	references	reference	NOUN
bjos-8668473	182	2	1	1	NUM
bjos-8668473	182	3	.	.	PUNCT
bjos-8668473	182	4	sung	sung	PROPN
bjos-8668473	182	5	h	h	NOUN
bjos-8668473	182	6	,	,	PUNCT
bjos-8668473	182	7	ferlay	ferlay	PROPN
bjos-8668473	182	8	j	j	PROPN
bjos-8668473	182	9	,	,	PUNCT
bjos-8668473	182	10	siegel	siegel	PROPN
bjos-8668473	182	11	rl	rl	PROPN
bjos-8668473	182	12	,	,	PUNCT
bjos-8668473	182	13	laversanne	laversanne	NOUN
bjos-8668473	182	14	m	m	PROPN
bjos-8668473	182	15	,	,	PUNCT
bjos-8668473	182	16	soerjomataram	soerjomataram	PROPN
bjos-8668473	182	17	i	i	PROPN
bjos-8668473	182	18	,	,	PUNCT
bjos-8668473	182	19	jemal	jemal	PROPN
bjos-8668473	182	20	a	a	X
bjos-8668473	182	21	,	,	PUNCT
bjos-8668473	182	22	et	et	PROPN
bjos-8668473	182	23	al	al	PROPN
bjos-8668473	182	24	.	.	PUNCT
bjos-8668473	183	1	global	global	ADJ
bjos-8668473	183	2	cancer	cancer	NOUN
bjos-8668473	183	3	statistics	statistic	NOUN
bjos-8668473	183	4	2020	2020	NUM
bjos-8668473	183	5	:	:	PUNCT
bjos-8668473	183	6	globocan	globocan	PROPN
bjos-8668473	183	7	estimates	estimate	NOUN
bjos-8668473	183	8	of	of	ADP
bjos-8668473	183	9	incidence	incidence	NOUN
bjos-8668473	183	10	and	and	CCONJ
bjos-8668473	183	11	mortality	mortality	NOUN
bjos-8668473	183	12	worldwide	worldwide	ADV
bjos-8668473	183	13	for	for	ADP
bjos-8668473	183	14	36	36	NUM
bjos-8668473	183	15	cancers	cancer	NOUN
bjos-8668473	183	16	in	in	ADP
bjos-8668473	183	17	185	185	NUM
bjos-8668473	183	18	countries	country	NOUN
bjos-8668473	183	19	.	.	PUNCT
bjos-8668473	184	1	ca	can	AUX
bjos-8668473	184	2	cancer	cancer	PROPN
bjos-8668473	184	3	j	j	PROPN
bjos-8668473	184	4	clin	clin	PROPN
bjos-8668473	184	5	.	.	PUNCT
bjos-8668473	185	1	2021	2021	NUM
bjos-8668473	185	2	may;71(3):209	may;71(3):209	NOUN
bjos-8668473	185	3	-	-	PUNCT
bjos-8668473	185	4	49	49	NUM
bjos-8668473	185	5	.	.	PUNCT
bjos-8668473	186	1	doi	doi	NOUN
bjos-8668473	186	2	:	:	PUNCT
bjos-8668473	186	3	10.3322	10.3322	NUM
bjos-8668473	186	4	/	/	SYM
bjos-8668473	186	5	caac.21660	caac.21660	NOUN
bjos-8668473	186	6	.	.	NOUN
bjos-8668473	186	7	2	2	NUM
bjos-8668473	186	8	.	.	PUNCT
bjos-8668473	187	1	amit	amit	PROPN
bjos-8668473	187	2	m	m	PROPN
bjos-8668473	187	3	,	,	PUNCT
bjos-8668473	187	4	yen	yen	PROPN
bjos-8668473	187	5	tc	tc	PROPN
bjos-8668473	187	6	,	,	PUNCT
bjos-8668473	187	7	liao	liao	PROPN
bjos-8668473	187	8	ct	ct	PROPN
bjos-8668473	187	9	,	,	PUNCT
bjos-8668473	187	10	chaturvedi	chaturvedi	PROPN
bjos-8668473	187	11	p	p	PROPN
bjos-8668473	187	12	,	,	PUNCT
bjos-8668473	187	13	agarwal	agarwal	PROPN
bjos-8668473	187	14	jp	jp	PROPN
bjos-8668473	187	15	,	,	PUNCT
bjos-8668473	187	16	kowalski	kowalski	PROPN
bjos-8668473	187	17	lp	lp	PROPN
bjos-8668473	187	18	,	,	PUNCT
bjos-8668473	187	19	et	et	PROPN
bjos-8668473	187	20	al	al	PROPN
bjos-8668473	187	21	.	.	PUNCT
bjos-8668473	187	22	improvement	improvement	NOUN
bjos-8668473	187	23	in	in	ADP
bjos-8668473	187	24	survival	survival	NOUN
bjos-8668473	187	25	of	of	ADP
bjos-8668473	187	26	patients	patient	NOUN
bjos-8668473	187	27	with	with	ADP
bjos-8668473	187	28	oral	oral	ADJ
bjos-8668473	187	29	cavity	cavity	NOUN
bjos-8668473	187	30	squamous	squamous	ADJ
bjos-8668473	187	31	cell	cell	NOUN
bjos-8668473	187	32	carcinoma	carcinoma	NOUN
bjos-8668473	187	33	:	:	PUNCT
bjos-8668473	187	34	an	an	DET
bjos-8668473	187	35	international	international	ADJ
bjos-8668473	187	36	collaborative	collaborative	ADJ
bjos-8668473	187	37	study	study	NOUN
bjos-8668473	187	38	.	.	PUNCT
bjos-8668473	188	1	cancer	cancer	NOUN
bjos-8668473	188	2	.	.	PUNCT
bjos-8668473	189	1	2013	2013	NUM
bjos-8668473	189	2	dec;119(24):4242	dec;119(24):4242	PROPN
bjos-8668473	189	3	-	-	PUNCT
bjos-8668473	189	4	8	8	NUM
bjos-8668473	189	5	.	.	PUNCT
bjos-8668473	190	1	doi	doi	NOUN
bjos-8668473	190	2	:	:	PUNCT
bjos-8668473	190	3	10.1002	10.1002	NUM
bjos-8668473	190	4	/	/	SYM
bjos-8668473	190	5	cncr.28357	cncr.28357	PROPN
bjos-8668473	190	6	..	..	NOUN
bjos-8668473	190	7	3	3	X
bjos-8668473	190	8	.	.	X
bjos-8668473	190	9	ishikawa	ishikawa	PROPN
bjos-8668473	190	10	s	s	PROPN
bjos-8668473	190	11	,	,	PUNCT
bjos-8668473	190	12	sugimoto	sugimoto	PROPN
bjos-8668473	190	13	m	m	PROPN
bjos-8668473	190	14	,	,	PUNCT
bjos-8668473	190	15	kitabatake	kitabatake	PROPN
bjos-8668473	190	16	k	k	NOUN
bjos-8668473	190	17	,	,	PUNCT
bjos-8668473	190	18	sugano	sugano	VERB
bjos-8668473	190	19	a	a	PRON
bjos-8668473	190	20	,	,	PUNCT
bjos-8668473	190	21	nakamura	nakamura	PROPN
bjos-8668473	190	22	m	m	PROPN
bjos-8668473	190	23	,	,	PUNCT
bjos-8668473	190	24	kaneko	kaneko	PROPN
bjos-8668473	190	25	m	m	PROPN
bjos-8668473	190	26	,	,	PUNCT
bjos-8668473	190	27	et	et	PROPN
bjos-8668473	190	28	al	al	PROPN
bjos-8668473	190	29	.	.	PUNCT
bjos-8668473	190	30	identification	identification	NOUN
bjos-8668473	190	31	of	of	ADP
bjos-8668473	190	32	salivary	salivary	ADJ
bjos-8668473	190	33	metabolomic	metabolomic	ADJ
bjos-8668473	190	34	biomarkers	biomarker	NOUN
bjos-8668473	190	35	for	for	ADP
bjos-8668473	190	36	oral	oral	ADJ
bjos-8668473	190	37	cancer	cancer	NOUN
bjos-8668473	190	38	screening	screening	NOUN
bjos-8668473	190	39	.	.	PUNCT
bjos-8668473	191	1	sci	sci	PROPN
bjos-8668473	191	2	rep	rep	PROPN
bjos-8668473	191	3	.	.	PROPN
bjos-8668473	191	4	2016	2016	NUM
bjos-8668473	191	5	aug;6:31520	aug;6:31520	NOUN
bjos-8668473	191	6	.	.	PUNCT
bjos-8668473	192	1	doi	doi	NOUN
bjos-8668473	192	2	:	:	PUNCT
bjos-8668473	192	3	10.1038	10.1038	NUM
bjos-8668473	192	4	/	/	SYM
bjos-8668473	192	5	srep31520	srep31520	PROPN
bjos-8668473	192	6	.	.	NOUN
bjos-8668473	193	1	4	4	NUM
bjos-8668473	193	2	.	.	X
bjos-8668473	193	3	nagler	nagler	PROPN
bjos-8668473	193	4	rm	rm	PROPN
bjos-8668473	193	5	.	.	PROPN
bjos-8668473	193	6	saliva	saliva	NOUN
bjos-8668473	193	7	as	as	ADP
bjos-8668473	193	8	a	a	DET
bjos-8668473	193	9	tool	tool	NOUN
bjos-8668473	193	10	for	for	ADP
bjos-8668473	193	11	oral	oral	ADJ
bjos-8668473	193	12	cancer	cancer	NOUN
bjos-8668473	193	13	diagnosis	diagnosis	NOUN
bjos-8668473	193	14	and	and	CCONJ
bjos-8668473	193	15	prognosis	prognosis	NOUN
bjos-8668473	193	16	.	.	PUNCT
bjos-8668473	194	1	oral	oral	ADJ
bjos-8668473	194	2	oncol	oncol	ADJ
bjos-8668473	194	3	.	.	PUNCT
bjos-8668473	195	1	2009	2009	NUM
bjos-8668473	195	2	dec;45(12):1006	dec;45(12):1006	X
bjos-8668473	195	3	-	-	PUNCT
bjos-8668473	195	4	10	10	NUM
bjos-8668473	195	5	.	.	PUNCT
bjos-8668473	196	1	doi	doi	NOUN
bjos-8668473	196	2	:	:	PUNCT
bjos-8668473	196	3	10.1016	10.1016	NUM
bjos-8668473	196	4	/	/	SYM
bjos-8668473	196	5	j.oraloncology.2009.07.005	j.oraloncology.2009.07.005	PROPN
bjos-8668473	196	6	.	.	PUNCT
bjos-8668473	197	1	5	5	X
bjos-8668473	197	2	.	.	PUNCT
bjos-8668473	197	3	shankar	shankar	PROPN
bjos-8668473	197	4	aa	aa	PROPN
bjos-8668473	197	5	,	,	PUNCT
bjos-8668473	197	6	alex	alex	PROPN
bjos-8668473	197	7	s	s	PROPN
bjos-8668473	197	8	,	,	PUNCT
bjos-8668473	197	9	routray	routray	VERB
bjos-8668473	197	10	s.	s.	PROPN
bjos-8668473	197	11	incorporation	incorporation	NOUN
bjos-8668473	197	12	of	of	ADP
bjos-8668473	197	13	salivary	salivary	ADJ
bjos-8668473	197	14	metabolomics	metabolomic	NOUN
bjos-8668473	197	15	in	in	ADP
bjos-8668473	197	16	oral	oral	ADJ
bjos-8668473	197	17	cancer	cancer	NOUN
bjos-8668473	197	18	diagnostics	diagnostic	NOUN
bjos-8668473	197	19	.	.	PUNCT
bjos-8668473	198	1	oral	oral	ADJ
bjos-8668473	198	2	oncol	oncol	ADJ
bjos-8668473	198	3	.	.	PUNCT
bjos-8668473	199	1	2014	2014	NUM
bjos-8668473	199	2	oct;50(10):e53	oct;50(10):e53	NOUN
bjos-8668473	199	3	-	-	PUNCT
bjos-8668473	199	4	4	4	NUM
bjos-8668473	199	5	.	.	PUNCT
bjos-8668473	199	6	doi	doi	NOUN
bjos-8668473	199	7	:	:	PUNCT
bjos-8668473	199	8	10.1016	10.1016	NUM
bjos-8668473	199	9	/	/	SYM
bjos-8668473	199	10	j.oraloncology.2014.07.013	j.oraloncology.2014.07.013	PROPN
bjos-8668473	199	11	.	.	PROPN
bjos-8668473	200	1	6	6	NUM
bjos-8668473	200	2	.	.	X
bjos-8668473	200	3	sugimoto	sugimoto	PROPN
bjos-8668473	200	4	m	m	PROPN
bjos-8668473	200	5	,	,	PUNCT
bjos-8668473	200	6	wong	wong	PROPN
bjos-8668473	200	7	dt	dt	PROPN
bjos-8668473	200	8	,	,	PUNCT
bjos-8668473	200	9	hirayama	hirayama	PROPN
bjos-8668473	200	10	a	a	PRON
bjos-8668473	200	11	,	,	PUNCT
bjos-8668473	200	12	soga	soga	PROPN
bjos-8668473	200	13	t	t	PROPN
bjos-8668473	200	14	,	,	PUNCT
bjos-8668473	200	15	tomita	tomita	PROPN
bjos-8668473	200	16	m.	m.	NOUN
bjos-8668473	200	17	capillary	capillary	ADJ
bjos-8668473	200	18	electrophoresis	electrophoresis	NOUN
bjos-8668473	200	19	mass	mass	NOUN
bjos-8668473	200	20	spectrometrybased	spectrometrybase	VERB
bjos-8668473	200	21	saliva	saliva	NOUN
bjos-8668473	200	22	metabolomics	metabolomic	NOUN
bjos-8668473	200	23	identified	identify	VERB
bjos-8668473	200	24	oral	oral	ADJ
bjos-8668473	200	25	,	,	PUNCT
bjos-8668473	200	26	breast	breast	NOUN
bjos-8668473	200	27	and	and	CCONJ
bjos-8668473	200	28	pancreatic	pancreatic	ADJ
bjos-8668473	200	29	cancer	cancer	NOUN
bjos-8668473	200	30	-	-	PUNCT
bjos-8668473	200	31	specific	specific	ADJ
bjos-8668473	200	32	profiles	profile	NOUN
bjos-8668473	200	33	.	.	PUNCT
bjos-8668473	201	1	metabolomics	metabolomic	NOUN
bjos-8668473	201	2	.	.	PUNCT
bjos-8668473	202	1	2010	2010	NUM
bjos-8668473	202	2	mar;6(1):78	mar;6(1):78	NOUN
bjos-8668473	202	3	-	-	PROPN
bjos-8668473	202	4	95	95	NUM
bjos-8668473	202	5	.	.	PUNCT
bjos-8668473	203	1	doi	doi	NOUN
bjos-8668473	203	2	:	:	PUNCT
bjos-8668473	203	3	10.1007	10.1007	NUM
bjos-8668473	203	4	/	/	SYM
bjos-8668473	203	5	s11306	s11306	NUM
bjos-8668473	203	6	-	-	PUNCT
bjos-8668473	203	7	009	009	NUM
bjos-8668473	203	8	-	-	PUNCT
bjos-8668473	203	9	0178	0178	NUM
bjos-8668473	203	10	-	-	PUNCT
bjos-8668473	203	11	y.	y.	NOUN
bjos-8668473	203	12	7	7	NUM
bjos-8668473	203	13	.	.	PUNCT
bjos-8668473	204	1	king	king	PROPN
bjos-8668473	204	2	sl	sl	PROPN
bjos-8668473	204	3	,	,	PUNCT
bjos-8668473	204	4	hegadoren	hegadoren	PROPN
bjos-8668473	204	5	km	km	PROPN
bjos-8668473	204	6	.	.	PUNCT
bjos-8668473	205	1	stress	stress	NOUN
bjos-8668473	205	2	hormones	hormone	NOUN
bjos-8668473	205	3	:	:	PUNCT
bjos-8668473	205	4	how	how	SCONJ
bjos-8668473	205	5	do	do	AUX
bjos-8668473	205	6	they	they	PRON
bjos-8668473	205	7	measure	measure	VERB
bjos-8668473	205	8	up	up	ADP
bjos-8668473	205	9	?	?	PUNCT
bjos-8668473	206	1	biol	biol	PROPN
bjos-8668473	206	2	res	re	NOUN
bjos-8668473	206	3	nurs	nur	NOUN
bjos-8668473	206	4	.	.	PUNCT
bjos-8668473	207	1	2002	2002	NUM
bjos-8668473	207	2	oct;4(2):92	oct;4(2):92	NUM
bjos-8668473	207	3	-	-	SYM
bjos-8668473	207	4	103	103	NUM
bjos-8668473	207	5	.	.	PUNCT
bjos-8668473	208	1	doi	doi	NOUN
bjos-8668473	208	2	:	:	PUNCT
bjos-8668473	208	3	10.1177/1099800402238334	10.1177/1099800402238334	NUM
bjos-8668473	208	4	.	.	NOUN
bjos-8668473	208	5	8	8	NUM
bjos-8668473	208	6	.	.	PUNCT
bjos-8668473	209	1	liu	liu	PROPN
bjos-8668473	209	2	j	j	PROPN
bjos-8668473	209	3	,	,	PUNCT
bjos-8668473	209	4	duan	duan	PROPN
bjos-8668473	209	5	y.	y.	PROPN
bjos-8668473	209	6	saliva	saliva	PROPN
bjos-8668473	209	7	:	:	PUNCT
bjos-8668473	209	8	a	a	DET
bjos-8668473	209	9	potential	potential	ADJ
bjos-8668473	209	10	media	medium	NOUN
bjos-8668473	209	11	for	for	ADP
bjos-8668473	209	12	disease	disease	NOUN
bjos-8668473	209	13	diagnostics	diagnostic	NOUN
bjos-8668473	209	14	and	and	CCONJ
bjos-8668473	209	15	monitoring	monitoring	NOUN
bjos-8668473	209	16	.	.	PUNCT
bjos-8668473	210	1	oral	oral	ADJ
bjos-8668473	210	2	oncol	oncol	ADJ
bjos-8668473	210	3	.	.	PUNCT
bjos-8668473	211	1	2012	2012	NUM
bjos-8668473	211	2	jul;48(7):569	jul;48(7):569	PROPN
bjos-8668473	211	3	-	-	PUNCT
bjos-8668473	211	4	77	77	PROPN
bjos-8668473	211	5	.	.	PUNCT
bjos-8668473	212	1	doi	doi	NOUN
bjos-8668473	212	2	:	:	PUNCT
bjos-8668473	212	3	10.1016	10.1016	NUM
bjos-8668473	212	4	/	/	SYM
bjos-8668473	212	5	j.oraloncology.2012.01.021	j.oraloncology.2012.01.021	PROPN
bjos-8668473	212	6	.	.	PROPN
bjos-8668473	213	1	9	9	NUM
bjos-8668473	213	2	.	.	X
bjos-8668473	213	3	nonaka	nonaka	PROPN
bjos-8668473	213	4	t	t	PROPN
bjos-8668473	213	5	,	,	PUNCT
bjos-8668473	213	6	wong	wong	PROPN
bjos-8668473	213	7	dtw	dtw	PROPN
bjos-8668473	213	8	.	.	PUNCT
bjos-8668473	214	1	liquid	liquid	ADJ
bjos-8668473	214	2	biopsy	biopsy	NOUN
bjos-8668473	214	3	in	in	ADP
bjos-8668473	214	4	head	head	NOUN
bjos-8668473	214	5	and	and	CCONJ
bjos-8668473	214	6	neck	neck	NOUN
bjos-8668473	214	7	cancer	cancer	NOUN
bjos-8668473	214	8	:	:	PUNCT
bjos-8668473	214	9	promises	promise	NOUN
bjos-8668473	214	10	and	and	CCONJ
bjos-8668473	214	11	challenges	challenge	NOUN
bjos-8668473	214	12	.	.	PUNCT
bjos-8668473	215	1	j	j	PROPN
bjos-8668473	215	2	dent	dent	NOUN
bjos-8668473	215	3	res	re	NOUN
bjos-8668473	215	4	.	.	PUNCT
bjos-8668473	215	5	2018	2018	NUM
bjos-8668473	215	6	jun;97(6):701	jun;97(6):701	NOUN
bjos-8668473	215	7	-	-	PUNCT
bjos-8668473	215	8	8	8	PROPN
bjos-8668473	215	9	.	.	PUNCT
bjos-8668473	216	1	doi	doi	NOUN
bjos-8668473	216	2	:	:	PUNCT
bjos-8668473	217	1	10.1177/0022034518762071	10.1177/0022034518762071	NUM
bjos-8668473	217	2	.	.	PROPN
bjos-8668473	217	3	10	10	NUM
bjos-8668473	217	4	.	.	X
bjos-8668473	217	5	gohel	gohel	PROPN
bjos-8668473	217	6	v	v	PROPN
bjos-8668473	217	7	,	,	PUNCT
bjos-8668473	217	8	jones	jones	PROPN
bjos-8668473	217	9	ja	ja	PROPN
bjos-8668473	217	10	,	,	PUNCT
bjos-8668473	217	11	wehler	wehler	PROPN
bjos-8668473	217	12	cj	cj	PROPN
bjos-8668473	217	13	.	.	PUNCT
bjos-8668473	218	1	salivary	salivary	ADJ
bjos-8668473	218	2	biomarkers	biomarker	NOUN
bjos-8668473	218	3	and	and	CCONJ
bjos-8668473	218	4	cardiovascular	cardiovascular	ADJ
bjos-8668473	218	5	disease	disease	NOUN
bjos-8668473	218	6	:	:	PUNCT
bjos-8668473	218	7	a	a	DET
bjos-8668473	218	8	systematic	systematic	ADJ
bjos-8668473	218	9	review	review	NOUN
bjos-8668473	218	10	.	.	PUNCT
bjos-8668473	219	1	clin	clin	PROPN
bjos-8668473	219	2	chem	chem	NOUN
bjos-8668473	219	3	lab	lab	NOUN
bjos-8668473	219	4	med	me	VERB
bjos-8668473	219	5	.	.	PUNCT
bjos-8668473	220	1	2018	2018	NUM
bjos-8668473	220	2	aug;56(9):1432	aug;56(9):1432	PROPN
bjos-8668473	220	3	-	-	PUNCT
bjos-8668473	220	4	42	42	PROPN
bjos-8668473	220	5	.	.	PUNCT
bjos-8668473	221	1	doi	doi	NOUN
bjos-8668473	221	2	:	:	PUNCT
bjos-8668473	221	3	10.1515	10.1515	NUM
bjos-8668473	221	4	/	/	SYM
bjos-8668473	221	5	cclm-2017	cclm-2017	NOUN
bjos-8668473	221	6	-	-	PUNCT
bjos-8668473	221	7	1018	1018	NUM
bjos-8668473	221	8	.	.	PUNCT
bjos-8668473	222	1	11	11	NUM
bjos-8668473	222	2	.	.	X
bjos-8668473	222	3	hizir	hizir	PROPN
bjos-8668473	222	4	ms	ms	PROPN
bjos-8668473	222	5	,	,	PUNCT
bjos-8668473	222	6	balcioglu	balcioglu	PROPN
bjos-8668473	222	7	m	m	PROPN
bjos-8668473	222	8	,	,	PUNCT
bjos-8668473	222	9	rana	rana	PROPN
bjos-8668473	222	10	m	m	PROPN
bjos-8668473	222	11	,	,	PUNCT
bjos-8668473	222	12	robertson	robertson	PROPN
bjos-8668473	222	13	nm	nm	PROPN
bjos-8668473	222	14	,	,	PUNCT
bjos-8668473	222	15	yigit	yigit	PROPN
bjos-8668473	222	16	mv	mv	PROPN
bjos-8668473	222	17	.	.	PUNCT
bjos-8668473	223	1	simultaneous	simultaneous	ADJ
bjos-8668473	223	2	detection	detection	NOUN
bjos-8668473	223	3	of	of	ADP
bjos-8668473	223	4	circulating	circulate	VERB
bjos-8668473	223	5	oncomirs	oncomir	NOUN
bjos-8668473	223	6	from	from	ADP
bjos-8668473	223	7	body	body	NOUN
bjos-8668473	223	8	fluids	fluid	NOUN
bjos-8668473	223	9	for	for	ADP
bjos-8668473	223	10	prostate	prostate	NOUN
bjos-8668473	223	11	cancer	cancer	NOUN
bjos-8668473	223	12	staging	staging	NOUN
bjos-8668473	223	13	using	use	VERB
bjos-8668473	223	14	nanographene	nanographene	NOUN
bjos-8668473	223	15	oxide	oxide	NOUN
bjos-8668473	223	16	.	.	PUNCT
bjos-8668473	224	1	acs	acs	PROPN
bjos-8668473	224	2	appl	appl	PROPN
bjos-8668473	224	3	mater	mater	NOUN
bjos-8668473	224	4	interfaces	interface	NOUN
bjos-8668473	224	5	.	.	PUNCT
bjos-8668473	225	1	2014	2014	NUM
bjos-8668473	225	2	sep;6(17):14772	sep;6(17):14772	NOUN
bjos-8668473	225	3	-	-	PUNCT
bjos-8668473	225	4	8	8	NUM
bjos-8668473	225	5	.	.	PUNCT
bjos-8668473	226	1	doi	doi	NOUN
bjos-8668473	226	2	:	:	PUNCT
bjos-8668473	226	3	10.1021	10.1021	NUM
bjos-8668473	226	4	/	/	SYM
bjos-8668473	226	5	am504190a	am504190a	NOUN
bjos-8668473	226	6	.	.	PUNCT
bjos-8668473	227	1	12	12	NUM
bjos-8668473	227	2	.	.	PUNCT
bjos-8668473	228	1	xie	xie	PROPN
bjos-8668473	228	2	z	z	PROPN
bjos-8668473	228	3	,	,	PUNCT
bjos-8668473	228	4	yin	yin	PROPN
bjos-8668473	228	5	x	x	X
bjos-8668473	228	6	,	,	PUNCT
bjos-8668473	228	7	gong	gong	PROPN
bjos-8668473	228	8	b	b	PROPN
bjos-8668473	228	9	,	,	PUNCT
bjos-8668473	228	10	nie	nie	PROPN
bjos-8668473	228	11	w	w	PROPN
bjos-8668473	228	12	,	,	PUNCT
bjos-8668473	228	13	wu	wu	PROPN
bjos-8668473	228	14	b	b	PROPN
bjos-8668473	228	15	,	,	PUNCT
bjos-8668473	228	16	zhang	zhang	PROPN
bjos-8668473	228	17	x	x	PROPN
bjos-8668473	228	18	,	,	PUNCT
bjos-8668473	228	19	et	et	PROPN
bjos-8668473	228	20	al	al	PROPN
bjos-8668473	228	21	.	.	PROPN
bjos-8668473	229	1	salivary	salivary	PROPN
bjos-8668473	229	2	micrornas	microrna	NOUN
bjos-8668473	229	3	show	show	VERB
bjos-8668473	229	4	potential	potential	NOUN
bjos-8668473	229	5	as	as	ADP
bjos-8668473	229	6	a	a	DET
bjos-8668473	229	7	noninvasive	noninvasive	ADJ
bjos-8668473	229	8	biomarker	biomarker	NOUN
bjos-8668473	229	9	for	for	ADP
bjos-8668473	229	10	detecting	detect	VERB
bjos-8668473	229	11	resectable	resectable	ADJ
bjos-8668473	229	12	pancreatic	pancreatic	ADJ
bjos-8668473	229	13	cancer	cancer	NOUN
bjos-8668473	229	14	.	.	PUNCT
bjos-8668473	230	1	cancer	cancer	NOUN
bjos-8668473	230	2	prev	prev	PROPN
bjos-8668473	230	3	res	res	PROPN
bjos-8668473	230	4	(	(	PUNCT
bjos-8668473	230	5	phila	phila	PROPN
bjos-8668473	230	6	)	)	PUNCT
bjos-8668473	230	7	.	.	PUNCT
bjos-8668473	231	1	2015	2015	NUM
bjos-8668473	231	2	feb;8(2):165	feb;8(2):165	PROPN
bjos-8668473	231	3	-	-	PUNCT
bjos-8668473	231	4	73	73	NUM
bjos-8668473	231	5	.	.	PUNCT
bjos-8668473	232	1	doi	doi	NOUN
bjos-8668473	232	2	:	:	PUNCT
bjos-8668473	232	3	10.1158/1940	10.1158/1940	NUM
bjos-8668473	232	4	-	-	PUNCT
bjos-8668473	232	5	6207.capr-14	6207.capr-14	NUM
bjos-8668473	232	6	-	-	PUNCT
bjos-8668473	232	7	0192	0192	NUM
bjos-8668473	232	8	.	.	PUNCT
bjos-8668473	233	1	13	13	NUM
bjos-8668473	233	2	.	.	PUNCT
bjos-8668473	233	3	guerra	guerra	PROPN
bjos-8668473	233	4	en	en	PROPN
bjos-8668473	233	5	,	,	PUNCT
bjos-8668473	233	6	acevedo	acevedo	PROPN
bjos-8668473	233	7	ac	ac	PROPN
bjos-8668473	233	8	,	,	PUNCT
bjos-8668473	233	9	leite	leite	PROPN
bjos-8668473	233	10	af	af	PROPN
bjos-8668473	233	11	,	,	PUNCT
bjos-8668473	233	12	gozal	gozal	NOUN
bjos-8668473	233	13	d	d	PROPN
bjos-8668473	233	14	,	,	PUNCT
bjos-8668473	233	15	chardin	chardin	VERB
bjos-8668473	233	16	h	h	NOUN
bjos-8668473	233	17	,	,	PUNCT
bjos-8668473	233	18	de	de	PROPN
bjos-8668473	233	19	luca	luca	PROPN
bjos-8668473	233	20	canto	canto	PROPN
bjos-8668473	233	21	g.	g.	PROPN
bjos-8668473	233	22	diagnostic	diagnostic	ADJ
bjos-8668473	233	23	capability	capability	NOUN
bjos-8668473	233	24	of	of	ADP
bjos-8668473	233	25	salivary	salivary	ADJ
bjos-8668473	233	26	biomarkers	biomarker	NOUN
bjos-8668473	233	27	in	in	ADP
bjos-8668473	233	28	the	the	DET
bjos-8668473	233	29	assessment	assessment	NOUN
bjos-8668473	233	30	of	of	ADP
bjos-8668473	233	31	head	head	NOUN
bjos-8668473	233	32	and	and	CCONJ
bjos-8668473	233	33	neck	neck	NOUN
bjos-8668473	233	34	cancer	cancer	NOUN
bjos-8668473	233	35	:	:	PUNCT
bjos-8668473	233	36	a	a	DET
bjos-8668473	233	37	systematic	systematic	ADJ
bjos-8668473	233	38	review	review	NOUN
bjos-8668473	233	39	and	and	CCONJ
bjos-8668473	233	40	meta	meta	ADJ
bjos-8668473	233	41	-	-	PUNCT
bjos-8668473	233	42	analysis	analysis	NOUN
bjos-8668473	233	43	.	.	PUNCT
bjos-8668473	234	1	oral	oral	ADJ
bjos-8668473	234	2	oncol	oncol	ADJ
bjos-8668473	234	3	.	.	PUNCT
bjos-8668473	235	1	2015	2015	NUM
bjos-8668473	235	2	sep;51(9):805	sep;51(9):805	PROPN
bjos-8668473	235	3	-	-	SYM
bjos-8668473	235	4	18	18	NUM
bjos-8668473	236	1	.	.	PUNCT
bjos-8668473	236	2	doi	doi	NOUN
bjos-8668473	236	3	:	:	PUNCT
bjos-8668473	236	4	10.1016	10.1016	NUM
bjos-8668473	236	5	/	/	SYM
bjos-8668473	236	6	j.oraloncology.2015.06.010	j.oraloncology.2015.06.010	PROPN
bjos-8668473	236	7	.	.	PUNCT
bjos-8668473	237	1	14	14	NUM
bjos-8668473	237	2	.	.	PUNCT
bjos-8668473	238	1	lim	lim	PROPN
bjos-8668473	238	2	y	y	PROPN
bjos-8668473	238	3	,	,	PUNCT
bjos-8668473	238	4	sun	sun	PROPN
bjos-8668473	238	5	cx	cx	PROPN
bjos-8668473	238	6	,	,	PUNCT
bjos-8668473	238	7	tran	tran	PROPN
bjos-8668473	238	8	p	p	PROPN
bjos-8668473	238	9	,	,	PUNCT
bjos-8668473	238	10	punyadeera	punyadeera	ADJ
bjos-8668473	238	11	c.	c.	NOUN
bjos-8668473	238	12	salivary	salivary	VERB
bjos-8668473	238	13	epigenetic	epigenetic	ADJ
bjos-8668473	238	14	biomarkers	biomarker	NOUN
bjos-8668473	238	15	in	in	ADP
bjos-8668473	238	16	head	head	NOUN
bjos-8668473	238	17	and	and	CCONJ
bjos-8668473	238	18	neck	neck	VERB
bjos-8668473	238	19	squamous	squamous	ADJ
bjos-8668473	238	20	cell	cell	NOUN
bjos-8668473	238	21	carcinomas	carcinoma	NOUN
bjos-8668473	238	22	.	.	PUNCT
bjos-8668473	239	1	biomark	biomark	PROPN
bjos-8668473	239	2	med	med	PROPN
bjos-8668473	239	3	.	.	PUNCT
bjos-8668473	240	1	2016;10(3):301	2016;10(3):301	NUM
bjos-8668473	240	2	-	-	SYM
bjos-8668473	240	3	13	13	NUM
bjos-8668473	240	4	.	.	PUNCT
bjos-8668473	241	1	doi	doi	NOUN
bjos-8668473	241	2	:	:	PUNCT
bjos-8668473	241	3	10.2217	10.2217	NUM
bjos-8668473	241	4	/	/	SYM
bjos-8668473	241	5	bmm.16.2	bmm.16.2	NOUN
bjos-8668473	241	6	.	.	PUNCT
bjos-8668473	242	1	12	12	NUM
bjos-8668473	242	2	ferrazzo	ferrazzo	VERB
bjos-8668473	242	3	et	et	PROPN
bjos-8668473	242	4	al	al	PROPN
bjos-8668473	242	5	.	.	PROPN
bjos-8668473	243	1	braz	braz	PROPN
bjos-8668473	243	2	j	j	PROPN
bjos-8668473	243	3	oral	oral	PROPN
bjos-8668473	243	4	sci	sci	PROPN
bjos-8668473	243	5	.	.	PUNCT
bjos-8668473	244	1	2023;22	2023;22	NUM
bjos-8668473	244	2	:	:	PUNCT
bjos-8668473	244	3	e238473	e238473	NUM
bjos-8668473	244	4	15	15	NUM
bjos-8668473	244	5	.	.	PUNCT
bjos-8668473	244	6	fujita	fujita	PROPN
bjos-8668473	244	7	t	t	PROPN
bjos-8668473	244	8	,	,	PUNCT
bjos-8668473	244	9	hada	hada	PROPN
bjos-8668473	244	10	t	t	PROPN
bjos-8668473	244	11	,	,	PUNCT
bjos-8668473	244	12	higashino	higashino	PROPN
bjos-8668473	244	13	k.	k.	PROPN
bjos-8668473	244	14	origin	origin	PROPN
bjos-8668473	244	15	of	of	ADP
bjos-8668473	244	16	dand	dand	PROPN
bjos-8668473	244	17	l	l	PROPN
bjos-8668473	244	18	-	-	PUNCT
bjos-8668473	244	19	pipecolic	pipecolic	ADJ
bjos-8668473	244	20	acid	acid	NOUN
bjos-8668473	244	21	in	in	ADP
bjos-8668473	244	22	human	human	ADJ
bjos-8668473	244	23	physiological	physiological	ADJ
bjos-8668473	244	24	fluids	fluid	NOUN
bjos-8668473	244	25	:	:	PUNCT
bjos-8668473	244	26	a	a	DET
bjos-8668473	244	27	study	study	NOUN
bjos-8668473	244	28	of	of	ADP
bjos-8668473	244	29	the	the	DET
bjos-8668473	244	30	catabolic	catabolic	ADJ
bjos-8668473	244	31	mechanism	mechanism	NOUN
bjos-8668473	244	32	to	to	PART
bjos-8668473	244	33	pipecolic	pipecolic	NOUN
bjos-8668473	244	34	acid	acid	PROPN
bjos-8668473	244	35	using	use	VERB
bjos-8668473	244	36	the	the	DET
bjos-8668473	244	37	lysine	lysine	NOUN
bjos-8668473	244	38	loading	loading	NOUN
bjos-8668473	244	39	test	test	NOUN
bjos-8668473	244	40	.	.	PUNCT
bjos-8668473	245	1	clin	clin	PROPN
bjos-8668473	245	2	chim	chim	PROPN
bjos-8668473	245	3	acta	acta	PROPN
bjos-8668473	245	4	.	.	PUNCT
bjos-8668473	246	1	1999	1999	NUM
bjos-8668473	246	2	sep;287(1	sep;287(1	NUM
bjos-8668473	246	3	-	-	PUNCT
bjos-8668473	246	4	2):145	2):145	NUM
bjos-8668473	246	5	-	-	PUNCT
bjos-8668473	246	6	56	56	NUM
bjos-8668473	246	7	.	.	PUNCT
bjos-8668473	247	1	doi	doi	NOUN
bjos-8668473	247	2	:	:	PUNCT
bjos-8668473	247	3	10.1016	10.1016	NUM
bjos-8668473	247	4	/	/	SYM
bjos-8668473	247	5	s0009	s0009	PROPN
bjos-8668473	247	6	-	-	PUNCT
bjos-8668473	247	7	8981(99)00129	8981(99)00129	NUM
bjos-8668473	247	8	-	-	PUNCT
bjos-8668473	247	9	1	1	NUM
bjos-8668473	247	10	.	.	NOUN
bjos-8668473	247	11	16	16	NUM
bjos-8668473	247	12	.	.	PUNCT
bjos-8668473	248	1	peduto	peduto	PROPN
bjos-8668473	248	2	a	a	PRON
bjos-8668473	248	3	,	,	PUNCT
bjos-8668473	248	4	baumgartner	baumgartner	PROPN
bjos-8668473	248	5	mr	mr	PROPN
bjos-8668473	248	6	,	,	PUNCT
bjos-8668473	248	7	verhoeven	verhoeven	PROPN
bjos-8668473	248	8	nm	nm	PROPN
bjos-8668473	248	9	,	,	PUNCT
bjos-8668473	248	10	rabier	rabier	NOUN
bjos-8668473	248	11	d	d	PROPN
bjos-8668473	248	12	,	,	PUNCT
bjos-8668473	248	13	spada	spada	PROPN
bjos-8668473	248	14	m	m	PROPN
bjos-8668473	248	15	,	,	PUNCT
bjos-8668473	248	16	nassogne	nassogne	PROPN
bjos-8668473	248	17	mc	mc	PROPN
bjos-8668473	248	18	,	,	PUNCT
bjos-8668473	248	19	et	et	PROPN
bjos-8668473	248	20	al	al	PROPN
bjos-8668473	248	21	.	.	PROPN
bjos-8668473	249	1	hyperpipecolic	hyperpipecolic	PROPN
bjos-8668473	249	2	acidaemia	acidaemia	NOUN
bjos-8668473	249	3	:	:	PUNCT
bjos-8668473	249	4	a	a	DET
bjos-8668473	249	5	diagnostic	diagnostic	ADJ
bjos-8668473	249	6	tool	tool	NOUN
bjos-8668473	249	7	for	for	ADP
bjos-8668473	249	8	peroxisomal	peroxisomal	ADJ
bjos-8668473	249	9	disorders	disorder	NOUN
bjos-8668473	249	10	.	.	PUNCT
bjos-8668473	250	1	mol	mol	ADP
bjos-8668473	250	2	genet	genet	PROPN
bjos-8668473	250	3	metab	metab	PROPN
bjos-8668473	250	4	.	.	PUNCT
bjos-8668473	251	1	2004	2004	NUM
bjos-8668473	251	2	jul;82(3):224	jul;82(3):224	PROPN
bjos-8668473	251	3	-	-	PUNCT
bjos-8668473	251	4	30	30	NUM
bjos-8668473	251	5	.	.	PUNCT
bjos-8668473	252	1	doi	doi	NOUN
bjos-8668473	252	2	:	:	PUNCT
bjos-8668473	252	3	10.1016	10.1016	NUM
bjos-8668473	252	4	/	/	SYM
bjos-8668473	252	5	j.ymgme.2004.04.010	j.ymgme.2004.04.010	PROPN
bjos-8668473	252	6	.	.	PUNCT
bjos-8668473	253	1	17	17	NUM
bjos-8668473	253	2	.	.	PUNCT
bjos-8668473	254	1	steinberg	steinberg	PROPN
bjos-8668473	254	2	sj	sj	PROPN
bjos-8668473	254	3	,	,	PUNCT
bjos-8668473	254	4	dodt	dodt	PROPN
bjos-8668473	254	5	g	g	PROPN
bjos-8668473	254	6	,	,	PUNCT
bjos-8668473	254	7	raymond	raymond	PROPN
bjos-8668473	254	8	gv	gv	PROPN
bjos-8668473	254	9	,	,	PUNCT
bjos-8668473	254	10	braverman	braverman	PROPN
bjos-8668473	254	11	ne	ne	PROPN
bjos-8668473	254	12	,	,	PUNCT
bjos-8668473	254	13	moser	moser	PROPN
bjos-8668473	254	14	ab	ab	PROPN
bjos-8668473	254	15	,	,	PUNCT
bjos-8668473	254	16	moser	moser	PROPN
bjos-8668473	254	17	hw	hw	PROPN
bjos-8668473	254	18	.	.	PUNCT
bjos-8668473	255	1	peroxisome	peroxisome	VERB
bjos-8668473	255	2	biogenesis	biogenesis	NOUN
bjos-8668473	255	3	disorders	disorder	NOUN
bjos-8668473	255	4	.	.	PUNCT
bjos-8668473	256	1	biochim	biochim	PROPN
bjos-8668473	256	2	biophys	biophy	NOUN
bjos-8668473	256	3	acta	acta	PROPN
bjos-8668473	256	4	.	.	PUNCT
bjos-8668473	257	1	2006	2006	NUM
bjos-8668473	257	2	dec;1763(12):1733	dec;1763(12):1733	NOUN
bjos-8668473	257	3	-	-	PUNCT
bjos-8668473	257	4	48	48	NUM
bjos-8668473	257	5	.	.	PUNCT
bjos-8668473	258	1	doi	doi	NOUN
bjos-8668473	258	2	:	:	PUNCT
bjos-8668473	258	3	10.1016	10.1016	NUM
bjos-8668473	258	4	/	/	SYM
bjos-8668473	258	5	j.bbamcr.2006.09.010	j.bbamcr.2006.09.010	PROPN
bjos-8668473	258	6	.	.	PROPN
bjos-8668473	259	1	18	18	NUM
bjos-8668473	259	2	.	.	PUNCT
bjos-8668473	260	1	wang	wang	PROPN
bjos-8668473	260	2	q	q	PROPN
bjos-8668473	260	3	,	,	PUNCT
bjos-8668473	260	4	gao	gao	PROPN
bjos-8668473	260	5	p	p	X
bjos-8668473	260	6	,	,	PUNCT
bjos-8668473	260	7	wang	wang	PROPN
bjos-8668473	260	8	x	x	PROPN
bjos-8668473	260	9	,	,	PUNCT
bjos-8668473	260	10	duan	duan	PROPN
bjos-8668473	260	11	y.	y.	PROPN
bjos-8668473	260	12	investigation	investigation	PROPN
bjos-8668473	260	13	and	and	CCONJ
bjos-8668473	260	14	identification	identification	NOUN
bjos-8668473	260	15	of	of	ADP
bjos-8668473	260	16	potential	potential	ADJ
bjos-8668473	260	17	biomarkers	biomarker	NOUN
bjos-8668473	260	18	in	in	ADP
bjos-8668473	260	19	human	human	ADJ
bjos-8668473	260	20	saliva	saliva	NOUN
bjos-8668473	260	21	for	for	ADP
bjos-8668473	260	22	the	the	DET
bjos-8668473	260	23	early	early	ADJ
bjos-8668473	260	24	diagnosis	diagnosis	NOUN
bjos-8668473	260	25	of	of	ADP
bjos-8668473	260	26	oral	oral	ADJ
bjos-8668473	260	27	squamous	squamous	ADJ
bjos-8668473	260	28	cell	cell	NOUN
bjos-8668473	260	29	carcinoma	carcinoma	NOUN
bjos-8668473	260	30	.	.	PUNCT
bjos-8668473	261	1	clin	clin	PROPN
bjos-8668473	261	2	chim	chim	PROPN
bjos-8668473	261	3	acta	acta	PROPN
bjos-8668473	261	4	.	.	PUNCT
bjos-8668473	262	1	2014	2014	NUM
bjos-8668473	262	2	jan;427:79	jan;427:79	NOUN
bjos-8668473	262	3	-	-	PUNCT
bjos-8668473	262	4	85	85	NUM
bjos-8668473	262	5	.	.	PUNCT
bjos-8668473	263	1	doi	doi	NOUN
bjos-8668473	263	2	:	:	PUNCT
bjos-8668473	263	3	10.1016	10.1016	NUM
bjos-8668473	263	4	/	/	SYM
bjos-8668473	263	5	j.cca.2013.10.004	j.cca.2013.10.004	PROPN
bjos-8668473	263	6	.	.	PUNCT
bjos-8668473	264	1	19	19	NUM
bjos-8668473	264	2	.	.	X
bjos-8668473	264	3	patterson	patterson	PROPN
bjos-8668473	264	4	ad	ad	PROPN
bjos-8668473	264	5	,	,	PUNCT
bjos-8668473	264	6	bonzo	bonzo	PROPN
bjos-8668473	264	7	ja	ja	PROPN
bjos-8668473	264	8	,	,	PUNCT
bjos-8668473	264	9	li	li	PROPN
bjos-8668473	264	10	f	f	PROPN
bjos-8668473	264	11	,	,	PUNCT
bjos-8668473	264	12	krausz	krausz	PROPN
bjos-8668473	264	13	kw	kw	PROPN
bjos-8668473	264	14	,	,	PUNCT
bjos-8668473	264	15	eichler	eichler	NOUN
bjos-8668473	264	16	gs	gs	PROPN
bjos-8668473	264	17	,	,	PUNCT
bjos-8668473	264	18	aslam	aslam	PROPN
bjos-8668473	264	19	s	s	PROPN
bjos-8668473	264	20	,	,	PUNCT
bjos-8668473	264	21	et	et	PROPN
bjos-8668473	264	22	al	al	PROPN
bjos-8668473	264	23	.	.	PUNCT
bjos-8668473	265	1	metabolomics	metabolomic	NOUN
bjos-8668473	265	2	reveals	reveal	VERB
bjos-8668473	265	3	attenuation	attenuation	NOUN
bjos-8668473	265	4	of	of	ADP
bjos-8668473	265	5	the	the	DET
bjos-8668473	265	6	slc6a20	slc6a20	NOUN
bjos-8668473	265	7	kidney	kidney	NOUN
bjos-8668473	265	8	transporter	transporter	NOUN
bjos-8668473	265	9	in	in	ADP
bjos-8668473	265	10	nonhuman	nonhuman	ADJ
bjos-8668473	265	11	primate	primate	NOUN
bjos-8668473	265	12	and	and	CCONJ
bjos-8668473	265	13	mouse	mouse	NOUN
bjos-8668473	265	14	models	model	NOUN
bjos-8668473	265	15	of	of	ADP
bjos-8668473	265	16	type	type	NOUN
bjos-8668473	265	17	2	2	NUM
bjos-8668473	265	18	diabetes	diabetes	NOUN
bjos-8668473	265	19	mellitus	mellitus	NOUN
bjos-8668473	265	20	.	.	PUNCT
bjos-8668473	266	1	j	j	PROPN
bjos-8668473	266	2	biol	biol	PROPN
bjos-8668473	266	3	chem	chem	NOUN
bjos-8668473	266	4	.	.	PUNCT
bjos-8668473	267	1	2011	2011	NUM
bjos-8668473	267	2	jun;286(22):19511	jun;286(22):19511	NOUN
bjos-8668473	267	3	-	-	PUNCT
bjos-8668473	267	4	22	22	NUM
bjos-8668473	267	5	.	.	PUNCT
bjos-8668473	268	1	doi	doi	NOUN
bjos-8668473	268	2	:	:	PUNCT
bjos-8668473	268	3	10.1074	10.1074	NUM
bjos-8668473	268	4	/	/	SYM
bjos-8668473	268	5	jbc.m111.221739	jbc.m111.221739	PROPN
bjos-8668473	268	6	.	.	PROPN
bjos-8668473	268	7	20	20	NUM
bjos-8668473	268	8	.	.	PUNCT
bjos-8668473	269	1	priyadarsini	priyadarsini	PROPN
bjos-8668473	269	2	s	s	PROPN
bjos-8668473	269	3	,	,	PUNCT
bjos-8668473	269	4	mckay	mckay	PROPN
bjos-8668473	269	5	tb	tb	PROPN
bjos-8668473	269	6	,	,	PUNCT
bjos-8668473	269	7	sarker	sarker	NOUN
bjos-8668473	269	8	-	-	PUNCT
bjos-8668473	269	9	nag	nag	NOUN
bjos-8668473	269	10	a	a	DET
bjos-8668473	269	11	,	,	PUNCT
bjos-8668473	269	12	allegood	allegood	ADJ
bjos-8668473	269	13	j	j	NOUN
bjos-8668473	269	14	,	,	PUNCT
bjos-8668473	269	15	chalfant	chalfant	ADJ
bjos-8668473	269	16	c	c	PROPN
bjos-8668473	269	17	,	,	PUNCT
bjos-8668473	269	18	ma	ma	PROPN
bjos-8668473	269	19	jx	jx	PROPN
bjos-8668473	269	20	,	,	PUNCT
bjos-8668473	269	21	et	et	PROPN
bjos-8668473	269	22	al	al	PROPN
bjos-8668473	269	23	.	.	PROPN
bjos-8668473	270	1	complete	complete	ADJ
bjos-8668473	270	2	metabolome	metabolome	PROPN
bjos-8668473	270	3	and	and	CCONJ
bjos-8668473	270	4	lipidome	lipidome	VERB
bjos-8668473	270	5	analysis	analysis	NOUN
bjos-8668473	270	6	reveals	reveal	VERB
bjos-8668473	270	7	novel	novel	ADJ
bjos-8668473	270	8	biomarkers	biomarker	NOUN
bjos-8668473	270	9	in	in	ADP
bjos-8668473	270	10	the	the	DET
bjos-8668473	270	11	human	human	ADJ
bjos-8668473	270	12	diabetic	diabetic	ADJ
bjos-8668473	270	13	corneal	corneal	ADJ
bjos-8668473	270	14	stroma	stroma	NOUN
bjos-8668473	270	15	.	.	PUNCT
bjos-8668473	271	1	exp	exp	NOUN
bjos-8668473	271	2	eye	eye	NOUN
bjos-8668473	271	3	res	re	NOUN
bjos-8668473	271	4	.	.	PUNCT
bjos-8668473	272	1	2016	2016	NUM
bjos-8668473	272	2	dec;153:90	dec;153:90	NOUN
bjos-8668473	272	3	-	-	PUNCT
bjos-8668473	272	4	100	100	NUM
bjos-8668473	272	5	.	.	PUNCT
bjos-8668473	273	1	doi	doi	NOUN
bjos-8668473	273	2	:	:	PUNCT
bjos-8668473	273	3	10.1016	10.1016	NUM
bjos-8668473	273	4	/	/	SYM
bjos-8668473	273	5	j.exer.2016.10.010	j.exer.2016.10.010	PROPN
bjos-8668473	273	6	.	.	PUNCT
bjos-8668473	274	1	21	21	NUM
bjos-8668473	274	2	.	.	PUNCT
bjos-8668473	275	1	razquin	razquin	PROPN
bjos-8668473	275	2	c	c	NOUN
bjos-8668473	275	3	,	,	PUNCT
bjos-8668473	275	4	ruiz	ruiz	NOUN
bjos-8668473	275	5	-	-	PUNCT
bjos-8668473	275	6	canela	canela	PROPN
bjos-8668473	275	7	m	m	PROPN
bjos-8668473	275	8	,	,	PUNCT
bjos-8668473	275	9	clish	clish	PROPN
bjos-8668473	275	10	cb	cb	PROPN
bjos-8668473	275	11	,	,	PUNCT
bjos-8668473	275	12	li	li	PROPN
bjos-8668473	275	13	j	j	PROPN
bjos-8668473	275	14	,	,	PUNCT
bjos-8668473	275	15	toledo	toledo	PROPN
bjos-8668473	275	16	e	e	PROPN
bjos-8668473	275	17	,	,	PUNCT
bjos-8668473	275	18	dennis	dennis	PROPN
bjos-8668473	275	19	c	c	PROPN
bjos-8668473	275	20	,	,	PUNCT
bjos-8668473	275	21	et	et	PROPN
bjos-8668473	275	22	al	al	PROPN
bjos-8668473	275	23	.	.	PROPN
bjos-8668473	275	24	lysine	lysine	NOUN
bjos-8668473	275	25	pathway	pathway	NOUN
bjos-8668473	275	26	metabolites	metabolite	NOUN
bjos-8668473	275	27	and	and	CCONJ
bjos-8668473	275	28	the	the	DET
bjos-8668473	275	29	risk	risk	NOUN
bjos-8668473	275	30	of	of	ADP
bjos-8668473	275	31	type	type	NOUN
bjos-8668473	275	32	2	2	NUM
bjos-8668473	275	33	diabetes	diabetes	NOUN
bjos-8668473	275	34	and	and	CCONJ
bjos-8668473	275	35	cardiovascular	cardiovascular	ADJ
bjos-8668473	275	36	disease	disease	NOUN
bjos-8668473	275	37	in	in	ADP
bjos-8668473	275	38	the	the	DET
bjos-8668473	275	39	predimed	predimed	ADJ
bjos-8668473	275	40	study	study	NOUN
bjos-8668473	275	41	:	:	PUNCT
bjos-8668473	275	42	results	result	NOUN
bjos-8668473	275	43	from	from	ADP
bjos-8668473	275	44	two	two	NUM
bjos-8668473	275	45	casecohort	casecohort	NOUN
bjos-8668473	275	46	studies	study	NOUN
bjos-8668473	275	47	.	.	PUNCT
bjos-8668473	276	1	cardiovasc	cardiovasc	PROPN
bjos-8668473	276	2	diabetol	diabetol	VERB
bjos-8668473	276	3	.	.	PUNCT
bjos-8668473	277	1	2019	2019	NUM
bjos-8668473	277	2	nov;18(1):151	nov;18(1):151	NUM
bjos-8668473	277	3	.	.	PUNCT
bjos-8668473	278	1	doi	doi	NOUN
bjos-8668473	278	2	:	:	PUNCT
bjos-8668473	278	3	10.1186	10.1186	NUM
bjos-8668473	278	4	/	/	SYM
bjos-8668473	278	5	s12933	s12933	NOUN
bjos-8668473	278	6	-	-	PUNCT
bjos-8668473	278	7	019	019	NUM
bjos-8668473	278	8	-	-	PUNCT
bjos-8668473	278	9	0958	0958	NUM
bjos-8668473	278	10	-	-	SYM
bjos-8668473	278	11	2	2	NUM
bjos-8668473	278	12	.	.	NOUN
bjos-8668473	278	13	22	22	NUM
bjos-8668473	278	14	.	.	PUNCT
bjos-8668473	279	1	nalbantoglu	nalbantoglu	PROPN
bjos-8668473	279	2	s.	s.	PROPN
bjos-8668473	279	3	metabolomics	metabolomic	NOUN
bjos-8668473	279	4	:	:	PUNCT
bjos-8668473	279	5	basic	basic	ADJ
bjos-8668473	279	6	principles	principle	NOUN
bjos-8668473	279	7	and	and	CCONJ
bjos-8668473	279	8	strategies	strategy	NOUN
bjos-8668473	279	9	.	.	PUNCT
bjos-8668473	280	1	in	in	ADP
bjos-8668473	280	2	:	:	PUNCT
bjos-8668473	280	3	nalbantoglu	nalbantoglu	PROPN
bjos-8668473	280	4	s	s	PROPN
bjos-8668473	280	5	,	,	PUNCT
bjos-8668473	280	6	amri	amri	PROPN
bjos-8668473	280	7	h	h	PROPN
bjos-8668473	280	8	,	,	PUNCT
bjos-8668473	280	9	editors	editor	NOUN
bjos-8668473	280	10	.	.	PUNCT
bjos-8668473	281	1	molecular	molecular	ADJ
bjos-8668473	281	2	medicine	medicine	NOUN
bjos-8668473	281	3	.	.	PUNCT
bjos-8668473	282	1	rijeka	rijeka	PROPN
bjos-8668473	282	2	:	:	PUNCT
bjos-8668473	282	3	intechopen	intechopen	ADJ
bjos-8668473	282	4	;	;	PUNCT
bjos-8668473	282	5	2019	2019	NUM
bjos-8668473	283	1	[	[	PUNCT
bjos-8668473	283	2	cited	cite	VERB
bjos-8668473	283	3	2022	2022	NUM
bjos-8668473	283	4	jan	jan	PROPN
bjos-8668473	283	5	8	8	NUM
bjos-8668473	283	6	]	]	PUNCT
bjos-8668473	283	7	.	.	PUNCT
bjos-8668473	284	1	available	available	ADJ
bjos-8668473	284	2	from	from	ADP
bjos-8668473	284	3	:	:	PUNCT
bjos-8668473	284	4	https://doi.org/10.5772/intechopen.88563	https://doi.org/10.5772/intechopen.88563	NUM
bjos-8668473	284	5	.	.	X
bjos-8668473	285	1	23	23	NUM
bjos-8668473	285	2	.	.	PUNCT
bjos-8668473	286	1	edge	edge	PROPN
bjos-8668473	286	2	sb	sb	PROPN
bjos-8668473	286	3	,	,	PUNCT
bjos-8668473	286	4	compton	compton	PROPN
bjos-8668473	286	5	cc	cc	PROPN
bjos-8668473	286	6	.	.	PUNCT
bjos-8668473	287	1	the	the	DET
bjos-8668473	287	2	american	american	PROPN
bjos-8668473	287	3	joint	joint	PROPN
bjos-8668473	287	4	committee	committee	PROPN
bjos-8668473	287	5	on	on	ADP
bjos-8668473	287	6	cancer	cancer	NOUN
bjos-8668473	287	7	:	:	PUNCT
bjos-8668473	287	8	the	the	DET
bjos-8668473	287	9	7th	7th	ADJ
bjos-8668473	287	10	edition	edition	NOUN
bjos-8668473	287	11	of	of	ADP
bjos-8668473	287	12	the	the	DET
bjos-8668473	287	13	ajcc	ajcc	PROPN
bjos-8668473	287	14	cancer	cancer	NOUN
bjos-8668473	287	15	staging	staging	NOUN
bjos-8668473	287	16	manual	manual	NOUN
bjos-8668473	287	17	and	and	CCONJ
bjos-8668473	287	18	the	the	DET
bjos-8668473	287	19	future	future	NOUN
bjos-8668473	287	20	of	of	ADP
bjos-8668473	287	21	tnm	tnm	PROPN
bjos-8668473	287	22	.	.	PUNCT
bjos-8668473	288	1	ann	ann	PROPN
bjos-8668473	288	2	surg	surg	PROPN
bjos-8668473	288	3	oncol	oncol	PROPN
bjos-8668473	288	4	.	.	PUNCT
bjos-8668473	289	1	2010	2010	NUM
bjos-8668473	289	2	jun;17(6):1471	jun;17(6):1471	NOUN
bjos-8668473	289	3	-	-	PUNCT
bjos-8668473	289	4	4	4	NUM
bjos-8668473	289	5	.	.	PUNCT
bjos-8668473	289	6	doi	doi	NOUN
bjos-8668473	289	7	:	:	PUNCT
bjos-8668473	289	8	10.1245	10.1245	NUM
bjos-8668473	289	9	/	/	SYM
bjos-8668473	289	10	s10434	s10434	PROPN
bjos-8668473	289	11	-	-	PUNCT
bjos-8668473	289	12	010	010	NUM
bjos-8668473	289	13	-	-	PUNCT
bjos-8668473	289	14	0985	0985	NUM
bjos-8668473	289	15	-	-	PUNCT
bjos-8668473	289	16	4	4	NUM
bjos-8668473	289	17	.	.	NUM
bjos-8668473	289	18	24	24	NUM
bjos-8668473	289	19	.	.	PUNCT
bjos-8668473	290	1	ferreira	ferreira	PROPN
bjos-8668473	290	2	antunes	antunes	PROPN
bjos-8668473	290	3	jl	jl	PROPN
bjos-8668473	290	4	,	,	PUNCT
bjos-8668473	290	5	toporcov	toporcov	PROPN
bjos-8668473	290	6	tn	tn	PROPN
bjos-8668473	290	7	,	,	PUNCT
bjos-8668473	290	8	biazevic	biazevic	ADJ
bjos-8668473	290	9	mg	mg	PROPN
bjos-8668473	290	10	,	,	PUNCT
bjos-8668473	290	11	boing	boe	VERB
bjos-8668473	290	12	af	af	PROPN
bjos-8668473	290	13	,	,	PUNCT
bjos-8668473	290	14	scully	scully	ADV
bjos-8668473	290	15	c	c	AUX
bjos-8668473	290	16	,	,	PUNCT
bjos-8668473	290	17	petti	petti	PROPN
bjos-8668473	290	18	s.	s.	PROPN
bjos-8668473	290	19	joint	joint	PROPN
bjos-8668473	290	20	and	and	CCONJ
bjos-8668473	290	21	independent	independent	ADJ
bjos-8668473	290	22	effects	effect	NOUN
bjos-8668473	290	23	of	of	ADP
bjos-8668473	290	24	alcohol	alcohol	NOUN
bjos-8668473	290	25	drinking	drinking	NOUN
bjos-8668473	290	26	and	and	CCONJ
bjos-8668473	290	27	tobacco	tobacco	NOUN
bjos-8668473	290	28	smoking	smoking	NOUN
bjos-8668473	290	29	on	on	ADP
bjos-8668473	290	30	oral	oral	ADJ
bjos-8668473	290	31	cancer	cancer	NOUN
bjos-8668473	290	32	:	:	PUNCT
bjos-8668473	290	33	a	a	DET
bjos-8668473	290	34	large	large	ADJ
bjos-8668473	290	35	case	case	NOUN
bjos-8668473	290	36	-	-	PUNCT
bjos-8668473	290	37	control	control	NOUN
bjos-8668473	290	38	study	study	NOUN
bjos-8668473	290	39	.	.	PUNCT
bjos-8668473	291	1	plos	plos	PROPN
bjos-8668473	291	2	one	one	NUM
bjos-8668473	291	3	.	.	PUNCT
bjos-8668473	292	1	2013	2013	NUM
bjos-8668473	292	2	jul;8(7):e68132	jul;8(7):e68132	SYM
bjos-8668473	292	3	.	.	PUNCT
bjos-8668473	292	4	doi	doi	PROPN
bjos-8668473	292	5	:	:	PUNCT
bjos-8668473	292	6	10.1371	10.1371	NUM
bjos-8668473	292	7	/	/	SYM
bjos-8668473	292	8	journal.pone.0068132	journal.pone.0068132	PROPN
bjos-8668473	292	9	.	.	PROPN
bjos-8668473	292	10	25	25	NUM
bjos-8668473	292	11	.	.	PUNCT
bjos-8668473	293	1	navazesh	navazesh	PROPN
bjos-8668473	293	2	m	m	PROPN
bjos-8668473	293	3	,	,	PUNCT
bjos-8668473	293	4	kumar	kumar	PROPN
bjos-8668473	293	5	sk	sk	PROPN
bjos-8668473	293	6	;	;	PUNCT
bjos-8668473	293	7	university	university	PROPN
bjos-8668473	293	8	of	of	ADP
bjos-8668473	293	9	southern	southern	PROPN
bjos-8668473	293	10	california	california	PROPN
bjos-8668473	293	11	school	school	PROPN
bjos-8668473	293	12	of	of	ADP
bjos-8668473	293	13	dentistry	dentistry	NOUN
bjos-8668473	293	14	.	.	PUNCT
bjos-8668473	294	1	measuring	measure	VERB
bjos-8668473	294	2	salivary	salivary	ADJ
bjos-8668473	294	3	flow	flow	NOUN
bjos-8668473	294	4	:	:	PUNCT
bjos-8668473	294	5	challenges	challenge	NOUN
bjos-8668473	294	6	and	and	CCONJ
bjos-8668473	294	7	opportunities	opportunity	NOUN
bjos-8668473	294	8	.	.	PUNCT
bjos-8668473	295	1	j	j	PROPN
bjos-8668473	295	2	am	be	AUX
bjos-8668473	295	3	dent	dent	ADJ
bjos-8668473	295	4	assoc	assoc	NOUN
bjos-8668473	295	5	.	.	PUNCT
bjos-8668473	296	1	2008	2008	NUM
bjos-8668473	297	1	may;139	may;139	ADJ
bjos-8668473	297	2	suppl:35s-40s	suppl:35s-40s	PROPN
bjos-8668473	297	3	.	.	PUNCT
bjos-8668473	298	1	doi	doi	NOUN
bjos-8668473	298	2	:	:	PUNCT
bjos-8668473	298	3	10.14219	10.14219	NUM
bjos-8668473	298	4	/	/	SYM
bjos-8668473	298	5	jada.archive.2008.0353	jada.archive.2008.0353	PROPN
bjos-8668473	298	6	.	.	PUNCT
bjos-8668473	299	1	26	26	NUM
bjos-8668473	299	2	.	.	PUNCT
bjos-8668473	300	1	wei	wei	PROPN
bjos-8668473	300	2	j	j	PROPN
bjos-8668473	300	3	,	,	PUNCT
bjos-8668473	300	4	xie	xie	PROPN
bjos-8668473	300	5	g	g	PROPN
bjos-8668473	300	6	,	,	PUNCT
bjos-8668473	301	1	zhou	zhou	PROPN
bjos-8668473	301	2	z	z	PROPN
bjos-8668473	301	3	,	,	PUNCT
bjos-8668473	301	4	shi	shi	PROPN
bjos-8668473	301	5	p	p	X
bjos-8668473	301	6	,	,	PUNCT
bjos-8668473	301	7	qiu	qiu	PROPN
bjos-8668473	301	8	y	y	PROPN
bjos-8668473	301	9	,	,	PUNCT
bjos-8668473	301	10	zheng	zheng	PROPN
bjos-8668473	301	11	x	x	PROPN
bjos-8668473	301	12	,	,	PUNCT
bjos-8668473	301	13	et	et	PROPN
bjos-8668473	301	14	al	al	PROPN
bjos-8668473	301	15	.	.	PROPN
bjos-8668473	301	16	salivary	salivary	ADJ
bjos-8668473	301	17	metabolite	metabolite	NOUN
bjos-8668473	301	18	signatures	signature	NOUN
bjos-8668473	301	19	of	of	ADP
bjos-8668473	301	20	oral	oral	ADJ
bjos-8668473	301	21	cancer	cancer	NOUN
bjos-8668473	301	22	and	and	CCONJ
bjos-8668473	301	23	leukoplakia	leukoplakia	NOUN
bjos-8668473	301	24	.	.	PUNCT
bjos-8668473	302	1	int	int	NOUN
bjos-8668473	302	2	j	j	PROPN
bjos-8668473	302	3	cancer	cancer	NOUN
bjos-8668473	302	4	.	.	PUNCT
bjos-8668473	303	1	2011	2011	NUM
bjos-8668473	303	2	nov;129(9):2207	nov;129(9):2207	NOUN
bjos-8668473	303	3	-	-	SYM
bjos-8668473	303	4	17	17	NUM
bjos-8668473	303	5	.	.	PUNCT
bjos-8668473	304	1	doi	doi	NOUN
bjos-8668473	304	2	:	:	PUNCT
bjos-8668473	304	3	10.1002	10.1002	NUM
bjos-8668473	304	4	/	/	SYM
bjos-8668473	304	5	ijc.25881	ijc.25881	NUM
bjos-8668473	304	6	.	.	PROPN
bjos-8668473	304	7	27	27	NUM
bjos-8668473	304	8	.	.	PUNCT
bjos-8668473	305	1	assad	assad	PROPN
bjos-8668473	305	2	dx	dx	PROPN
bjos-8668473	305	3	,	,	PUNCT
bjos-8668473	305	4	mascarenhas	mascarenhas	PROPN
bjos-8668473	305	5	ecp	ecp	PROPN
bjos-8668473	305	6	,	,	PUNCT
bjos-8668473	305	7	de	de	X
bjos-8668473	305	8	lima	lima	PROPN
bjos-8668473	305	9	cl	cl	NOUN
bjos-8668473	305	10	,	,	PUNCT
bjos-8668473	305	11	de	de	PROPN
bjos-8668473	305	12	toledo	toledo	PROPN
bjos-8668473	305	13	ip	ip	PROPN
bjos-8668473	305	14	,	,	PUNCT
bjos-8668473	305	15	chardin	chardin	VERB
bjos-8668473	305	16	h	h	NOUN
bjos-8668473	305	17	,	,	PUNCT
bjos-8668473	305	18	combes	combes	PROPN
bjos-8668473	305	19	a	a	PROPN
bjos-8668473	305	20	,	,	PUNCT
bjos-8668473	305	21	et	et	PROPN
bjos-8668473	305	22	al	al	PROPN
bjos-8668473	305	23	.	.	PROPN
bjos-8668473	305	24	salivary	salivary	ADJ
bjos-8668473	305	25	metabolites	metabolite	NOUN
bjos-8668473	305	26	to	to	PART
bjos-8668473	305	27	detect	detect	VERB
bjos-8668473	305	28	patients	patient	NOUN
bjos-8668473	305	29	with	with	ADP
bjos-8668473	305	30	cancer	cancer	NOUN
bjos-8668473	305	31	:	:	PUNCT
bjos-8668473	305	32	a	a	DET
bjos-8668473	305	33	systematic	systematic	ADJ
bjos-8668473	305	34	review	review	NOUN
bjos-8668473	305	35	.	.	PUNCT
bjos-8668473	306	1	int	int	PROPN
bjos-8668473	307	1	j	j	PROPN
bjos-8668473	307	2	clin	clin	PROPN
bjos-8668473	307	3	oncol	oncol	PROPN
bjos-8668473	307	4	.	.	PUNCT
bjos-8668473	308	1	2020	2020	NUM
bjos-8668473	309	1	jun;25(6):1016	jun;25(6):1016	PROPN
bjos-8668473	309	2	-	-	PROPN
bjos-8668473	309	3	36	36	NUM
bjos-8668473	309	4	.	.	PUNCT
bjos-8668473	310	1	doi	doi	NOUN
bjos-8668473	310	2	:	:	PUNCT
bjos-8668473	310	3	10.1007	10.1007	NUM
bjos-8668473	310	4	/	/	SYM
bjos-8668473	310	5	s10147	s10147	NOUN
bjos-8668473	310	6	-	-	PUNCT
bjos-8668473	310	7	020	020	NUM
bjos-8668473	310	8	-	-	PUNCT
bjos-8668473	310	9	01660	01660	NUM
bjos-8668473	310	10	-	-	SYM
bjos-8668473	310	11	7	7	NUM
bjos-8668473	310	12	.	.	NOUN
bjos-8668473	310	13	28	28	NUM
bjos-8668473	310	14	.	.	PUNCT
bjos-8668473	311	1	wang	wang	PROPN
bjos-8668473	311	2	tj	tj	PROPN
bjos-8668473	311	3	,	,	PUNCT
bjos-8668473	311	4	ngo	ngo	PROPN
bjos-8668473	311	5	d	d	PROPN
bjos-8668473	311	6	,	,	PUNCT
bjos-8668473	311	7	psychogios	psychogio	NOUN
bjos-8668473	311	8	n	n	CCONJ
bjos-8668473	311	9	,	,	PUNCT
bjos-8668473	311	10	dejam	dejam	VERB
bjos-8668473	311	11	a	a	X
bjos-8668473	311	12	,	,	PUNCT
bjos-8668473	311	13	larson	larson	PROPN
bjos-8668473	311	14	mg	mg	PROPN
bjos-8668473	311	15	,	,	PUNCT
bjos-8668473	311	16	vasan	vasan	ADJ
bjos-8668473	311	17	rs	rs	NOUN
bjos-8668473	311	18	,	,	PUNCT
bjos-8668473	311	19	et	et	PROPN
bjos-8668473	311	20	al	al	PROPN
bjos-8668473	311	21	.	.	PROPN
bjos-8668473	312	1	2	2	NUM
bjos-8668473	312	2	-	-	PUNCT
bjos-8668473	312	3	aminoadipic	aminoadipic	ADJ
bjos-8668473	312	4	acid	acid	NOUN
bjos-8668473	312	5	is	be	AUX
bjos-8668473	312	6	a	a	DET
bjos-8668473	312	7	biomarker	biomarker	NOUN
bjos-8668473	312	8	for	for	ADP
bjos-8668473	312	9	diabetes	diabetes	NOUN
bjos-8668473	312	10	risk	risk	NOUN
bjos-8668473	312	11	.	.	PUNCT
bjos-8668473	313	1	j	j	PROPN
bjos-8668473	313	2	clin	clin	PROPN
bjos-8668473	313	3	invest	invest	PROPN
bjos-8668473	313	4	.	.	PUNCT
bjos-8668473	314	1	2013	2013	NUM
bjos-8668473	314	2	oct;123(10):4309	oct;123(10):4309	PROPN
bjos-8668473	314	3	-	-	PUNCT
bjos-8668473	314	4	17	17	NUM
bjos-8668473	314	5	.	.	PUNCT
bjos-8668473	315	1	doi	doi	NOUN
bjos-8668473	315	2	:	:	PUNCT
bjos-8668473	315	3	10.1172	10.1172	NUM
bjos-8668473	315	4	/	/	SYM
bjos-8668473	315	5	jci64801	jci64801	ADJ
bjos-8668473	315	6	.	.	PUNCT
bjos-8668473	316	1	29	29	NUM
bjos-8668473	316	2	.	.	PUNCT
bjos-8668473	316	3	esteller	esteller	NOUN
bjos-8668473	316	4	m.	m.	NOUN
bjos-8668473	316	5	epigenetics	epigenetic	NOUN
bjos-8668473	316	6	in	in	ADP
bjos-8668473	316	7	cancer	cancer	NOUN
bjos-8668473	316	8	.	.	PUNCT
bjos-8668473	317	1	n	n	PROPN
bjos-8668473	317	2	engl	engl	PROPN
bjos-8668473	317	3	j	j	PROPN
bjos-8668473	317	4	med	med	PROPN
bjos-8668473	317	5	.	.	PROPN
bjos-8668473	317	6	2008	2008	NUM
bjos-8668473	317	7	mar;358(11):1148	mar;358(11):1148	NOUN
bjos-8668473	317	8	-	-	PUNCT
bjos-8668473	317	9	59	59	NUM
bjos-8668473	317	10	.	.	PUNCT
bjos-8668473	318	1	doi	doi	NOUN
bjos-8668473	318	2	:	:	PUNCT
bjos-8668473	318	3	10.1056	10.1056	NUM
bjos-8668473	318	4	/	/	SYM
bjos-8668473	318	5	nejmra072067	nejmra072067	PROPN
bjos-8668473	318	6	.	.	PROPN
bjos-8668473	319	1	30	30	NUM
bjos-8668473	319	2	.	.	PUNCT
bjos-8668473	320	1	chen	chen	PROPN
bjos-8668473	320	2	yw	yw	PROPN
bjos-8668473	320	3	,	,	PUNCT
bjos-8668473	320	4	kao	kao	PROPN
bjos-8668473	320	5	sy	sy	PROPN
bjos-8668473	320	6	,	,	PUNCT
bjos-8668473	320	7	wang	wang	PROPN
bjos-8668473	320	8	hj	hj	PROPN
bjos-8668473	320	9	,	,	PUNCT
bjos-8668473	320	10	yang	yang	PROPN
bjos-8668473	320	11	mh	mh	PROPN
bjos-8668473	320	12	.	.	PUNCT
bjos-8668473	321	1	histone	histone	NOUN
bjos-8668473	321	2	modification	modification	NOUN
bjos-8668473	321	3	patterns	pattern	NOUN
bjos-8668473	321	4	correlate	correlate	VERB
bjos-8668473	321	5	with	with	ADP
bjos-8668473	321	6	patient	patient	ADJ
bjos-8668473	321	7	outcome	outcome	NOUN
bjos-8668473	321	8	in	in	ADP
bjos-8668473	321	9	oral	oral	ADJ
bjos-8668473	321	10	squamous	squamous	ADJ
bjos-8668473	321	11	cell	cell	NOUN
bjos-8668473	321	12	carcinoma	carcinoma	NOUN
bjos-8668473	321	13	.	.	PUNCT
bjos-8668473	322	1	cancer	cancer	NOUN
bjos-8668473	322	2	.	.	PUNCT
bjos-8668473	323	1	2013	2013	NUM
bjos-8668473	323	2	dec;119(24):4259	dec;119(24):4259	NOUN
bjos-8668473	323	3	-	-	SYM
bjos-8668473	323	4	67	67	NUM
bjos-8668473	323	5	.	.	PUNCT
bjos-8668473	324	1	doi	doi	NOUN
bjos-8668473	324	2	:	:	PUNCT
bjos-8668473	324	3	10.1002	10.1002	NUM
bjos-8668473	324	4	/	/	SYM
bjos-8668473	324	5	cncr.28356	cncr.28356	NOUN
bjos-8668473	324	6	.	.	PUNCT
bjos-8668473	325	1	31	31	NUM
bjos-8668473	325	2	.	.	PUNCT
bjos-8668473	326	1	dyar	dyar	PROPN
bjos-8668473	326	2	ka	ka	PROPN
bjos-8668473	326	3	,	,	PUNCT
bjos-8668473	326	4	eckel	eckel	PROPN
bjos-8668473	326	5	-	-	PUNCT
bjos-8668473	326	6	mahan	mahan	PROPN
bjos-8668473	326	7	kl	kl	PROPN
bjos-8668473	326	8	.	.	PUNCT
bjos-8668473	327	1	circadian	circadian	ADJ
bjos-8668473	327	2	metabolomics	metabolomic	NOUN
bjos-8668473	327	3	in	in	ADP
bjos-8668473	327	4	time	time	NOUN
bjos-8668473	327	5	and	and	CCONJ
bjos-8668473	327	6	space	space	NOUN
bjos-8668473	327	7	.	.	PUNCT
bjos-8668473	328	1	front	front	ADJ
bjos-8668473	328	2	neurosci	neurosci	PROPN
bjos-8668473	328	3	.	.	PUNCT
bjos-8668473	329	1	2017	2017	NUM
bjos-8668473	329	2	jul;11:369	jul;11:369	PROPN
bjos-8668473	329	3	.	.	PUNCT
bjos-8668473	330	1	doi	doi	NOUN
bjos-8668473	330	2	:	:	PUNCT
bjos-8668473	330	3	10.3389	10.3389	NUM
bjos-8668473	330	4	/	/	SYM
bjos-8668473	330	5	fnins.2017.00369	fnins.2017.00369	NOUN
bjos-8668473	330	6	.	.	NOUN
bjos-8668473	330	7	13	13	NUM
bjos-8668473	330	8	ferrazzo	ferrazzo	VERB
bjos-8668473	330	9	et	et	PROPN
bjos-8668473	330	10	al	al	PROPN
bjos-8668473	330	11	.	.	PROPN
bjos-8668473	331	1	braz	braz	PROPN
bjos-8668473	331	2	j	j	PROPN
bjos-8668473	331	3	oral	oral	PROPN
bjos-8668473	331	4	sci	sci	PROPN
bjos-8668473	331	5	.	.	PUNCT
bjos-8668473	332	1	2023;22	2023;22	NUM
bjos-8668473	332	2	:	:	PUNCT
bjos-8668473	332	3	e238473	e238473	NUM
bjos-8668473	332	4	32	32	NUM
bjos-8668473	332	5	.	.	PUNCT
bjos-8668473	333	1	ishikawa	ishikawa	PROPN
bjos-8668473	333	2	s	s	PROPN
bjos-8668473	333	3	,	,	PUNCT
bjos-8668473	333	4	sugimoto	sugimoto	PROPN
bjos-8668473	333	5	m	m	PROPN
bjos-8668473	333	6	,	,	PUNCT
bjos-8668473	333	7	kitabatake	kitabatake	PROPN
bjos-8668473	333	8	k	k	PROPN
bjos-8668473	333	9	,	,	PUNCT
bjos-8668473	333	10	tu	tu	PROPN
bjos-8668473	333	11	m	m	PROPN
bjos-8668473	333	12	,	,	PUNCT
bjos-8668473	333	13	sugano	sugano	VERB
bjos-8668473	333	14	a	a	X
bjos-8668473	333	15	,	,	PUNCT
bjos-8668473	333	16	yamamori	yamamori	PROPN
bjos-8668473	333	17	i	i	PROPN
bjos-8668473	333	18	,	,	PUNCT
bjos-8668473	333	19	et	et	PROPN
bjos-8668473	333	20	al	al	PROPN
bjos-8668473	333	21	.	.	PROPN
bjos-8668473	333	22	effect	effect	NOUN
bjos-8668473	333	23	of	of	ADP
bjos-8668473	333	24	timing	timing	NOUN
bjos-8668473	333	25	of	of	ADP
bjos-8668473	333	26	collection	collection	NOUN
bjos-8668473	333	27	of	of	ADP
bjos-8668473	333	28	salivary	salivary	ADJ
bjos-8668473	333	29	metabolomic	metabolomic	ADJ
bjos-8668473	333	30	biomarkers	biomarker	NOUN
bjos-8668473	333	31	on	on	ADP
bjos-8668473	333	32	oral	oral	ADJ
bjos-8668473	333	33	cancer	cancer	NOUN
bjos-8668473	333	34	detection	detection	NOUN
bjos-8668473	333	35	.	.	PUNCT
bjos-8668473	334	1	amino	amino	ADJ
bjos-8668473	334	2	acids	acid	NOUN
bjos-8668473	334	3	.	.	PUNCT
bjos-8668473	335	1	2017	2017	NUM
bjos-8668473	335	2	apr;49(4):761	apr;49(4):761	NOUN
bjos-8668473	335	3	-	-	PUNCT
bjos-8668473	335	4	70	70	NUM
bjos-8668473	335	5	.	.	PUNCT
bjos-8668473	336	1	doi	doi	NOUN
bjos-8668473	336	2	:	:	PUNCT
bjos-8668473	336	3	10.1007	10.1007	NUM
bjos-8668473	336	4	/	/	SYM
bjos-8668473	336	5	s00726	s00726	NOUN
bjos-8668473	336	6	-	-	PUNCT
bjos-8668473	336	7	017	017	NUM
bjos-8668473	336	8	-	-	PUNCT
bjos-8668473	336	9	2378	2378	NUM
bjos-8668473	336	10	-	-	SYM
bjos-8668473	336	11	5	5	NUM
bjos-8668473	336	12	.	.	NOUN
bjos-8668473	336	13	33	33	NUM
bjos-8668473	336	14	.	.	PUNCT
bjos-8668473	336	15	yan	yan	PROPN
bjos-8668473	337	1	w	w	PROPN
bjos-8668473	337	2	,	,	PUNCT
bjos-8668473	337	3	apweiler	apweiler	NOUN
bjos-8668473	337	4	r	r	NOUN
bjos-8668473	337	5	,	,	PUNCT
bjos-8668473	337	6	balgley	balgley	PROPN
bjos-8668473	337	7	bm	bm	PROPN
bjos-8668473	337	8	,	,	PUNCT
bjos-8668473	337	9	boontheung	boontheung	VERB
bjos-8668473	337	10	p	p	PRON
bjos-8668473	337	11	,	,	PUNCT
bjos-8668473	337	12	bundy	bundy	PROPN
bjos-8668473	337	13	jl	jl	PROPN
bjos-8668473	337	14	,	,	PUNCT
bjos-8668473	337	15	cargile	cargile	ADJ
bjos-8668473	337	16	bj	bj	NOUN
bjos-8668473	337	17	,	,	PUNCT
bjos-8668473	337	18	et	et	PROPN
bjos-8668473	337	19	al	al	PROPN
bjos-8668473	337	20	.	.	PUNCT
bjos-8668473	338	1	systematic	systematic	ADJ
bjos-8668473	338	2	comparison	comparison	NOUN
bjos-8668473	338	3	of	of	ADP
bjos-8668473	338	4	the	the	DET
bjos-8668473	338	5	human	human	ADJ
bjos-8668473	338	6	saliva	saliva	NOUN
bjos-8668473	338	7	and	and	CCONJ
bjos-8668473	338	8	plasma	plasma	NOUN
bjos-8668473	338	9	proteomes	proteome	NOUN
bjos-8668473	338	10	.	.	PUNCT
bjos-8668473	339	1	proteomics	proteomic	NOUN
bjos-8668473	339	2	clin	clin	PROPN
bjos-8668473	339	3	appl	appl	PROPN
bjos-8668473	339	4	.	.	PROPN
bjos-8668473	340	1	2009	2009	NUM
bjos-8668473	340	2	jan;3(1):116	jan;3(1):116	PROPN
bjos-8668473	340	3	-	-	PUNCT
bjos-8668473	340	4	34	34	NUM
bjos-8668473	340	5	.	.	PUNCT
bjos-8668473	340	6	doi	doi	NOUN
bjos-8668473	340	7	:	:	PUNCT
bjos-8668473	340	8	10.1002	10.1002	NUM
bjos-8668473	340	9	/	/	SYM
bjos-8668473	340	10	prca.200800140	prca.200800140	PROPN
bjos-8668473	340	11	.	.	PROPN
bjos-8668473	340	12	34	34	NUM
bjos-8668473	340	13	.	.	NOUN
bjos-8668473	340	14	rifai	rifai	PROPN
bjos-8668473	340	15	n	n	CCONJ
bjos-8668473	340	16	,	,	PUNCT
bjos-8668473	340	17	gillette	gillette	PROPN
bjos-8668473	340	18	ma	ma	PROPN
bjos-8668473	340	19	,	,	PUNCT
bjos-8668473	340	20	carr	carr	PROPN
bjos-8668473	340	21	sa	sa	PROPN
bjos-8668473	340	22	.	.	PUNCT
bjos-8668473	340	23	protein	protein	NOUN
bjos-8668473	340	24	biomarker	biomarker	NOUN
bjos-8668473	340	25	discovery	discovery	NOUN
bjos-8668473	340	26	and	and	CCONJ
bjos-8668473	340	27	validation	validation	NOUN
bjos-8668473	340	28	:	:	PUNCT
bjos-8668473	340	29	the	the	DET
bjos-8668473	340	30	long	long	ADJ
bjos-8668473	340	31	and	and	CCONJ
bjos-8668473	340	32	uncertain	uncertain	ADJ
bjos-8668473	340	33	path	path	NOUN
bjos-8668473	340	34	to	to	ADP
bjos-8668473	340	35	clinical	clinical	ADJ
bjos-8668473	340	36	utility	utility	NOUN
bjos-8668473	340	37	.	.	PUNCT
bjos-8668473	341	1	nat	nat	PROPN
bjos-8668473	341	2	biotechnol	biotechnol	NOUN
bjos-8668473	341	3	.	.	PUNCT
bjos-8668473	342	1	2006	2006	NUM
bjos-8668473	342	2	aug;24(8):971	aug;24(8):971	NOUN
bjos-8668473	342	3	-	-	SYM
bjos-8668473	342	4	83	83	NUM
bjos-8668473	342	5	.	.	PUNCT
bjos-8668473	343	1	doi	doi	NOUN
bjos-8668473	343	2	:	:	PUNCT
bjos-8668473	343	3	10.1038	10.1038	NUM
bjos-8668473	343	4	/	/	SYM
bjos-8668473	343	5	nbt1235	nbt1235	NOUN
bjos-8668473	343	6	.	.	PUNCT